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Abstract        
 
Diet and other lifestyle factors play a critical role in the risk of developing many 
diseases. Metabolic profiles contain a wealth of biochemical and physiological 
information and are influenced by various factors such as gender, age, BMI or genetic 
background. Diet is an important factor, and long-term dietary habits as well as short-
term food challenges influence the metabolic phenotype. Metabolic profiling 
technology can be used to discover novel single or combination biomarkers of food 
intake. To aid personalised healthy lifestyle recommendations, it is necessary to 
characterise the metabolic phenotype of individuals and to establish the extent to 
which we can beneficially influence this phenotype by nutritional intervention.  
This thesis aims to evaluate metabonomics as a tool for systematically detecting 
metabolites related to inter-individual and food-related differences. In order to address 
these aims a nutrition study was undertaken, where individuals followed a strict diet 
regime consuming a standard diet including specific food challenges, spot urine 
collections were made throughout the study period. 1H NMR spectroscopy was 
performed to generate urinary metabolic profiles, which were subsequently analysed 
and interpreted using multivariate mathematical modelling methods.   
Clear metabolic signatures pertaining to the consumption of specific dietary 
components and ‘biomarker’ metabolites associated with particular foods were 
extracted. Further validation of a potential biomarker was undertaken interrogating a 
large-scale epidemiologic dataset, the INTERMAP Study.  
Inter-individual variation in the metabolic profile was observed, both in relation 
to differences in response to food ingestion and metabolic differences independent 
from immediate food ingestion. Among these alterations were metabolites originating 
from gut microbial-mammalian co-metabolism. The influence of the gut microbiota on 
the metabolic phenotype and obesity was further investigated using microbially 
modulated murine models.  
This thesis characterises the effects of the interaction of diet and microbial 
metabolism on the metabolic phenotype and provides a template for assessing 
complex dietary interventions with respect to beneficially modulating metabolism.  
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CHAPTER 1: General introduction 
 
The human body is composed of millions of cells that are assembled in a highly 
organised and specialised apparatus. Metabolic processes ongoing in the body for the 
purpose of development, reproduction and survival are the result of a complex 
interplay of chemical reactions in different organs, and require external influences such 
as energy supply and environmental factors. These chemical processes are summarised 
under the term “metabolism”. At the beginning of every metabolic process, our 
inherited genes are transcribed into RNA and translated into proteins. The end of this 
systems biology cascade concludes with metabolites: small molecules that act as 
intermediates and products of metabolism. In recent years OMICS techniques have 
been developed to generate a holistic overview of metabolism from start to finish and 
characterise each of these stages.  
 
Holistic Molecular Biology: the ‘omics  
Several techniques have been developed to monitor metabolic processes at all levels of 
molecular biology. These include: genomics to describe the whole gene-pool [1], 
transcriptomics to monitor all RNA [2], proteomics to assess all proteins in a given 
system [3] and finally metabonomics, the “quantitative measurement of the dynamic 
multiparametric response of living systems to pathophysiologic stimuli or genetic 
modification” [4]. The development of these core technologies enabled the 
development of new disciplines in molecular biology such as nutrigenomics (the 
application of high-throughput genomic tools in nutrition research [5]) and 
metagenomics (the study of genetic material from environmental samples, also 
referred to as ecogenomics or community genomics [6]), and illustrated the necessity 
for development of other molecular biological areas such as epigenetics (the study of 
temporal and spatial control of gene activity [7]). The integration of data across OMICS 
platforms is a challenging research field and includes the integration of transcriptomics 
and metabonomics [8], genomics and proteomics [9] or virtually any other possible 
combination of the above mentioned disciplines. Metabonomics is particularly useful as 
it describes the metabolic endpoints and enables scientific research in a top-down 
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systems biology approach. Metabonomics, or metabolite profiling, and its use for 
biomarker identification in health and disease is the primary focus of this thesis and will 
be explained in greater detail herein.  
 
Metabolite profiling for the identification of novel biomarkers 
Metabolic profiling can be performed in either a targeted or untargeted fashion. The 
utility of the latter approach has proven in identifying novel biomarkers for health and 
disease states [4]. It has been first applied to monitor changes in urinary and plasma 
metabolites after external and disease stimuli in humans [10] and further developed for 
the discovery of toxicity biomarkers in rodent models [11]. Since then, metabolite 
profiling has been extended to the studies of e.g. nutrition [12], cancer [13], drugs [14], 
epidemiology [15] and parasitology [16]  in various biological systems such as bacteria 
[17], plants [18], C. elegans [19], rodents [20], pigs [21], and humans. NMR-based 
metabolic profiling provides an unbiased, untargeted representation of the metabolic 
composition of a given biological matrix and requires minimal sample preparation. Its 
use in conjunction with the application of multivariate analysis (chemometrics) has 
proven to be a powerful tool for the detection of novel biomarkers [22].  
Specifically in humans, extensive metabonomics-based research has been carried out 
to characterise disease aetiologies, the impact of diet and the metabolic variations 
introduced by diurnal cycles, gender, age, eating habits and gut microbiota [23-26]. 
These influences impact significantly on the metabolic phenotype of an individual.  
 
The metabolic phenotype 
Historically, the “phenotype” refers to observable properties of an organism resulting 
from the expression of genes under environmental influences, whereas the 
“genotype” refers to an organisms’ actual inherited genetic information. In the past, 
most clinical and nutritional studies were limited to monitoring only a small number of 
parameters. We can now extend this “phenotype” to observations collected from 
proteomics, metabonomics, anthropometry and from psychological and behavioural 
measurements [27]. The comprehensive integration of the whole “new” phenotype 
can give us additional knowledge of systemic changes, pathway relationships, a 
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broader understanding of metabolism and the discovery of new predictive biomarkers 
for health and disease. The metabolic phenotype in this thesis refers to the biochemical 
composition of biofluids under investigation that provides insight into metabolic 
processes occurring in the body.  
For this approach, it is important to analyse appropriate biofluids and tissues according 
to the research question in mind. Most metabolic processes occur in the liver, as the 
central organ for macronutrient modifications. Plasma is the central biofluid for 
metabolite transport between the locations of metabolite production, consumption 
and degradation, and serves as a transport system for signalling molecules. It is, 
however, under tight homeostatic control: changes in plasma are often dependent on 
an immediate stimulus (e.g. fasting vs. fed) or appear when disregulation of 
metabolism is already pronounced. Urine provides a broader overview of metabolic 
processes that occur in the body and also includes gut microbial-mammalian co-
metabolites that have been co-absorbed with nutrients. However, as urine is a waste 
biofluid, it is challenging to clearly link metabolite levels to metabolic processes 
occurring in the body. For specific analysis of gut microbial metabolic activity it is useful 
to add analysis of faeces and other samples collected from gut compartments.  
 
Our extended genome: the microbiota  
Mammals are composed of ~1013 cells which accomplish diverse functions depending 
on their differentiation in embryogenesis. In addition to this highly organised and 
specialised mammalian cell cluster, the body is inhabited by ~1014 bacterial cells that are 
mainly found in the digestive tract, vaginal tract and on skin surfaces [28]. This 
coexistence/cohabitation is characterised by a host-microbe mutualism [28], where 
benefits occur in both directions. In the digestive tract, microbes take over various 
physiological functions such as vitamin synthesis, immunological functions, influence 
on proliferation and differentiation of intestinal cells, pH modulation, pathogen 
responses and fermentation of host-indigestible food [29-33].  
The bacterial species’ distribution changes significantly in quantity and variety from 
oesophagus to rectum [34]. The stomach is inhabited by mainly Lactobacilli and 
Helicobacter pylori (density < 102), the ileal microbiota is dominated by Bacilli, 
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Streptococcacaeae, Actinobacteria, Actinomycinaeae and Cornebacteriacaeae (density: 
104-107) and predominant species in the colon are Bacteroidetes, Clostridia and 
Bifidobacteria (density: 1010-1012).  
This distribution of bacterial species is influenced by compartment pH, nutrient 
availability, oxygen availability and gut structure. However, instead of a continuous 
longitudinal distributional change in the populations, it is assumed that microbes 
occupy specific ecological niches. This niches theory assumes a pattern of patchiness of 
mucosal bacteria, rather than a homogeneous gradient [35]. In this patchwork, bacteria 
are influenced by diet, genotype and microbial interactions [36]: macronutrient 
composition, e.g. high-fat diet, is known to affect the microbiome [37, 38],  specific 
dietary ingredients have particular effects on the growth of specific bacteria,  dietary 
sulphate affect sulphate-reducing bacteria [39] and probiotics influence Bifidobacteria 
[40]. Genotypic influences are introduced for example through immunological 
parameters, i.e. major histocompatibility complex [41], and production of attachment 
sites for specific bacterial species [42]. Furthermore, microbial species influence and 
depend on each other (e.g. cross-feeding), where some bacteria ferment 
polysaccharides and others metabolise the formed oligo- or monosaccharides [43, 44]. 
Some species can also modify pH, thus affecting the habitability of the niche of other 
residents [45] and many species are capable of producing toxins which can affect the 
surrounding microbial population [46]. External influences on the microbiota 
composition are introduced via the host by nutrition, antibiotics use, infection, stress, 
hygiene, and drugs [47-49].  All these alterations in the microbiome feed back on host 
health and can impact the development of allergies [50], inflammatory bowel disease 
[51, 52] and obesity [53, 54].  
 
Interactions between host and gut microbiota  
The gut microbiota have been recognised to play an important part in nutrient 
digestion. Fermentation of indigestible fibre decreases the intestinal pH and provides 
energy to the host by production of e.g. short-chain fatty acids (SCFA). The 
degradation of polyphenols and fibre to benzoic acid can be seen in excretion of 
hippurate (i.e. glycine-conjugated benzoic acid) with urine. Protein and choline 
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escaping host digestion processes are fermented to phenols (i.e. p-cresol, indole and 
phenylacetate) and methylamines, which are metabolites usually seen in urine. These 
metabolites have a toxic potential and are therefore excreted with urine, while other 
metabolites such as SCFA are used as energy source for the host and therefore usually 
not seen in urine. The mechanisms and to what extend microbiota-derived products 
affect the host are only partly understood: SCFA, peptidoglycan, lipopolysaccharides 
and possibly other microbiota-derived metabolites act as signalling molecules and can 
affect inflammation processes among others  [55]. A shift in the ratio of aerobes : 
anaerobes, caused by increased intestinal ammonium in kidney disease, can increase 
the production of indoxylsulphate [56]. The microbiota profile was shown to be 
influenced by dietary habits (i.e. high fibre diets), which in turn has an influence on 
intestinal SCFA composition and energy harvest from indigestible fibre [57].  
Metabolite profiling is a tool to enhance the understanding of cross-talk mechanisms 
that exist between the gut microbiome and the host metabolome and to characterise 
the interaction of diet and gut microbiota on host metabolism.  
 
 All humans are different  
It is well documented that defined population groups have different dietary needs. For 
example, a diet high in carbohydrates and starch is not recommended for people with 
insulin resistance [58], yet is beneficial for athletes who need to store readily available 
energy in muscle [59]. On the same note, high-protein diets are detrimental to 
metabolic programming in infants [60], but adjuvant for the preservation of muscle 
mass in the elderly [61]. In a less group-defined way, every person has specific needs in 
terms of nutritional supply and dependent on intrinsic and extrinsic factors, which all 
influence their metabolism (Figure 1). Accurate characterisation of the metabolic 
phenotype and discovery of novel biomarkers for such descriptions and evaluation of 
dietary, microbial and other external influences are crucial when aiming to make 
appropriate dietary, lifestyle or medical recommendations [62]. For this approach, it is 
necessary to be able to define this metabolic phenotype and predict how the 
phenotype will change after an intervention [63] or what interventions and lifestyle 
alterations are necessary to achieve a set metabolic goal [64].  
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Figure 1 Scheme of intrinsic and extrinsic influences on the metabolic phenotype (adapted from [65]). 
 
Objectives and project aims  
The aim of this thesis is to investigate the metabolic phenotype using NMR-based 
metabolic profiling techniques. Special interests are directed to phenotype alterations 
by nutritional influences, independent and dependent of inter-individual differences. 
The influence of gut microbiota and obesity on the metabolic phenotype of a specific 
disease model, the ob/ob mouse with a synthetic defined microbiota, is also 
investigated.  
 
Specific research aims are as follows:    
- Description of the metabolic phenotype of selected number of people under a 
dietary regimen 
- Elucidation of immediate dietary influences on the metabolic phenotype and 
evaluation of its use as biomarkers 
- Validation of potential food biomarkers in a large-scale population study and 
relation to overall lifestyle and health parameters   
- Investigation of intrinsic and food-related inter-individual differences  
- Investigation of individual differences introduced by the gut microbiota  
- Metabolic description of an obesity model, the ob/ob mouse  
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- Investigation of the influence of a defined microbiota on the metabolic profiles 
of wildtype and ob/ob animals  
 
An outline of the thesis can be seen in Figure 2.  
 
Figure 2 Flowchart of the thesis structure. 
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CHAPTER 2: Methods and analytical strategies 
 
2.1  Nuclear magnetic resonance (NMR) spectroscopy  
NMR spectroscopy is a powerful tool for detecting, identifying and quantifying a wide 
range of high and low molecular weight compounds without any prior selection and 
without the necessity for extensive sample preparation. Furthermore, it provides 
invaluable information about the detailed molecular and chemical structure of the 
measured compounds. The theory of NMR spectroscopy is well documented in various 
books [66-68] and is therefore only briefly introduced here.  
 
2.1.1  Fundamental principles of NMR spectroscopy 
NMR spectroscopy takes advantage of the fact that certain nuclei possess a spin, 
besides their mass and charge. Spin is characterised by a quantum number I and nuclei 
with I > 0 are NMR-active. For example, the elemental isotopes 1H, 13C, 19F and 31P all 
have a nuclear spin of I = ½.  
The nucleus has a magnetic moment (μ), created by the spinning charge. When placed 
in a magnetic field (B0) it experiences a torque which results in the axis of the spin 
precessing about the axis of B0 in one of 2(I) + 1 allowed orientations. For nuclei with I = 
½, there are two spin states +½ and -½ and these can be considered as parallel to the 
external magnetic field (lower energy state) and anti-parallel (higher energy state) to 
it. The difference in energy between these two states is related to the strength of the 
external magnetic field. Therefore, NMR spectroscopy typically profits from strong 
magnetic fields. In a sample at thermal equilibrium, there will be an excess of spin in 
the lower energy level which leads to a bulk magnetisation (M) of the sample. In what 
is known as the vector model, we can imagine M along the z-axis in a xyz-coordinate, 
where z is aligned along the magnetic field Bo (Figure 3). By applying a pulse of the 
correct energy, a linear oscillating magnetic field with a defined radiofrequency energy, 
the nuclei in the lower energy levels are excited to the high energy level spin state. The 
pulse is used to tilt M away from the z-axis and after the duration of the pulse, M will 
precess back to z, i.e. nuclei relax and return to their Boltzmann equilibrium, thereby 
inducing an oscillating voltage (Figure 3). This oscillating voltage is recorded in a 
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detector coil placed along the x or y axes. A typical frequency for 1H observation is 600 
MHz at a B0 field of 14.1 Tesla.   
 
 
 
Figure 3 Illustration of the effect of a radiofrequency pulse on bulk magnetisation M in a vector 
representation model. M is aligned along the z axis, which is the direction of the external magnetic field. 
By applying a pulse along y, M is tilted away towards x axis. The magnetisation vector precesses around z 
inducing an oscillating voltage in a detector coil along x or y. 
 
The measured NMR signal is known as a Free Induction Decay (FID) and is measured by 
the detector coil in the NMR probe, where the sample is placed. The time it takes to 
return to the initial spin distribution is known as the spin-lattice or longitudinal 
relaxation (T1) and generally is in the order of magnitude of a few seconds. There is a 
second relaxation process that occurs in the xy (transverse) plane called spin-spin or 
transverse relaxation (T2) and is often described as a loss of phase coherence between 
individual spins and also reduces the net magnetisation. The measured FID is 
transformed from a time domain into a frequency domain, by applying a Fourier 
Transformation (FT), and thus the typical NMR spectrum is obtained. In order to 
improve the signal-to-noise in a spectrum, the experiment is repeated many times, and 
the FIDs summed.  
 
2.1.2  1H NMR spectral parameters 
Not all nuclei of the same type (e.g. 1H) have the same NMR resonance frequency. This 
is because every proton in a compound is surrounded by an electron cloud and these 
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electrons create a secondary magnetic field, which introduces a nuclear shielding 
effect. The stronger the shielding is, the more the resonance signals get shifted 
towards higher fields. The chemical shift is the position at which a signal resonates. For 
example, protons in a benzyl ring are less shielded than protons in saturated alkanes; 
and their resonances can therefore be found in the area ~6-8 ppm (benzyl ring) 
compared to ~0.5-2 ppm (saturated alkanes). Chemical shifts are displayed in parts per 
million (ppm) from that of a reference compound. To anchor the chemical shift, a 
reference compound (e.g. deuterated TSP, trimethylsilylpropionic-d4-acid sodium salt) 
is normally added to the sample as a standard. The single resonance from that 
compound is then adjusted to δ 0.00 (see Figure 4). The chemical shift in ppm is 
independent of the strength of the applied magnetic field; however, the peak 
dispersion increases with higher fields and therefore the resolution of the resonances 
improves.  
 
 
Figure 4 1H NMR chemical shifts of different chemicals with their chemical shifts (δ) referenced relative 
to TSP δ=0.00, adapted from1. 
 
Different resonances in the spectrum can be seen with different intensities which are 
related to (i) the concentration of the compound and (ii) the number of protons that 
give rise to that signal. Therefore, NMR can be quantitative, if the experiment is carried 
out appropriately.  
                                                        
1 http://www.cem.msu.edu/~reusch/OrgPage/Images/nmr1.gif 
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When two non-equivalent protons are only separated by a few bonds, their nuclear 
spins can interact with each other. This phenomenon is called spin-spin-coupling or J-
coupling and results in a splitting of the NMR signal. The magnetic moment of a given 
nucleus influences the nuclei nearby by transmission of the effect through the 
electrons in the intervening bonds. This coupling is characterised by its coupling 
constant J, measured in Hertz, which is the frequency difference between the two lines 
(for a doublet, for example). J is independent of B0.   
The main parameters obtainable from a NMR spectrum are the chemical shifts of the 
various distinct nuclei and the spin-spin couplings.  
Furthermore, the relaxation time is dependent on the size and mobility of a molecule, 
and is affected by molecular tumbling. This property is used to remove the signals from 
large molecules by using a short relaxation time in Carr-Purcell Meiboom-Gill (CPMG) 
experiment [69, 70]. First, a 90° pulse creates transverse magnetisation, followed by a 
spin-echo period (delay-180°-delay), where the decay of transverse magnetisation is 
determined. By selecting an appropriate delay time, large molecules (with fast T2 
relaxation) will not be recorded in the FID. In alternative manner, small molecules will 
diffuse rapidly and this property can be used to advantage in a diffusion-edited 
spectrum where resonances from such small rapidly moving molecules will be 
attenuated [71].  
 
2.1.3  Magic angle spinning (MAS) spectroscopy 
High resolution MAS NMR spectroscopy enables the analysis of solid samples and 
biological tissues. The main challenge of solid-state NMR spectroscopy is the line 
broadening caused by the limited and often anisotropic molecular motion. In liquids, 
the two NMR parameters chemical shift anisotropy and dipolar interactions are zero 
because of the isotropic motion, i.e. the tumbling of the molecule averages these 
effects out, resulting in the typical sharp observed resonance peaks. In tissue samples, 
which do not allow the molecules to have rapid isotropic motion, the resonances in 
their NMR spectrum are broadened by the partially averaged set of anisotropic 
interactions such as non-zero chemical shift anisotropy and dipolar interactions. Thus 
the problem is overcome by the use of MAS NMR, where the tissue sample is spun at 
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~5000 Hz and placed in a rotor at an angle (“magic angle”) of 54.7° to the magnetic 
field [72, 73]. This causes the main line broadening factors, dipolar interactions and 
anisotropy, to be averaged out, and therefore the resulting chemical shift spectrum will 
be more similar to liquid state spectra.  
 
2.1.4  Two-dimensional (2D) NMR spectroscopy  
Two-dimensional (2D) NMR spectroscopy has been used for assignment purposes in 
this thesis. This spreads the spectral peaks into two frequency dimensions and hence 
increases spectral dispersion, and also allows connectivities of signals between 
neighbouring nuclei to be observed. Two approaches were used: 1H-1H homonuclear 
and 1H-13C heteronuclear experiments. All 2D experiments involve preparation and 
mixing steps in the pulse sequence, where the sample is subjected to a series of pulses, 
and evolution and detection periods, in which the magnetisation precesses. The 
detection period produces one time-domain data set from the FID, which can be 
Fourier transformed yielding one frequency axis. The evolution step repeats 
experiments sequentially; each experiment has a slightly longer time period than the 
one before it to create a second time-domain. This produces the second frequency axis. 
Below is a short description of each 2D experiment used in this thesis. 
 
COrrelation SpectroscopY (COSY) 
The COSY experiment correlates J-coupled spins [74] of neighbouring nuclei. Both 
frequency axes contain chemical shifts and the cross-peaks in the 2D spectrum indicate 
which nuclei are coupled and this provides structural information. The magnetisation is 
transferred from one spin to its J-coupled partner in a process known as coherence 
transfer.  
 
TOtal Correlation SpectroscopY (TOCSY)  
TOCSY correlates spins over a larger range than COSY when they are involved in an 
unbroken chain of couplings, and thus can provide information on spins up to 5 or 
more bonds apart, as well as directly connected spins. It can therefore be seen as an 
extension providing additional information compared to COSY [75].   
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J-Resolved (JRES) spectroscopy 
This experiment gives coupling and multiplicity information [76]. It is formed of an 
array of spin-echo pulse elements, in which an incremented delay period is used to 
define a second frequency dimension. After data processing, the chemical shift and J-
coupling information are resolved on two orthogonal axes, allowing one to clearly 
observe the multiplicity of peaks and chemical shift, and allowing a direct measurement 
of coupling constants. It works best for small molecules since it is a spin-echo 
experiment and for first-order spin systems as second order effects can give rise to 
spurious peaks.  
 
Heteronuclear Single Quantum Coherence (HSQC) 
This experiment allows the correlation of 1H and 13C resonances via their CH couplings 
and hence to correlate directly bound 1H-13C heteronuclear groups [77]. This experiment 
can also be adapted to other heteronuclear groups, such as 1H-15N.  
 
Heteronuclear Multiple Bond Correlation (HMBC) 
This technique correlates coupled spins of two types of nuclei (typically 1H and 13C) 
across multiple bonds [78].  1H and 13C chemical shifts are correlated based on their 
mutual long range J couplings, typically over 2 to 4 bonds. 
 
2.1.5  NMR acquisition parameters 
 
2.1.5.1  Biofluid 1H NMR experiments  
1H NMR spectra were acquired on a Bruker 600 MHz Spectrometer (Bruker Biospin, 
Rheinstetten, Germany) operating at 600.29 MHz. For an overview of all molecules 
present in the sample under investigation, a standard 1-dimensional (1D) pulse 
sequence [recycle delay (RD)-90°-t1-90°-tm-90°-acquire FID] was acquired, with water 
suppression irradiation during RD of 2 s, mixing time (tm) set on 100 ms and a 90° pulse 
set to 10 μs, using 128 scans into 32 K data points with a spectral width of 12,000 Hz. A 
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single 1H NMR spectrum was acquired on a Bruker 950 MHz Spectrometer, operating at 
950.12 MHz, see chapter 3.5.1.   
To remove the broad signals of large molecules in tissues and plasma samples, and get 
a clearer signal for smaller molecules in the sample, a CPMG pulse sequence [RD-90°-(τ-
180°-τ)n - acquire FID] with a spin-spin relaxation delay (2nτ) of 240ms (n=600 loops, 
τ=200µs) for tissue samples and 64ms (n=160 loops, τ=200µs) for plasma samples  
were carried out. For all spectra the sum of 128 free induction decays (FIDs) were 
collected into 32 K data points with a spectral width of 12,000 Hz.  
 
2.1.5.2  High-resolution MAS-NMR  
All 1H MAS NMR spectra were acquired using a Bruker DRX600C spectrometer (Bruker 
Biospin, Rheinstetten, Germany), operating at a temperature of 283K, a spin rate of 
5000 Hz, and a 1H NMR frequency of 600.11 MHz using a MAS probe. Standard 1D pulse 
sequence, CPMG pulse sequence and 2D NMR experiments were acquired as specified 
in chapter sections 2.2.1 and 2.2.3.  
 
2.1.5.3  Two-dimensional (2D) NMR experiments  
The 2D 1H-1H NMR spectra were performed on selected samples for metabolite 
identification purposes on Bruker 800MHz or 600MHz spectrometers (Bruker Biospin) 
operating at 800.32 MHz and 600.22 MHz respectively with a cryoprobe for improved 
sensitivity, using standard 2D correlation spectroscopy (COSY) and total correlation 
spectroscopy (TOCSY) pulse sequences. 2D 1H-13C NMR spectroscopy was performed 
using the heteronuclear single quantum coherence (HSQC) method and heteronuclear 
multiple bond (HMBC) method.  
J-resolved (JRES) 1H NMR spectra were acquired with the pulse sequence [d1-90°-τ-180°-
τ-acquire FID], with suppression of the water resonance during d1 (2s) into 4K data 
points in F2 and 8 transients using 32 increments of τ; the spectral widths in F2 and F1 
were 16 384 and 64 Hz, respectively. 
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2.1.6  Spectral processing  
Processing of the spectra was carried out in TopSpin 2.0 (Bruker). FIDs were multiplied 
by an exponential decaying function corresponding to a line broadening of 0.3 Hz 
before Fourier transformation. All spectra from urine, gut content aqueous extracts 
and beverage samples were manually phased, baseline corrected and calibrated to TSP 
(δ  0.00), or to the α-anomeric proton signal of α-glucose (δ 5.23) for plasma, foods and 
tissue samples. The data were exported into Matlab with a resolution of 0.00025 ppm 
and a sweep width of 0.5 – 9.5 ppm. Then, the water region (δ 4.8 – 5.1) was removed 
to eliminate the impact of water suppression. For human urine samples, a region of δ 
4.54 – 6.35 was removed to eliminate both water and urea, as the urea resonance is 
also influenced by water suppression, due to chemical exchange with water. 
 
2.2  Biofluid and tissue sample preparation for 1H NMR analysis 
1H NMR spectroscopy has been widely applied to the analysis of biofluids and tissues. 
This analysis provides a wealth of information on the chemical composition of the 
biological matrix, and this is invaluable for monitoring biochemical and physiological 
processes in living systems. So far, biofluids such as urine, plasma, cerebrospinal fluid 
[79], saliva [80], amniotic fluid [81], seminal fluid [82] and bile [83] have been 
investigated. Furthermore, the NMR metabolic profiles of liver [84], kidney cortex and 
kidney medulla [85], different parts of the intestine [86], brain [87], breast [88], 
prostate [89] and many others are described. In addition, aqueous or lipid extracts can 
be prepared from stool and tissue samples. Depending on the biological question and 
the ease of system access, the biological matrix of investigation is chosen. The biofluids 
urine and saliva and stool samples are easiest to collect, followed by plasma. For most 
other fluids, invasive technology is necessary. In addition, for all interior organs, 
surgery or biopsy is necessary. Therefore, the biological matrices of choice for the 
investigation of processes in healthy individuals are urine, plasma and faecal water 
extracts.  
Sample preparation for NMR spectroscopy is minimal. As NMR chemical shifts are 
susceptible to pH variation, the sample needs to be pH-adjusted by buffering, a 
reference compound such as TSP and a locking substance (D20) need to be added to 
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the solution. The sample preparation procedures for each biological matrix used in this 
thesis are described below.  
 
2.2.1  Human urine samples 
An aliquot of 500 μL for each urine sample was mixed with 250 μL  50mM phosphate 
D2O buffer (20% D2O, pH 7.4) containing 0.05% TSP. Samples were vortexed and 
centrifuged for 5 min at 16,000 g. Afterwards, 600 μL of the supernatant was 
transferred into 5 mm outer diameter NMR tubes for analysis by NMR spectroscopy.  
 
2.2.2  Fruit juices and beverages 
An aliquot of 500 μL of each fruit juice or wine was mixed with 250 μL of 50 mM 
phosphate D2O buffer (20% D2O, pH 7.4) containing 0.05% TSP. Samples were vortexed 
and centrifuged for 5 min at 16,000 g and 600 μL of the supernatant was transferred 
into 5 mm outer diameter NMR tubes. 
 
2.2.3  Murine urine samples  
An aliquot of 30 μL for each urine sample was mixed with 20 μL 50 mM phosphate 
buffer (90% D2O, pH 7.4) containing 0.05% TSP. Samples were vortexed and centrifuged 
at 16,000 g and the supernatant transferred into 1.7 mm NMR tubes . 
 
2.2.3  Murine plasma samples 
An aliquot of 150 μL plasma was mixed with 400 μL 90% saline buffer (0.9% NaCl). 
Samples were vortexed and centrifuged for 5 min at 16,000 g and transferred into 5 
mm NMR tubes. The total available volume of some plasma samples was less than 150 
μL; in these cases an excess of saline buffer had to be used. The dilution effect was 
accounted for by later normalisation of the spectra.  
 
2.2.4  Murine gut content and faeces pellet aqueous extract 
Extraction was performed by suspending 1 pellet of faeces or the equivalent volume of 
gut content in 600 μL 95% D2O phosphate buffer. The suspension was vortexed and 
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sonicated for 30 mins. After centrifugation (10 min at 16,000 g), the supernatant was 
centrifuged again and the final supernatant was transferred into 5 mm NMR tubes.  
 
2.2.5  HR-MAS NMR for food spectra, and murine liver and kidney samples 
For all HR-MAS analyses, a small piece of sample (~15 mg) was excised and placed in a 
zirconium oxide MAS rotor, to which a drop of saline D2O (0.9% NaCl) was added.  
  
2.3  Chemometrics analysis 
1H NMR spectroscopy of biological samples creates a massive amount of data. These 
metabolic profiles of biological matrices have to be expressed in a comprehensive way; 
therefore it is necessary to use data reduction and mathematical modelling tools to 
characterise the data. Physiological and pathological factors influence the metabolic 
profiles. Strong metabolic stimuli are introduced by e.g. disease and drug treatment 
and weaker responses are expected with variation in gender, age, diurnal variation and 
nutritional stimuli. With multivariate data analysis it is possible to summarise latent 
information from a high-dimension dataset in fewer dimensions. For this approach, 
both unsupervised and supervised pattern recognition, such as Principal Component 
Analysis (PCA) and Partial Least Squares (PLS) analysis methods have been used. 
Supervised pattern recognition is necessary when the stimulus is weak, such as in a 
nutritional intervention. In unsupervised pattern recognition no prior information on 
grouping or classification is known, while in supervised pattern recognition the 
statistical model is designed to find maximal variation describing the class information 
given in a Y matrix by using knowledge about the class or nature of the samples. These 
two methods are described in more detail in the chapter sections 2.3.2 and 2.3.3. 
 
2.3.1  Data pre-treatment 
 
2.3.1.1  Pre-processing the samples (normalisation) 
Normalisation is often necessary to account for different concentrations across a range 
of samples. As such, urine samples are subject to dilution effects and other samples, 
such as plasma, can show dilution effects when buffer : sample volume ratios vary. 
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Normalisation of NMR metabolite profile datasets can generally be done in multiple 
ways, the four most common being: (i) normalisation to TSP as internal reference, (ii) 
normalisation to creatinine, (iii) normalisation to total area and (iv) probabilistic 
quotient normalisation. The later normalisation calculates the median of quotients of 
all variables across the spectrum to a selected reference spectrum and divides each 
variable by this median [90]. Normalisation to TSP was not used in this thesis as urine 
samples have different dilution factors. Normalisation to creatinine is only 
recommended when 24-hr urine is collected, as creatinine is affected by diurnal 
changes and total area normalisation is susceptible to influences from highly 
concentrated molecules in a subset of samples. Therefore, probabilistic quotient 
normalisation was used for all biological matrices in this thesis. NMR chemical shifts are 
influenced by small resonance shifts introduced by variation of pH, salt concentration 
and other factors in the biofluid. Therefore, alignment of spectra is sometimes 
necessary. This alignment approach was carried out using a recently developed 
recursive segment-wise peak-alignment algorithm [91]. 
 
2.3.1.2  Pre-processing the variables (scaling) 
Prior to the application of any pattern recognition techniques, the variables also 
typically need to be pre-treated, using for example centring and scaling. 
Mean-centring is a common pre-processing tool that is used to take into account a 
possible intercept in the data. The average value of each variable across the NMR 
spectrum is calculated and subtracted from the data point for each 
observation/sample.   
Scaling of the data is usually done in one of two different ways. Firstly, unit-variance 
(UV) scaling can be applied, where each variable is divided by its standard deviation. 
This results in equal importance of each variable to the model, independent of its initial 
variance, which is often related to its magnitude. It ensures that low concentration 
molecules have the same contribution to the model as highly abundant molecules. As a 
drawback, it also increases the contribution of noise in the data, as signal-poor spectral 
areas will contribute in the same way as information-rich areas. The second approach is 
Pareto-scaling, where each variable is divided by the square-root of its standard 
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deviation. This scaling method serves as a compromise between no scaling and UV 
scaling. Molecules in high concentrations are reduced in their impact and lower 
concentration molecules increased, but to a smaller extent, hence the noise level 
remains manageable. However, the difference in impact of high and low concentrated 
metabolites is still present. Unless specified otherwise, multivariate analyses in this 
thesis were done using mean-centring and UV scaling.  
 
2.3.2  Unsupervised pattern recognition techniques: Principal component analysis 
(PCA) 
PCA is an unsupervised method that reduces the complexity of multivariate data and 
displays the information in fewer dimensions, with principal components as the new 
variables. Statistically, PCA tries to find lines, planes and hyperplanes to approximate 
the data as closely as possible by explaining the maximum amount of variance in the 
data for each successive component calculated. If we imagine each NMR metabolic 
profile as a point in an n-dimensional space (data matrix X), PCA analysis will project 
this data into a new coordinate system where the first latent variable summarises the 
largest variation across the samples, as illustrated in Figure 5.  
 
 
Figure 5 Graphic illustration of the principal component analysis projection method. The observations 
(here in red in a 3 dimensional space, left), are projected onto a 2-dimensional space (right), formed by 
the new principal components 1 and 2. 
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Successive components are calculated to be orthogonal to the prior component and to 
capture the maximal remaining variation. The data X is modelled as  
 
XPCA = 1*X ’ + T*P’ + E                                             (equation 1) 
 
Where 1*X ’ represent the variable averages (which are removed by mean-centering) 
and the second term (T*P’) is the PCA model, and E is the residual matrix, containing 
noise and residual variance. The matrix T contains the scores of the principal 
components (t1, t2, t3, etc.) and matrix P contains information on the loadings (p1, p2, 
p3, etc.) of the principal components. A 2D plot of T (e.g. t1 vs. t2) is called a scores plot 
and gives the coordinates of the observations/samples in the new model space. A 1D 
plot of P (e.g. p1) is called a loadings plot and shows the contributions of the original 
variables to the new axis (the loading).  
The PCA loadings plots in this thesis have been generated by back-scaling the loading P 
from a PCA with unit-variance or Pareto scaling. The back-scaled loading is obtained by 
multiplying the loadings by the standard deviation (UV) of the corresponding variable 
or its square root (Pareto) and is used as the shape of the plot, which resembles a 1D 
NMR spectrum; the orientation representing a positive or a negative contribution of 
the variable to the component. The squared values of the loading (correlations 
between data matrix X and the latent variables) are then used as a colour-code to 
highlight the strongest variable contributors. The value corresponding to the colour-
code combined with the sign of the covariance is directly related to the PCA loadings of 
the original data after scaling. 
PCA analysis is used to create an overview of the data and can reveal outliers, 
clustering and trends. Samples outside the 95% confidence interval were visually 
inspected throughout this thesis for technical errors (e.g bad water suppression) and 
excluded where appropriate. As a downside of PCA, this analysis focuses on the 
description of main variation in a dataset and is therefore particularly suitable for data 
from studies designed for introduction of one major influence. It is also susceptible to 
outliers, as they affect the projection of latent variables. This is especially a problem 
when dealing with small datasets where all samples are aimed to be kept in the model.  
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2.3.3  Supervised pattern recognition techniques: projection to latent structures 
(PLS)  
PLS is a supervised technique developed by Wold et al. [92] to find the relationship of 
two data matrices, X and Y, by linear multivariate modelling. PLS analysis can deal with 
large, incomplete, noisy, collinear datasets [93]. In PLS regression, in comparison to 
PCA, every observation has two sets of values. That is, one vector of values in the X 
matrix (e.g. spectral intensities) and one or more in the Y matrix (e.g. sample class or a 
continuous variable). The mathematical algorithm tries to describe the relationship 
between the positions of the observations in both the X-space and the Y-space. The 
first PLS component will then approximate the maximal variation in the X-space (eq. 2) 
that has a good correlation to the Y-space (eq. 3). The data X and Y is then modelled as 
following:  
 
 XPLS = 1*X ’ + T*P’ + E                                              (equation 2) 
YPLS = 1*Y ’ + U*C’ + F                                             (equation 3) 
T = X * w                                                                (equation 4) 
 
T and U are the new scores and the weights (w) combine the X variable to the scores T 
(eq. 4) and are also selected to maximise the correlation between t and u. The new 
latent variables can then be evaluated for their predictive ability with the parameters 
R2X, R2Y, and Q2Y. R2X is the percent of X variance explained by the model, R2Y is the 
percent of Y variance explained by the model and Q2Y is the cross-validated (e.g. 7-fold 
cross-validation) predicted percent of Y variance that is explained by the model. 7-Fold 
cross-validation is performed by dividing the dataset into 7 subsets, six of which will be 
used to build the model and the omitted subset is modelled, and used to validate its 
quality (i.e. produce cross-validated scores). After repeating this procedure 7 times, all 
data has been predicted once. A low or negative Q2Y indicates low predictive ability, 
which can be caused by over-fitting of the model. If the Y matrix is a group classifier, 
presented as a dummy matrix consisting of 0s and 1s rather than a continuous variable, 
the method is called PLS discriminant analysis (PLS-DA).  
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2.3.4  Supervised pattern recognition techniques: orthogonal projection to latent 
structures (O-PLS) 
Biological datasets often contain lots of variation irrelevant to the problem of interest 
such as due to gender, diurnal cycle, hormonal cycle, diet etc. When investigating 
effects of nutrition, the metabolic responses are very subtle and can be superimposed 
on larger inherent variation in the data. Therefore, it can be necessary to remove these 
confounding factors before nutritional effects can be extracted. To achieve this, an 
Orthogonal Signal Correction (OSC) filter [94, 95] can be applied within the PLS model, 
which separates systematic variation not related to the property of interest (described 
in the Y) into one or more components orthogonal to the predictive component 
containing the information related to the Y-matrix. This analysis is called orthogonal 
projection to latent structure (O-PLS) and the discriminant analysis (O-PLS-DA) version 
is widely used in metabonomics [96]. 
Similarly to PCA, the new latent variables in PLS or O-PLS can then be visualised by their 
cross-validated scores (Tcv) and their weights (w). The cross-validated scores are the 
scores that were predicted in the 7-fold cross-validation. Again, as the weights do not 
mimic the original shape of an NMR spectrum it is advantageous to back-scale the 
weights to their initial metric of the data and the PLS or O-PLS coefficient as a colour-
code superimposed on the covariance plot. In this way, the resonances from 
metabolites which most strongly influence the discrimination are highlighted in red. 
These plots are created with an in-house developed Matlab script according to the 
method described by Cloarec et al. [96]. 
 
2.4  Statistical TOtal Correlation SpectroscopY (STOCSY) 
STOCSY analysis takes advantage of the collinearity of the intensity variables in a set of 
spectra, so that correlations from resonances of the same molecule can be identified 
[97, 98]. The method calculates the correlation between a chosen individual data point 
in the 1H NMR spectrum, corresponding to the peak of interest, and all the other data 
points, and plots a 1D NMR spectrum with a colour-coding to show the correlation 
coefficients. The advantages of STOCSY over 2D spectroscopy methods include the 
visualisation of related resonances that would possess no spin-coupling. In principle, all 
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peaks from the same molecule are highlighted; however, this method performs 
suboptimally for overlapping peaks, which interfere with the correlation matrix [99]. 
Besides structural correlation, biological covariance can also result in correlation of 
resonances and therefore the STOCSY method can be helpful for metabolite 
assignment as well as for detection of different metabolites appearing at the same 
time (e.g. compound in the same biological pathway, excretion of metabolites from a 
food item).   
 
2.5  Investigation of excretion kinetics  
To compare the relative amount of urinary metabolite excretion between different 
food challenges and different volunteers, several peaks of each NMR spectrum were 
integrated using Matlab and plotted against sampling time. Thus, appearance of 
certain metabolites and their subsequent increased or decreased excretion can be 
monitored over time. 
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CHAPTER 3: Food-related variations in human metabolic profiles 
 
3.1  Summary 
This chapter focuses on the modulation of the urinary metabolome by food 
consumption and shows how urinary metabolites can be used as potential food 
biomarkers. A strategy is developed, that combines identification of potential 
biomarkers via untargeted metabolic profiling in nutritional intervention studies with 
validation in free-living populations. Subsequently, the validated food biomarkers are 
related to overall dietary intake and health parameters.  
 
 
3.2  Aims and Objectives 
 To investigate metabolic changes introduced by multiple short-term food 
challenges 
 To investigate the dietary origin of urinary metabolites that differ according to 
food challenge 
 To develop a strategy where metabolic profiling is used as a method to 
elucidate potential food biomarkers from human metabolite profiles 
 To validate a potential food biomarker in a large free-living population 
 To use the identified food intake biomarker as an external food-protocol 
independent measure for specific food intake and show a possible implication in 
health and disease 
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3.3  Introduction 
High resolution spectroscopic analysis, typically nuclear magnetic resonance (NMR) 
spectroscopy or mass spectrometry (MS), has been used to generate metabolic 
signatures from biological samples and to obtain complex profiles of a wide range of 
metabolite classes. Such metabolic profiles are influenced by gender, age, diurnal 
variation, menstruation cycle, physical activity, drugs, the gut microbiome and many 
other factors [65, 100]. Population-based studies have shown marked differences in 
metabolic profiles both within and between populations, reflecting in part dietary 
differences, which represent a key component of the complex interplay between 
environmental and genetic influences on disease risk [15]. Effects of specific dietary 
interventions on the metabolic phenotype have also been explored, including 
comparison of a high-meat versus vegetarian diet [101] and evaluation of the metabolic 
effects of various dietary components such as soy [102], cocoa [103], coffee [104], wine 
and grapes [105] and various teas [106, 107] have been shown to impact the metabolic 
phenotype. The technology has also been applied to the correlation of dietary 
preferences with metabolic phenotypes [108] and thus can be seen as a useful non-
invasive strategy to ascertain the impact of dietary intervention from a ‘systems 
biology’ approach.  
The metabolomes of different foods have been widely investigated using NMR and MS 
[109] to capture their composition [110-112], genetic variation [113], biological [114] and 
geographical origin [115, 116], ripening status [117] and aspects of food processing [118, 
119].   
Nutritional factors play a major underlying role in the causation of the global burden of 
chronic disease; specifically a healthy diet rich in fruit and vegetables is associated with 
lower rates of cancers, diabetes, cardiovascular diseases and related risk factors such 
as raised blood pressure and elevated serum cholesterol [120-125]. Recently, research 
focus has shifted from examining single nutrient relations with disease towards 
analysing complex nutrient interactions and dietary patterns to define a more holistic 
relationship between nutrition and associated diseases [126, 127]. A food pattern high 
in fruit, vegetables, fish, whole-grains and legumes shows inverse correlations with 
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features of the metabolic syndrome [128], risk of colorectal cancer [129], and adverse 
blood pressure and serum lipid profiles [124, 130, 131]. 
Such large-scale population studies crucially rely on good dietary assessment methods 
to describe each person’s food intake. Established methods are food-frequency 
questionnaires (FFQ), 24-hr dietary recall or food diaries; although these are subject to 
possible reporting bias such as over-reporting of healthy foods and under-reporting of 
energy-dense foods [132-134] and other biases [135]. Objective measures using 
biomarkers are needed both to validate dietary assessment and to check adherence to 
dietary recommendations and healthy eating patterns, but few such biomarkers are 
available [136, 137].  
Biomarkers can be divided into three groups, recovery biomarkers, predictive 
biomarkers and concentration biomarkers [138]. Recovery biomarkers include urinary 
nitrogen excretion as a gross biomarker of protein intake reflecting the nitrogenous 
end-point of catabolism [139]. Urinary sucrose and fructose are predictive biomarkers 
for assessing sugar consumption [140]. Concentration biomarkers such as fatty acids in 
adipose tissue give a good estimate of chronic dietary fatty acid composition [141, 142] 
and excretion of some vitamins and minerals have also been shown to positively 
correlate with dietary vitamin and mineral intake [143]. In order to be of practical use, a 
biomarker should be easy to identify, recover, quantify and validate, and additionally 
should not demonstrate strong inter-individual differences in metabolism. We 
therefore seek a new strategy for biomarker discovery, which can be applied in a high-
throughput screening mode to ensure the applicability in large-scale epidemiological 
studies. Development of robust food biomarkers may help to improve disease risk 
stratification by better characterising the metabolic phenotype at the individual level. 
Numerous studies addressing single food components or nutrients have been 
conducted in small scale laboratory studies but few have been translated into free 
living population studies.  
It is therefore of interest to identify a new strategy for biomarker discovery, which can 
be applied in a high-throughput screening mode to ensure the applicability in large-
scale epidemiological studies.  
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Here, a strategy for biomarker discovery for “healthy eating” in a high-throughput 
screening approach via 1H NMR spectroscopy is outlined. First, a nutritional 
intervention followed by metabolic profiling is carried out to elucidate potential food 
biomarkers. These biomarkers are then linked to the ingested food metabolome. 
Finally, nutritional intervention, metabolic profiling and biomarker cross-validation in 
large-scale epidemiologic data are combined.       
 
3.4.  Methods 
 
3.4.1 Nutritional intervention study: Experimental design  
To investigate the influence of food consumption on the metabolic phenotype of urine, 
a nutritional intervention study was undertaken. Urine was chosen as it is known that 
urine responds to external stimuli, whereas plasma is generally under tight 
homeostatic control and metabolite variation is generally lower that that observed in 
urine. The food challenge study presented herein involved 7 volunteers (6 females, 1 
male, 28-44 years, BMI 20-25 kg/m2) who consumed a standardised breakfast, lunch and 
dinner (Figure 6). The following diet plan was used and the “standard meals” adapted:  
 
 Breakfast: wholegrain bread and cheese 
 Mid morning: a cup of coffee or tea 
 Lunch: ham sandwich with wholegrain bread, ham, mayonnaise, lettuce, 
cucumber and red pepper) 
 Dinner: pasta with tomato sauce  
 
This standard diet was consumed for 7 days, from day 0 (run-in day) until breakfast on 
day 7. In addition to the standard dinner, supplementary meals were given in the 
evenings on days 2 (mixed fruit meal: apple, orange, grapes and grapefruit), day 3 
(salmon), day 4 (wine and grapes), day 5 (beef), and lunch on day 6 (salmon), see 
Figure 6. Only water and one cup of coffee/tea daily were allowed as beverages.  
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Figure 6 Illustration of the study design. 7 volunteers were enrolled over a period of 8 days. The diet was 
standardised over the whole study period and food challenges were introduced on days 2-6. Urine 
sample collection was carried out four times a day, from day 1 until the morning of day 7.  
 
3.4.2 Sample collection procedure 
Urine was collected at least 4 times per day (first morning urine, before lunch, before 
dinner and at bed time), from the morning of day 1 until the morning on day 7. Urine 
specimens were collected into sterile tubes (Sterilin, U.K.) and stored at -40 ºC until 
analysis. The study was approved by Imperial College London Research Ethics 
Committee. All timed spot urine specimens collected on day 1 in the morning until 
evening of day 2 (before fruit meal) were defined as “standard class”; specimens 
collected up to 24 hours after the fruit meal (bed time of day 2 until evening of day 3) 
were defined as “fruit class”, up to 24 hours after fish (bed time of day 3 until evening 
of day 4) to “fish class”, up to 24 hours after wine and grapes (bed time of day 4 until 
evening of day 5) to “wine class”, up to 16 hours after beef consumption to ‘beef class’ 
(bed time day 5 until lunch day 6) and the last samples (afternoon day 6 until morning 
day 7) were allocated to “fish class”. 
 
3.4.3 NMR spectroscopy of urine samples and selected foods   
To investigate the metabolite composition of collected urine samples and to assess the 
dietary composition of consumed foods, the metabolite profiles of urine and selected 
foods and beverages were analysed. Sample preparation and NMR acquisition was 
performed as described in chapter sections 2.1.5.1 and 2.2.1 respectively. Metabolite 
assignments were completed using an in-house database [144], various online 
accessible metabolite databases (e.g. Human Metabolome Database (HMDB) and 
Biological Magnetic Resonance Data Bank (BMRD)) SBASE database (Bruker), 2-
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dimensional NMR experiments, statistical total correlation spectroscopy (STOCSY, 
[97]) and standard compound spike-in experiments.   
 
3.4.4 Pattern Recognition techniques: Principal component analysis (PCA) and 
orthogonal projection to latent structures discriminant analysis (O-PLS-DA)  
PCA was performed as described in chapter section 2.3.2. Pair-wise O-PLS-DA, see 
chapter section 2.3.4, was carried out in Matlab comparing urine samples of each food 
group to all other food groups. The Y matrix contained information on the food classes, 
as described in the sample collection procedure (section 3.4.2).   
 
3.4.5 Investigation of excretion kinetics  
To compare the relative amount of urinary metabolite excretion between the different 
foods, several peaks of the NMR spectra were integrated and plotted against sampling 
time. This procedure is described in chapter section 2.5.   
 
3.4.6 Quantification of proline betaine via 1H NMR spectroscopy  
Urinary proline betaine showed the highest correlation to food consumption being 
highly correlated with consumption of the fruit meal and its origin was therefore 
investigated further. Quantification of proline betaine in various fruit juices and fruit 
extracts was achieved using 1H NMR spectroscopy. For the fruit extracts, whole fruits 
were homogenized, centrifuged for 5 min at 16,000 g and the supernatant used as fruit 
extract. An aliquot of 200 μL fruit juice or fruit extract was added to 800 μL phosphate 
D2O buffer 0.1 M (20% D2O, pH 7.4) containing 0.35 mM TSP. Samples were vortexed 
and centrifuged for 5 min at 16,000 g. Then, 600 μL sample of the supernatant was 
transferred into 5 mm outer diameter NMR tubes for analysis by 1H NMR spectroscopy. 
All 1H NMR spectra were recorded on a Bruker DRX600 NMR spectrometer, operating 
at 600.13 MHz with a Bruker 5mm TXI triple-resonance probe. Fruit juice/fruit extract 
spectra were acquired using a standard 1-dimensional (1D) pulse sequence with water 
suppression irradiating during RD of 2 s, mixing time (tm) set on 100 ms, a 90° pulse set 
to 10 μs. Optimal τ was determined empirically on a prepared orange juice sample and 
τ increased until both the TSP and proline betaine signal were fully relaxed. The proline 
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betaine and TSP resonances were fully relaxed after a delay time τ of 1.25 s and 3 s, 
respectively, resulting in a spin-lattice relaxation time T1 (=τ/ln2) of 4.33 s (with τ=3 s). 
The interpulse delay time d1 (=5xT1) was therefore set to 21.64 s. [145]. Final 
quantification was achieved calculating the ratio of area under the curves of TSP and 
proline betaine signals, where TSP concentration in the sample is known, and corrected 
for dilution, molecular weights and NMR signal stoichiometry (eq. 5):  
 
Proline betaine [mg/L] = (integral PB signal at δ 3.106-3.116)/(integral 
TSP signal at δ -0.035 – 0.035) * 9H/3H * 0.05g/L * juice-buffer-ratio 
* 146.26g/mol/143.18 g/mol * 1000 
 
The quantification was further ascertained by carrying out a standard additions 
experiment using a representative orange juice sample and proline betaine-
hydrochloride standard compound (see appendix).   
 
3.4.7  Confirmation study: proline betaine excretion after orange juice consumption  
A confirmation study was undertaken to test the reproducibility of urinary excretion of 
proline betaine after citrus fruit consumption. This study of orange juice consumption 
included 6 volunteers (4 females and 2 males, 24-36 years, BMI 20-25 kg/m2). 
Participants consumed a restricted diet excluding all citrus fruits, spicy foods, alcohol, 
grain legumes and cheese. Day 0 served as a run-in day; day 1 to collect baseline 
samples (6 times per day, at 8am, 10am, 12am, 4pm, 8pm, and at bed time); an orange 
juice challenge (250 mL orange juice) was administered on day 2 at 10am and urine was 
collected at the same times as for day 1 and continued until 10am on day 3 (study 
finish). Urine specimens were collected into sterile tubes (Sterilin, U.K.) and stored at -
40 ºC until analysis. 1H NMR spectroscopic analysis was conducted for metabolic 
profiling, spectra normalised using probabilistic quotient normalisation algorithm and 
the proline betaine resonance (δ 3.11 (s)) integrated for relative quantification of 
proline betaine excretion (arbitrary units) The study was approved by Imperial College 
London Research Ethics Committee. 
 
(equation 5) 
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3.4.8  Evaluation of urinary proline betaine excretion in an epidemiological study and 
comparison with dietary recall data 
To validate the experimental findings, proline betaine was investigated as a potential 
biomarker for citrus fruit consumption in a free-living human population using 1H NMR 
urinary spectral data obtained from the two UK INTERMAP Study centres. INTERMAP is 
a large-scale epidemiologic study, involving men and women aged 40-59 years from 17 
population samples in China, Japan, UK and USA. It investigates the role of multiple 
dietary factors in the aetiology of raised blood pressure, including use of the 
metabolome-wide association approach to identify blood pressure-related biomarkers 
of dietary patterns [15]. A 24-hr urine specimen and two consecutive in-depth multipass 
24-hr dietary recalls were collected from each participant, and the procedure repeated 
after 3 weeks. The two 24-hr urine collections were obtained on days two and four, 
corresponding to the first and second, and third and fourth dietary recalls respectively. 
INTERMAP received institutional ethics committee approval for each site, all 
participants gave written consent, and all procedures were in accordance with 
institutional guidelines. Details of methods including 24-hr dietary recall procedures are 
published [146, 147].  
Urine sample preparation, 1H NMR spectroscopy analysis and spectral processing 
methods are published [15] and previously acquired 1H NMR spectra were used to 
quantify proline betaine and creatinine.  
Two approaches were investigated: prediction of citrus fruit intake based on i) proline 
betaine excretion and ii) the ratio of proline betaine to creatinine (PB : CREA). For these 
prediction approaches, the Belfast sample (N=220) was used as the training set, and 
the West Bromwich sample (N=279) as the validation set. Proline betaine and creatinine 
were quantified by peak integration (spectral areas  3.106 - 3.116 and  4.041 – 4.075, 
respectively) using the 24-hr urinary 1H NMR spectral data from the first of the two 24-
hr collections from each participant. The technical error of metabolite quantification 
was calculated from data on specimens split in the field and blind to the laboratory 
(N=40, 8% of total samples) using the formula ((Σd2/2N)0.5×100)/ x , where d is the 
within-pair difference, N is the number of split sample pairs, and x is the mean of all 
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split sample values [148]. This approach has been previously used for nutritional 
evaluation [15].  
 
3.4.9 Records of citrus consumption: Mining of UK FOODBASE  
The 24-hr dietary recall data for the two UK population samples, Belfast (N=220) and 
West Bromwich (N=279), were coded using the UK FOODBASE software version 1.3 
(Institute of Brain Chemistry, London, UK) [149]. Original hand-written protocols were 
also available. This work was previously carried out by nutrition specialists from the 
INTERMAP Research group. From this database, information of all citrus fruits and 
citrus fruit juices consumed were obtained. Citrus consumption was classified as “citrus 
consumption” in any case where citrus fruit had been reported as being consumed, 
regardless of the quantity; with the exception of lemon/lime juice used in cooking since 
the amount used in this case generally related to less than 10 g. In addition, all cordial 
citrus drinks (i.e. orange squash, cordial lime juice, lemonade, Fanta) were assigned to a 
separate group as NMR analysis of these products showed they contain only low 
concentrations of proline betaine. Extraction of this information from the electronic 
recall data was done with help from Ms. Queenie Chan, Department of Epidemiology 
and Public Health, Imperial College London.  
 
3.4.10 Receiver operating characteristics curve comparison of 1H NMR calculated 
urinary proline betaine excretion values with 24-hour food record data 
Reported citrus consumption in the 24-hr recall data was categorised into 3 subgroups: 
‘No recorded citrus intake’, ‘recorded citrus intake’ (citrus intake on day 1 and day 2, or 
day 2 only) and ‘recorded citrus intake on day 1 only’. This was based on the 
observation that most urinary excretion of proline betaine occurred within 14 hours. 
Therefore, citrus consumption reported for the morning of the previous day (>20 hours 
before the start of urine collection) was not expected to affect urinary proline betaine 
levels, whereas citrus consumption on the previous evening (<12 hours before the start 
of urine collection) might result in elevation of urinary proline betaine. Boxplots 
comparing the proline betaine integrals and PB : CREA ratios of the three subgroups for 
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both the training set and validation set were created in Matlab and their p-value 
calculated.  
A receiver operating characteristics (ROC) curve was constructed using information of 
citrus fruit consumption in the 24-hr food record data for identification of citrus 
consumers and non-citrus consumers. Every participant who recorded citrus 
consumption was defined as citrus consumer. The ROC curve is a plot of sensitivity 
versus one minus specificity (1-specificity) for all possible values of the cut-off points 
from proline betaine integrals and the ratio PB : CREA of the NMR spectral data. The 
optimal operating point (shortest distance from optimal point (0,1) to the intersect of 
the ROC curve [150] was used to determine the optimal cut-off point, from which 
specificity and sensitivity were then calculated.   
 
3.4.11 Correlation analysis of the dietary data 
Investigation of the dietary data structure and relation of all nutrients to proline 
betaine was carried out in Matlab using the mean of four 24-hr dietary recalls of the 
western population samples (UK and USA, N=2,657). Correlation coefficients and p-
values were calculated and illustrated in a correlation map, where all correlations with 
a p-value ≥ 0.001 (= p-value ≥ 0.05 Bonferroni-corrected for multiple testing) are 
blanked.  
 
3.4.12 Classification of citrus consumption based on urinary proline betaine and 
association of spectroscopically calculated citrus consumption with nutrient 
intakes, body mass index and blood pressure  
Participants from the INTERMAP US and UK samples were classified as citrus 
consumers or non-citrus consumers using the urinary proline betaine integral. 
Individuals with proline betaine >39.4 in both 24-hr urine collections (N=787) were 
classified as citrus consumers and non-citrus consumers were defined as individuals 
with urinary proline betaine integral ≤39.4 in both 24-hr collections (N=1,211). The cut-
off value 39.4 was previously determined (see chapter 2.4.7) using ROC curve analysis. 
Mean values of selected non-nutrient and nutrient variables from all four 24-hr dietary 
recalls were compared between the two groups, with adjustment for age, sex, and 
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country, carried out in SAS 9.1 (SAS Institute, Cary N.C., USA). Individuals with urinary 
proline betaine integral >39.4 in one 24-hr collection only (N=645) were excluded. 
 
3.5 Results 
 
3.5.1 Typical urine spectra after the food challenges 
A typical 1H NMR urine spectrum is shown in Figure 7 with characteristic metabolites 
labelled. Visual inspection of all spectra revealed characteristic biomarkers for each 
post food consumption urine sample. Apparent biomarkers for the fruit mix, 
consumption of animal protein (fish and beef meal) and red wine with grapes are 
highlighted in Figure 7 and listed in Table 1.  
 
Figure 7 950MHz 1H NMR urine spectrum of human urine with the characteristic food ‘biomarkers’ 
highlighted: fruit mix, animal protein and wine and grapes. Abbreviations: 3-MH, 3-methylhistidine; PAG, 
phenylacetylglutamine; TMAO, trimethylamine-N-oxide; BCAA, branch-chain amino acids; SCFA, short-
chain fatty acids.  
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Table 1 List of apparent metabolites excreted after specific food consumption. 
 
fruit mix fish and beef wine and grapes 
proline betaine TMAO ethanol 
tartrate creatine 2-isopropylmalate 
4-hydroxyhippurate 3-methylhistidine 2,3-butanediol 
 taurine unknown (δ 1.10 (d)) 
  diethylmalonate 
  tartrate 
 
3.5.2 Untargeted 1H NMR metabolite profiling to reveal food-related differences in 
urine samples: PCA and O-PLS-DA 
Principal component analysis was used to determine the maximal variation and to 
detect outliers. These outliers were excluded where appropriate (i.e. highly diluted 
sample causing insufficient water suppression) or reanalysed/-processed (i.e. phasing 
and baseline differences). Scores plots of PCA analysis are shown in Figure 8. 
 
 
Figure 8 Scores plots of principal component analysis with principal components  (A) 1 and 2 and (B) 3 
and 4 including all samples and colour-coded for food challenges: standard class, beef and fish (= animal 
protein), fruit mix and wine and grapes. 
 
This plot clearly shows that maximal variation in the PCA scores plots was not simply 
attributable to specific food consumption. However, principal components three and 
four (5.16 and 5.10 % of total variation) slightly clusters urine samples collected after 
animal protein consumption. Further analysis was therefore necessary to elucidate a 
more complete set of ‘biomarkers’ for the different food consumptions.  
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To identify biomarkers related to specific food consumption, O-PLS-DA was performed. 
For this model, the urine spectra of all 7 volunteers were included for the period 
commencing from the sample after the consumption of the specific food until the 
sample just before consuming the next meal (~24 hours). Samples collected while 
consuming the standard meal were allocated to “standard class”, samples collected 
after the fruit challenge allocated to “fruit class”, samples collected after fish and beef 
challenge to “animal protein class” and to “wine and grape class” for the samples 
collected after consumption of wine and grapes. Two analyses were performed: (i) O-
PLS-DA analysis comparing each specific food class vs. all others and (ii) each specific 
food class vs. the standard food class. Figure 9A shows the scores plot of the first 
analysis with the components 1 - 3, where a separation of samples collected after fish 
and beef is observed in PC1, wine and grapes urine samples in PC2, and component 3 
separates urine samples collected after the consumption of a mix of citrus fruits, 
apples and grapes. Figure 9 B-D shows scores plots of the second analysis, where each 
specific food was discriminated against the standard class. The loadings plots obtained 
for the 1st analysis (specific food consumption vs. all others) and the 2nd analysis 
(specific food consumption vs. standard diet) analysis were comparable, with the 
exception of tartrate not being significant for the fruit class, as it appears in the urine 
of the “fruit class” and the “wine and grape class”. Therefore, the loadings plots from 
the pair-wise comparison analyses were chosen to illustrate metabolites responsible 
for the separation of food classes and are listed in Table 2. 
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Figure 9 (A) Orthogonal partial least squares discriminant analysis (1 orthogonal component) scores plot 
of urine specimens 0-24hr post food challenge of N=7 participants showing clear separation of all classes 
(R2Y=0.53, Q2Y=0.34): standard class, beef and fish (= animal protein), fruit mix and wine and grapes. 
Figures B-D show the scores plots of pair-wise O-PLS-DA “standard class” vs. (B) “fruit challenge” 
(R2Y=0.77, Q2Y=0.34), (C) animal protein (R2Y=0.73, Q2Y=0.48), and (D) “wine and grapes” (R2Y=0.75, 
Q2Y=0.40). 
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Table 2 Metabolic changes in urinary metabolic profiles after specific food challenges compared to the 
standard diet, from the loadings plots of pair-wise O-PLS-DA analysis. The name of the metabolite, their 
chemical shifts (and multiplicity) and the correlation coefficient (r2) are given. 
 
  
Metabolite Chemical shifts 
correlation 
coefficient (r
2
)
2
 
fruit       
  Unknown δ 1.12 (m) 0.31 
  Unknown δ 1.28 (s) 0.16 
  Proline betaine δ 3.11(s), 3.31 (s) 0.44 
  Unknown δ 4.28 (d) 0.12 
  Tartrate δ 4.34 (s) 0.18 
  Sugar resonance
3
 δ 4.52 (d) 0.12 
  
Hippurate 
δ 2.97 (d), 7.64 (t), 7.55 (t), 7.84 
(d) 0.1 
  4-OH-hippurate δ 6.98 (d), 7.74 (d), 3.93 (d) 0.13 
animal protein      
  
Unknown 
2.13 (dd), 2.57 (m), δ 2.90 (t), 
3.25 (dd), 4.43 (dd) 0.32 
  Choline δ 3.20 (s) 0.27 
  Carnitine δ 3.22 (s) 0.23 
  Unknown δ 3.23 (dd) 0.37 
  TMAO δ 3.27 (s) 0.26 
  Unknown δ 3.30 (m) 0.26 
  Taurine δ 3.25 (t), 3.43 (t) 0.14 
  Creatine δ 3.03 (s), 3.93 (s) 0.13 
  
1-methylnicotinamide δ 4.48 (s), 8.18 (t), 8.88 (d), 
8.98 (d), 9.27 (s) 
0.19 
  
3-methylhistidine δ 7.92 (s), 7.05 (s), 3.94 (dd), 
3.70 (s), 3.29 (m), 3.22 (m) 
0.15 
  
Pyridoxine
4
 δ 2.45 (s), 4.73 (s), 7.67 (s) 0.14 (negative 
correlation) 
wine and grapes      
  Tartrate δ 4.34 (s) 0.32 
  Ethanol δ 1.18 (t), 3.66 (q) 0.26 
  2-isopropylmalate δ 0.86 (d), 0.91 (d), 1.88 (m) 0.19 
  Diethylmalonate δ 1.22 (d), 3.91 (m) 0.24 
  Unknown δ 1.10 (d), 3.90 (m)  0.43 
  2,3-butanediol δ 1.15 (d), 3.62 (m), 3.72 (m) 0.40 
 
 
3.5.3 Time-dependent excretion of metabolites  
The integrated resonances for selected metabolite peaks were plotted over time to 
investigate food-related metabolite excretion kinetics. This was done in order to 
illustrate the delay of metabolite excretion following food ingestion.  
                                                        
2 Metabolites with a correlation coefficient larger than 0.1 were regarded as important 
3 Tentative assignment 
4 Tentative assignment 
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3.5.3.1 Metabolite excretion following fruit consumption 
Figure 10 shows the excretion kinetics of the metabolites hippurate, tartrate, proline 
betaine and 4-OH-hippurate. Proline betaine and tartrate excretion occurred directly 
after fruit consumption (before bedtime of day 2) and tartrate re-occurred after wine 
and grapes consumption. The excretion of 4-OH-hippurate after the fruit meals was 
delayed in comparison and started in the morning of day 3. Hippurate showed high 
inter-individual variation at each time point and the excretion was relatively higher 
after fruit consumption. In addition, there were apparent diurnal variations, as seen by 
low hippurate excretion in the lunchtime sample. However, the timing of the standard 
food consumption, with whole-grain bread as fibre sources being served for breakfast 
and lunch, might have biased this observation. 
 
 
Figure 10 Metabolite plot showing the mean peak integral and its standard deviation of hippurate, 
tartrate, proline betaine and 4-OH-hippurate over time. The time of food consumption is indicated in red. 
Tartrate and proline betaine are both immediately excreted after fruit excretion while 4-OH-hippurate 
appears 12 hours post fruit consumption. The second tartrate peak (end of day 4) occurred after 
consumption of wine and grapes. Excretion of hippurate showed apparent high diurnal variation and 
high standard deviation. 
 
3.5.3.2 Metabolite excretion following animal protein consumption  
Consumption of animal protein (fish and/or beef) lead to increased excretion of the 
metabolites TMAO, creatine, taurine, an unknown metabolite at δ 2.90 (t), choline and 
carnitine (Figure 11). The unknown metabolite with chemical shift at δ 2.90 (t) showed 
further resonances at δ 2.13 (m), δ 2.52 (m) and δ 4.43 (dd), as ascertained by COSY and 
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TOCSY, and corresponding 13C carbon shifts are listed in the appendix. Besides choline 
and carnitine, there were other resonances increased in the spectral area δ 3.21 – 3.33, 
all subject to peak shifts. These resonances might derive from ethanolamine, other 
amines and choline glycerophospholipids [151]. The integrals of the spectral areas δ 3.21 
– 3.26 and δ 3.29 – 3.33 were therefore chosen to illustrate these metabolites. After fish 
intake, all of the plotted metabolites were excreted in the next collected urine sample. 
Beef intake did not result in immediately increased excretion of TMAO and metabolites 
in the spectral area δ 3.29 – 3.33, but the metabolites creatine, taurine, δ 2.90 (t) and 
resonances in the spectral area δ 3.21 – 3.26 were excreted immediately afterwards. 
Another in-house nutritional study, where only beef consumption was investigated 
showed that TMAO excretion occurs after beef consumption but is delayed by up to 12 
hours. This suggests the possibility that endogenous or gut microbial metabolism is 
necessary to produce TMAO from beef sources. Interestingly, taurine excretion is 
slightly elevated in every night sample. This is likely to be due to consumption of a ham 
sandwich every day as part of the lunch meal, considering that ham is a good source of 
taurine. Apparent excretion of metabolites in the spectral area δ 3.29 – 3.33 at the end 
of day 2 and beginning of day 3 derives from peak overlap with proline betaine (proline 
betaine CH3 moiety δ 3.31).  
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Figure 11 Metabolite plot showing the mean peak integral and its standard deviation of (A) TMAO, 
creatine and spectral areas of δ 3.21 – 3.26 and δ 3.29 – 3.33 and (B) of δ 2.90 (t) and taurine. Creatine, δ 
2.90 (t) and taurine are observed in the urine collection within 2 hours post fish and beef consumption. 
TMAO excretion starts immediately after fish consumption but is delayed after beef consumption and 
therefore overlaps with the second fish meal. Metabolites in the spectral area of δ 3.21 – 3.26 get 
excreted after fish and beef consumption and metabolites in the spectral area δ 3.29 – 3.33 are excreted 
immediately only after fish excretion and might be delayed after beef consumption. The proline betaine 
peak (δ 3.31) is overlapped in the spectral region δ 3.29 – 3.33 (see end of day 2). The time of food 
consumption is indicated by the red arrows. 
 
 
3.5.3.3 Changes in metabolite excretion following consumption of wine and grapes  
Excretion kinetics of metabolites following wine and grape consumption on day 4 were 
investigated (Figure 12). Ethanol, δ 1.10 (d) and 2-isophenylmalate were present only in 
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the urine sample immediately following wine consumption. The amount of ethanol and 
δ 1.10 (d) excretions were highly variable between the individuals. Tartrate, 2,3-
butanediol and diethylmalonate were excreted up to 12 hours following wine and grape 
consumption.  
 
 
Figure 12 Metabolite plot showing the mean peak integral and its standard deviation of (A) ethanol, 2-
isophenylmalate and δ 1.10 (d) and (B) tartrate, 2,3-butanediol and diethylmalate. All 6 metabolites are 
immediately excreted after wine + grape consumption. The tartrate peak at the end of day 2 derives 
from consumption of grapes present in the fruit mix. 
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3.5.4 1H NMR spectra of the tested foods, food extracts and beverages 
To assign the origin of several elucidated urinary metabolites after the food challenges, 
all foods (fish, beef, orange, apple, grapes, grapefruit and wine) were analysed using 
1H-HR-MAS or 1H NMR spectroscopy. The origin of proline betaine in urine spectra could 
be assigned to proline betaine in orange and grapefruit, excreted tartrate was present 
due to ingestion of grapes and wine in the diet. Furthermore, wine and fruits were 
sources of polyphenols. Ethanol, 2,3-butanediol, 2-isophenylmalate, diethylmalonate 
and an unknown compound with chemical shifts at δ 1.10 (d) and 3.90 (m) were present 
in wine. Taurine, choline, carnitine and creatine were present in fish and beef, TMAO 
and anserine were only present in fish and carnosine was only present in beef. It is well 
established, that anserine and carnosine are found in fish and beef [152]. The fatty acid 
pattern differed between fish and beef, with the fish spectrum showing an additional 
resonance at δ 2.80 ppm. Spectra of these foods are shown in Figure 13-15.  
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Figure 13 1H-HR-MAS spectrum of (A) fish and (B) beef. The water resonance (5.1 – 4.9 ppm) is excluded.  
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Figure 14 1H NMR spectra of juices from (A) apple, (B) grapefruit and (C) orange. The aromatic region (δ 
9.5 – 5.45 ppm) is vertically enlarged by x 280 and the aliphatic region (δ 3.21 – 0.5 ppm) is vertically 
enlarged by x10. Abbreviations: BCAA, branch-chain amino acids; GABA, 4-aminobutyrate, Asn, 
asparagine; Asp, aspartate.  
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Figure 15 1H NMR spectrum of (A) grape juice and (B) red wine. The grape juice spectrum is vertically 
enlarged in the aromatic region by x400 and by x25 on the aliphatic region. The aromatic region of red 
wine spectrum is vertically enlarged by x77. Abbreviations: BCAA, branch-chain amino acids; GABA, 4-
aminobutyrate. 
 
3.5.5 Confirmatory study to proline betaine excretion after orange juice 
consumption 
As proline betaine showed the strongest correlation (r2=0.44) to fruit challenge, the 
possibility of proline betaine being a potential biomarker for fruit intake was further 
investigated. First, an additional food intervention study was undertaken to confirm 
proline betaine as a potential biomarker of citrus fruit intake. Urinary proline betaine 
was measured after consumption of 250 mL of orange juice via 1H NMR spectroscopy. 
Urine specimens were collected pre (-26 hr to 0 hr) and post (+2 hr to +24 hr) orange 
juice challenge (Figure 16A, B). The singlet peak at  3.11, representing the CH3 moiety 
of proline betaine, showed minimal overlap with other peaks in the spectrum. 
Excretion of proline betaine was rapid and peaked in all individuals at the 2 hr post-
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intervention collection, as calculated from the spectral integral (spectra normalised to 
probabilistic quotient [90]) over the region  3.106 - 3.116. In all participants, levels 
declined to almost baseline after +24h, with most proline betaine excretion occurring in 
the first 14 hours (83% of 24-hr excretion) (Figure 16B).  
 
 
Figure 16 Urinary excretion kinetics of proline betaine after orange juice consumption (N=6). (A) The 
proline betaine singlet at  3.11 was integrated over the spectral region  3.106-3.116 as shown, where the 
peak overlap is minimal. (B) Mean proline betaine integral and its standard deviation (solid bold line) and 
each of the 6 volunteers are plotted over time. The red arrow indicates time of orange juice 
consumption. 
 
3.5.6 Quantification of proline betaine in fruits and fruit juices 
To investigate further sources and concentration variations of proline betaine in foods, 
concentrations of proline betaine were measured in selected fruits and commercially 
available fruit juices using a standard 1H NMR experiment optimised for quantification 
of this compound (Table 3). A standard additions experiment, where proline betaine 
hydrochloride was added stepwise, confirmed these results. The correlation coefficient 
of the standard addition curve was 0.998 and quantification of proline betaine 4.0 % 
lower than listed in Table 3. All citrus fruits tested contained proline betaine. 
Concentrations varied depending on the type of citrus fruit (orange > lime > satsumas > 
grapefruit > lemon) and the method of juice processing (manufactured juice > freshly 
squeezed), ranging from 1062 mg/L in freshly squeezed orange juice to 1316 mg/L for 
orange juice from concentrate. In contrast, the proline betaine signal was of low 
intensity in spectra of the other commonly available fruits and fruit juices tested (Table 
3).  
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Table 3 Proline betaine concentration (mg/L) in fruits and fruit juices measured by 1H NMR spectroscopy. 
Concentrations are given in mean ± SD where more than one sample was analysed. 
 
Juice/fruit description Proline betaine (mg/L) 
Citrus fruit juice (authentic, all n=3)  
 Orange juice, from concentrate  1316 ± 72 
 Orange juice, not from concentrate 1189 ± 24 
 Orange juice, freshly squeezed 1062 ± 81 
 Grapefruit juice 766 ± 93  
Citrus fruit juice (synthetic, all n=1)  
 Orange soft drink  216 
 Orange squash  75 
Citrus fruit (all n=3)  
 Orange  761 ± 89 
 Lime  730 ± 126 
 Satsuma  461 ± 55 
 Lemon  251 ± 153 
Other fruit juice (all n=1)  
 Pineapple juice 57 
 Red grape and raspberry juice 46 
 Pomegranate and blueberry juice 18 
 Peach, mango, passionfruit juice 17 
 Apple juice 14 
 Blackcurrant juice 12 
Other fruit (all n=1)  
 Kiwi 66 
 Grape 51 
 Melon 34 
 Banana 28 
 Strawberry 22 
 Pear 14 
 Apricot 10 
 
 
3.5.7 Validation in epidemiologic data of proline betaine as a biomarker for citrus 
fruit intake  
To validate the experimental findings, proline betaine was investigated as a potential 
biomarker of citrus fruit consumption in a free-living human population using 1H NMR 
urinary spectral data obtained from the two UK INTERMAP Study centres [146]. Two 
consecutive in-depth multipass 24-hr dietary recall protocols were available from each 
participant, and the procedure repeated after ~4 weeks [147, 149]. The food records 
describe food consumption on day 1 and 2, and 24-hr urine collection was carried out on 
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day 2. To test the ability of proline betaine and PB : CREA to identify citrus fruit 
consumption, proline betaine and creatinine were quantified by peak integration and 
the dietary records were mined for citrus fruit consumption. The technical error of 
proline betaine quantification from 1H NMR spectra was 2.64%. All citrus fruits, citrus 
fruit juices and other citrus products were extracted from the FOODBASE database 
(Table 4). Analysis of various authentic and synthetic citrus products showed that 
synthetic citrus juices contain only low quantities of proline betaine. These were 
therefore tested in another group and shown to have no effect on urinary proline 
betaine.  
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Table 4 UK FoodBase Code for all citrus fruit items and their description. Items were sub-divided into 
fruit, drinks and others (such as cordial drinks). 
 
  FoodBase Code Description 
Fruits 6401 Clementines 
 6404 Grapefruits 
 6405 Kumquats 
 6414 Oranges 
 6417 Satsumas 
 6419 Tangerines 
 6516 Ortaniques 
 6710 Grapefruit, canned (own juice) 
 6711 Grapefruit, canned (syrup) 
 6713 Mandarin oranges, canned (own juice) 
 6714 Mandarin oranges, canned (syrup) 
    
Drinks 8505 Grapefruit juice, unsweetened 
 8509 Orange juice, unsweetened 
 8605 orange drink, undiluted 
 8507 orange juice, freshly squeezed 
 8607 orange juice tinned, sweetened 
 6941 lemon juice 
 6406 lemon juice, fresh 
 6410 lemon juice, whole, without pips 
 6411 lime juice, fresh 
    
Others 6707 fruit cocktail (own juice) 
 6708 fruit cocktail (syrup) 
 6932 fruit salad, homemade 
 8320 lemon sorbet 
 8628 lime juice cordial 
 8702 lemonade 
 8512 pineapple juice (Five Alive, orange + pineapple) 
 8606 orange juice concentrate, unsweetened (Tesco Hi Juice)  
 25135 squash lemon/orange cordial 
 25136 squash lemon/orange cordial 
 25137 orange drink, cordial, orange, pineapple, tropical 
 25138 orange drink, cordial, orange, pineapple, tropical 
 25139 co-op whole orange, cordial orange, squash orange  
 25149 co-op lime cordial, whole lemon drink 
 25176 Blackcurrant/Apple squash cordial 
 25209 Sunny Delight, all flavours 
 25314 Orange Ribena, Ocean Spray cranberry juice 
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Based on the excretion kinetics (Figure 16B) indicating that most urinary excretion of 
proline betaine occurred within 14 hours, citrus consumption reported for the morning 
of the previous day (>20 hours before the start of urine collection) was not expected to 
affect urinary proline betaine levels, whereas citrus consumption on the previous 
evening (<12 hours before the start of urine collection) might result in slight elevation 
of urinary proline betaine concentrations (Figure 17).  
 
 
Figure 17 Illustration of the urinary collection protocol in the INTERMAP dataset; arrows represent time 
of citrus fruit consumption and bars represent expected duration of proline betaine excretion (24 hours). 
Green: Consumption of citrus early morning day 1 results in no proline betaine in 24-hr urine. Magenta: 
Consumption of citrus evening day 1 affects proline betaine levels in 24-hr urine. 
 
Reported citrus fruit intake from the 24-hr recall data was categorized into 3 
subgroups: ‘No recorded citrus intake’, ‘recorded citrus intake’ (citrus intake on day 1 
and day 2, or day 2 only) and ‘recorded citrus intake on day 1 only’. Proline betaine 
levels and PB : CREA differed significantly between individuals with no recorded citrus 
consumption, and those with recorded citrus consumption, in both the training set and 
the validation set (Belfast sample p<0.0001, West Bromwich sample p<0.0001, Figure 
18A, B). In non-citrus consumers excreting proline betaine, we found no consistent 
pattern of blue or brie cheese consumption, or other foods reported to contain low 
amounts of proline betaine [153]. Receiver operating characteristic (ROC) curves for 
proline betaine were derived for both training and validation sets, with areas under the 
curve (AUC) of 92.3% and 93.5% respectively (Figure 18C) and 92.4% and 92.8% for PB : 
CREA. A cut-off point was calculated from the optimal operating point on the ROC 
curve of the training set, with a threshold of 39.4 for the proline betaine integral. This 
optimal point had a specificity and sensitivity of 90.6% and 86.2% for the training set, 
and 92.3% and 80.6% for the validation set respectively.  
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Figure 18 Box plots of urinary proline betaine excretion of volunteers recording no citrus fruit 
consumption (‘no citrus’), citrus fruit consumption (‘citrus’) and citrus fruit consumption only on day 1 
(‘only D1’). (A) Proline betaine (PB) and (C) PB : CREA in the Belfast sample (no citrus n=96, citrus n=96, 
only D1 n=28) and (B) proline betaine and (D) PB : CREA in the West Bromwich sample (no citrus n=181, 
citrus n=71, only day 1 n=27). (E) ROC curves to assess the predictive ability of excretion of proline betaine 
for discrimination of citrus fruit intake and no citrus fruit intake as reported in the dietary recall data for 
the training set (INTERMAP UK Belfast sample, solid line) and test set (INTERMAP UK West Bromwich 
sample, dashed line). Optimal operating point (■) for the training set was a peak integral value of 39.4 
for proline betaine. This represented a specificity and sensitivity of 90.6% and 86.3% for the training set 
and 92.3% and 80.6% for the validation set respectively. Sensitivity and specificity were similar for ROC 
curves constructed from proline betaine/creatinine ratio (89.1%/83.9%, AUC 93.5%). 
 
Similar results were obtained for ROC curves constructed from PB : CREA ratios at an 
optimal operating point at 0.065 with sensitivities of 88.5% and 77.8% and specificities 
of 84.0% and 91.2% for training and test set, respectively as well as for the second rather 
than first 24-hr urine collection (90.2%/84.8%, AUC 90.7%, Table 5). As proline betaine 
and PB : CREA predicted citrus consumption equally well, subsequent analyses were 
undertaken with proline betaine only.  
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Table 5 Summary of area under the curve (AUC), specificity and sensitivity for the Belfast and West 
Bromwich samples for receiver operating characteristic (ROC) curves constructed according to different 
data. Thresholds (proline betaine = 39.4 and proline betaine/creatinine ratio = 0.065) were determined 
with the training set Belfast (first urine collection). 
 
Biomarker, sample AUC Specificity Sensitivity 
Proline betaine    
 Belfast (first urine collection) 92.3% 90.6% 86.2% 
 West Bromwich (first urine collection) 93.5% 92.3% 80.6% 
 Both samples (first urine collection) 93.4% 90.6% 86.3% 
 Both samples (second urine collection) 90.7% 87.3% 86.3% 
Proline betaine/creatinine ratio    
 Belfast (first urine collection) 92.4% 84.0% 88.5% 
 West Bromwich (first urine collection) 92.8% 91.2% 77.8% 
 Both samples (first urine collection) 93.5% 89.1% 83.9% 
 Both samples (second urine collection) 91.5% 90.2% 84.8% 
 
3.5.8 Correlation analysis of urinary proline betaine and recorded citrus fruit intake 
To investigate the semi-quantitative relationship between proline betaine and citrus 
food intake, the mean proline betaine concentration and ratio of PB : CREA from first 
and repeat visit were regressed against the mean of recorded citrus intake in grams 
(excluding citrus intake on day 1 only) and Spearman correlation coefficient and p-value 
calculated (Figure 19). Both proline betaine and PB : CREA correlated strongly with 
recorded citrus intake (r = 0.80 and 0.81 respectively, p<0.0001).  
 
 
Figure 19 Regression analysis of (A) the 1H NMR integral of proline betaine and (B) PB : CREA ratio with 
citrus intake in grams and the corresponding Spearman correlation coefficient and p-value. 
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3.5.9 Correlation analysis of dietary data from the 24-hr dietary recalls and proline 
betaine 
In order to investigate the correlation structure of dietary intake and proline betaine, a 
correlation analysis was undertaken using the means of nutrient intake from four 24-hr 
dietary recall protocols and proline betaine excretion as a mean of two 24-hr urine 
samples. The nutrient intake data were prepared by nutrition specialists from 
INTERMAP, using 24-hr food protocols and converting the food records into nutrient 
intake with the FOODBASE database and the 5th edition (1991) of McCane and 
Widdowson’s national food tables [147]. Proline betaine correlated positively with 
fibre, vegetable protein, most carbohydrates, vitamin A, β-carotene, vitamin C, folic 
acid, pantothenic acid, vitamin B6, magnesium, potassium and copper and negatively 
with animal protein, cholesterol and all fats except omega-3 fatty acids (Figure 20). 
Furthermore, the correlation map additionally showed correlations of most vitamins 
and minerals with each other and most fats with each other. Several strong 
correlations, such as lactose and calcium or maltose and alcohol emphasised common 
predominant ingredients of foods (milk and beer, respectively). Other possible eating 
patterns of note were expressed via negative correlation of all fats and fibre, starch 
and vegetable protein.   
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Figure 20 Correlation analysis of the dietary data from four 24-hr dietary recalls (N=1,997, US and UK) and 
urinary proline betaine. The correlation coefficient r is illustrated by a colour-code and only correlations 
with a p-value < 0.001 (p<0.05, corrected for multiple testing of 43 variables after Bonferroni correction) 
are shown. Abbreviations: MFA=monounsaturated fatty acids, PFA=polyunsaturated fatty acids, 
SFA=saturated fatty acids, ω6=omega-6 fatty acids, ω3=omega-3 fatty acids, FA=fatty acids. Black solid 
boxes, examples for common predominant ingredients (calcium + lactose: milk, maltose + alcohol: beer); 
black dashed boxes, examples for eating pattern: negative correlation of all fats to carbohydrates, fibre, 
starch and vegetable protein. 
  
3.5.10 Comparison of nutrient intakes, body mass index and blood pressure between 
citrus fruit consumers and non-consumers  
Further implications of the citrus fruit biomarker proline betaine were assessed, 
comparing the overall food intake of citrus consumers and non-citrus consumers. 
Participants from the INTERMAP US and UK samples were classified as citrus 
consumers and non-citrus consumers based on their urinary proline betaine excretion. 
This analysis was done in collaboration with the Department of Epidemiology and 
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Public Health, Imperial College, and Ian J Brown performed the statistical analysis. 
Citrus consumers reported higher intakes of carbohydrate (49.2 vs. 45.5% kJ) and 
vegetable protein (5.8 vs. 5.4% kJ) and less total fat (31.0 vs. 34.2% kJ) and animal 
protein (9.7 vs. 10.2% kJ) (all P<0.0001) compared to non-citrus consumers; intakes of 
total saturated fatty acids, monounsaturated fatty acids, trans fatty acids, 
polyunsaturated fatty acids, omega-6 fatty acids and cholesterol were also lower in 
citrus consumers (Table 6). Most differences between citrus consumers and non-
consumers were favourable in terms of healthier diet (i.e. low-fat/high-carbohydrate 
diet, rich in fruit, vegetables and fibre). Citrus consumers ingested more total sugars 
(25.9 vs. 22.2% kJ), derived mainly from higher fructose (5.2 vs. 3.6% kJ) and glucose (5.3 
vs. 3.8 % kJ) intakes; fibre, most vitamin intakes (vitamin A, beta-carotene, thiamine, 
pantothenic acid, vitamin B6, vitamin C and folic acid) and mineral intakes (copper, 
iron, magnesium and urinary potassium) were also higher in citrus consumers, while 
urinary Na/K ratio was lower (2.9 vs. 2.3) (Table 6). Mean vitamin C intake for 
consumers was 17.4 mg/1000 kJ (160.5 mg/day), compared with 7.7 mg/1000 kJ (71.5 
mg/day) for non-consumers, who therefore as a group were not meeting the US 
National Academy of Sciences recommendations for vitamin C intake (75-90 mg/day 
[154]). In addition, citrus consumers had higher socio-economic status, assessed by 
education years (13.3 vs. 14.5), lower body mass index (BMI) (28.7 vs. 27.6) and lower 
systolic blood pressure (120.2 vs. 118.5 mmHg, p<0.0005).  
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Table 6 Selected nutrient and non-nutrient variables1 from four 24-hr dietary recalls and questionnaire 
data with comparison for proline betaine-predicted citrus consumers and non-citrus consumers2 from 
INTERMAP UK and USA participants (N=1,998).  
 
Variable Predicted non-citrus 
consumers
2
 
(N=1,211) 
Predicted citrus 
consumers
2
 
(N=787) 
P value 
 Mean (SD) Mean (SD)  
Energy, kJ/24-hr 9215 (2896) 9286 (2769) 0.53. 
Total fat, % kJ 34.2 (7.8) 31.0 (7.4) <0.0001 
Total SFA, % kJ 11.9 (3.4) 10.7 (3.2) <0.0001 
Total MFA, % kJ 12.1 (3.2) 10.9 (3.1) <0.0001 
Total PFA, % kJ 6.9 (2.6) 6.2 (2.5) <0.0001 
Omega-3 FA, % kJ 0.75 (0.36) 0.72 (0.34) 0.01 
Omega-6 FA, % kJ 6.2 (2.4) 5.5 (2.3) <0.0001 
Trans FA, % kJ 1.7 (0.9) 1.5 (0.9) <0.0001 
Cholesterol, mg/1,000 kJ 31.5 (15.2) 28.1 (14.6) <0.0001 
Keys dietary lipid score
3
 39.6 (11.4) 36.4 (10.9) <0.0001 
Total carbohydrate, % kJ 45.5 (8.9) 49.2 (8.5) <0.0001 
Starch, % kJ 24.0 (6.4) 24.0 (6.2) 0.95 
Total sugars, % kJ 22.2 (9.0) 25.9 (8.6) <0.0001 
Sum of fructose, glucose, sucrose 
from sweetened beverages, % kJ 3.4 (6.6) 2.9 (6.3) 
 
0.05 
Fructose, % kJ 3.6 (3.2) 5.2 (3.1) <0.0001 
Galactose, % kJ 0.05 (0.12) 0.06 (0.11) 0.007 
Glucose, % kJ 3.8 (2.9) 5.3 (2.7) <0.0001 
Lactose, % kJ 2.7 (2.1) 2.8 (2.0) 0.12 
Maltose, % kJ 0.77 (0.77) 0.72 (0.73) 0.10 
Sucrose, % kJ 10.1 (5.8) 10.3 (5.6) 0.21 
Fiber, g/1,000 kJ 2.4 (0.9) 2.7 (0.9) <0.0001 
Total protein, % kJ 15.7 (3.7) 15.5 (3.5) 0.19 
Vegetable protein, % kJ 5.4 (1.7) 5.8 (1.6) <0.0001 
Animal protein, % kJ 10.2 (3.7) 9.7 (3.6) 0.0003 
14-day alcohol, g/24-hr 11.1 (17.4) 9.9 (16.7) 0.08 
Caffeine, mg/1,000 kJ 35.3 (35.7) 24.8 (34.1) <0.0001 
Urinary sodium, mmol/24-hr 155.7 (64.2) 150.7 (61.4) 0.05 
Urinary potassium,  
mmol/24-hr 59.2 (22.4) 69.2 (21.4) <0.0001 
Urinary sodium/potassium ratio 
(mmol/mmol) 2.9 (1.3) 2.3 (1.3) 
 
<0.0001 
Calcium, mg/1,000 kJ 95.5 (38.3) 99.9 (36.6) 0.003 
Copper, mg/1,000 kJ 0.15 (0.05) 0.17 (0.05) <0.0001 
Iron, mg/1,000 kJ 1.63 (0.70) 1.74 (0.67) <0.0001 
Magnesium, mg/1,000 kJ 34.9 (10.4) 38.0 (10.0) <0.0001 
Phosphorus, mg/1,000 kJ 148.8 (34.4) 151.9 (32.9) 0.02 
Selenium, µg/1,000 kJ 12.5 (7.1) 12.3 (6.8) 0.46 
Vitamin A, IU/1,000 kJ 689.9 (823.9) 891.8 (787.8) <0.0001 
Beta-carotene, µg/1,000 kJ 315.8 (473.6) 427.8 (452.8) <0.0001 
Retinol, µg/1,000 kJ 48.9 (62.0) 53.4 (59.3) 0.07 
Thiamin, mg/1,000 kJ 0.20 (0.07) 0.22 (0.07) <0.0001 
Riboflavin, mg/1,000 kJ 0.21 (0.07) 0.22 (0.07) 0.003 
Niacin, mg/1,000 kJ 2.7 (1.0) 2.7 (0.9) 0.37 
Pantothenic acid, mg/1,000 kJ 0.56 (0.19) 0.61 (0.18) <0.0001 
Vitamin B6, mg/1,000 kJ 0.22 (0.08) 0.24 (0.08) <0.0001 
Vitamin B12, µg/1,000 kJ 0.54 (0.56) 0.56 (0.54) 0.32 
Vitamin C, mg/1,000 kJ 7.7 (8.3) 17.4 (7.9) <0.0001 
Vitamin E, mg/1,000 kJ 1.1 (0.5) 1.1 (0.5) 0.44 
Folic acid, µg/1,000 kJ 31.2 (14.3) 36.9 (13.7) <0.0001 
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Variable Predicted non-citrus 
consumers
2
 
(N=1,211) 
Predicted citrus 
consumers
2
 
(N=787) 
P value 
 Mean (SD) Mean (SD)  
Systolic blood pressure,  
mm Hg 120.2 (15.8) 118.5 (15.1) 0.005 
Diastolic blood pressure,  
mm Hg 75.3 (10.8) 75.5 (10.3) 0.64 
Body mass index, kg/m
2
 28.7 (6.7) 27.6 (6.4) <0.0001 
Education, years 13.3 (3.4) 14.5 (3.2) <0.0001 
 
Abbreviations: FA=fatty acids, MFA=monounsaturated fatty acids, PFA=polyunsaturated fatty acids, 
SFA=saturated fatty acids 
1Adjusted for age, gender, and country by least squares means from all four visits 
2Predicted citrus consumer = urinary proline betaine integral >39.4 in both 24-hr collections; Predicted 
non-citrus consumer = urinary proline betaine integral ≤39.4 in both 24-hr collections. Individuals with 
urinary proline betaine integral >39.4 in one 24-hr collection only (N=645) were excluded. The value 39.4 
translated to a PB : CREA ratio threshold of 0.065, as assessed independently and described in chapter  
section 3.5.7  
3Keys score = 1.35 × (2×SFA [% kcal] – PFA [% kJ]) + 1. 5×√cholesterol [mg/4,184 kJ] 
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3.6 Discussion 
 
Linking the food metabolome and urinary metabolome  
A nutrition study was undertaken to investigate metabolic changes of the urinary 
metabolome induced by specific food consumption. Exemplar food challenges were a 
fruit mix (comprising orange, grapefruit, apple, and grapes), animal protein (beef and 
fish) and wine and grapes. A set of metabolites occurring in urine samples post food 
challenge was elucidated using untargeted 1H NMR metabolic profiling. The food 
metabolome was investigated in order to biologically link the urinary metabolite 
excretion to ingested food metabolites. As there are no real ‘control’ diets in 
nutritional studies, each food challenge was compared to the standard diet but also to 
all other food challenges, with similar results, except for tartrate as this metabolite 
occurred in two challenges. In the past, most nutritional studies and 
nutrimetabonomics studies have focussed on collecting 24-hr urine [155-157]. This 
approach allows to control for completeness of urine collection [158], opens the 
possibility to correct biomarker excretion (i.e. urinary dilution effects) for 24-hr 
creatinine and reduces variability (i.e. diurnal variability [159]). However, this study 
aimed to enable the investigation of both urinary metabolome alterations as well as 
monitoring of excretion kinetics over time. Furthermore, creatinine excretion is biased 
by muscle mass, BMI, age and physical activity [160-162]. In addition, 24-hr urine is less 
feasible and more expensive to sample for epidemiologic studies than spot urines. 
Therefore, timed spot urine samples were collected rather than averaged 24-hr 
collections. To account for differences in urinary volume and dilution effects, NMR 
spectra were normalised using probabilistic quotient normalisation [90]. The excretion 
kinetics were studied by integrating the spectral area of each characteristic NMR peak 
and plotted over time. This was done in a straightforward approach by selecting the 
main peak area and integrating the peak area. This method introduces variation due to 
overlapping peaks, small peak shifts and incomplete peak area integration. These 
variations explain in parts the relatively high standard deviation of each metabolite plot 
and the non-zero integral even when the metabolite is not excreted. However, the 
relative concentration measured by peak integration after food ingestion was markedly 
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higher than the “background” measurements. The origin of each plotted urinary 
metabolite was explored by investigating the food metabolome of each dietary 
component. In the past, exploration of food composition was focussed mainly on 
macronutrients and micronutrients, and more recently on polyphenols. However, there 
is only limited data on the overall metabolite composition. Ripening status, origin, fruit 
varieties, cooking and wine maturation affect the metabolite composition of fruits, 
vegetables and wine. Animal protein composition is affected by factors such as origin, 
animal feeding, cooking and food processing [117, 163, 164]. Consumption of a fruit mix 
composed of apples, oranges, grapefruit and grapes, resulted in excretion of proline 
betaine and tartrate, which are ingredients of oranges/grapefruits [165] and grapes 
(and wine), respectively. As expected, tartrate was excreted after grape and wine 
consumption. The excretion of 4-OH-hippurate and hippurate after fruit consumption 
occurred only after several hours. 4-OH-hippurate and hippurate are products of gut 
microbiota metabolism of fibre and different polyphenols present in fruits, and of 
conjugation with glycine in the liver and gut mucosa [166, 167]. Fibre and polyphenols 
are present in many other food components, e.g. whole-grains. Since the standard diet 
included whole-grain bread in the morning and for lunch, the hippurate excretion 
varied over the course of the day and diminished the observable effects of fruit 
consumption on hippurate excretion. These effects were also observed by van Dorsten 
et al. [105] who examined the effects of grapes and wine via mass spectrometry and 
found elevated hippurate and phenolic acids excretion.  
Excretion of metabolites present in wine (tartrate, ethanol, 2,3-butanediol, 2-
isopropylmalate, diethymalonate and an unknown compound, δ 1.10 (d)) were 
observed within 2 hours after the consumption of wine. Most of these metabolites 
undergo transformation in liver. Ethanol is oxidised to acetaldehyde and further to 
acetate successively by alcohol dehydrogenase and acetaldehyde dehydrogenase. 
Finally, acetate can be activated to acetyl-CoA (acetyl-CoA synthetase) and used for 
NADH production in the citric acid cycle. Acetate is also a direct constituent of wine; 
however, increased excretion of acetate could only be observed in some volunteers 
and was therefore not significantly correlated with wine consumption. 2,3-Butanediol is 
known to get reversibly oxidised to acetoin and oxidised to CO2 and acetate in rat liver 
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[168]. 2,3-butanediol is also discussed as a potential biomarker for alcohol abuse [169-
171]. 2-Isopropylmalate can be metabolised to leucine and 2-oxoisovalerate, but this has 
only been shown for yeast and bacteria [172, 173]. None of the metabolised compounds 
appeared to be increased in the urinary metabolite profile. This might highlight the fact 
that human metabolism transforms specific food metabolites to metabolites that are 
less specific, and how transformation of exogenous metabolites opens the possibility 
to further use the metabolite for energy production (e.g. acetate) and body mass 
turnover (e.g. leucine). All observed changes are summarised in a metabolism overview 
flowchart in Figure 21.  
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Figure 21 Summary figure illustrating the involvement of human metabolism in the processing of the 
food metabolome of fruit and wine.  
 
Fish and beef consumption resulted in excretion of TMAO, choline, carnitine, taurine, 
creatine, 3-methylhistidine and an unknown metabolite with resonance at δ 2.90 (t). 
This confirms findings from Stella et al., who also reported increased excretion of 
TMAO, creatine, taurine and (acetyl-)carnitine in response to a high meat diet [101] and 
of other authors [174-176]. The majority of creatine is utilised by the muscle to form 
phosphocreatine to regenerate ADP to ATP for energy metabolism. However, small 
quantities of creatine are excreted in urine after consumption of a creatine-rich meal 
[177]. Creatine and phosphocreatine are non-enzymatically converted to creatinine and 
subsequently excreted via urine. Creatinine undergoes large diurnal and inter-individual 
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differences and the proportionally small diet-induced changes could therefore not be 
observed. However, a separate investigation of metabolic changes in fish consumers, 
where 24-hr urine was collected (INTERMAP UK), confirmed these effects. Fish and 
beef are an important source of carnitine.  L-carnitine is essential for the transport of 
long-chain acyl-groups from the cytosol into mitochondrial matrix to undergo β-
oxidation for energy production [178]. Choline, which is present as choline chloride or 
as lecithin in beef and fish, is taken up by liver and kidney to form betaine, phospho-
choline and lecithin, and betaine is successively excreted via urine [179]. Taurine is used 
to conjugate bile acids, and gets converted into sulphate by the gut microbiota, 
metabolised to isethionic acid, or is incorporated in the exchangeable muscle taurine 
pool [180]. Most ingested taurine however is readily excreted, which was also 
confirmed in this study. The metabolite with a triplet at the chemical shift δ 2.90 
remained unassigned, despite effort using STOCSY and various 2D-NMR experiments. 
However, it is possible that this metabolite has a structure similar to glutamyl-cysteine 
or glutathione. This assumption is based on similar 1H-1H and 13C chemical shifts of these 
compounds to the unknown metabolite (see appendix). Besides many common 
ingredients, the animal proteins fish and beef had distinct composition differences such 
as anserine and carnosine [152], different fatty acid pattern [181] and the absence of 
TMAO in beef. These differences explain the lack of immediate TMAO and 3-
methylhistidine excretion after beef consumption. TMAO, in turn, is likely to be 
produced by the gut microbiota from choline present in beef, along with 
trimethylamine and dimethyamine [179]. Due to the short succession of fish 
consumption after beef, it was not possible to confirm these effects with the chosen 
study design. 3-methylhistidine was excreted after consumption of fish. The liver 
metabolises anserine to 3-methylhistidine and β-alanine (by anserinase), thereafter 3-
methylhistidine is excreted. A similar reaction occurs after the consumption of 
carnosine in beef with β-alanine and histidine being produced (enzyme: carnosinase). 
Histidine, however, is likely to be used for protein synthesis in the body and was 
therefore not observed to be elevated in urine after beef consumption.  
All observed changes are summarised in a metabolism overview flowchart in Figure 22. 
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Figure 22 Summary figure illustrating the involvement of human metabolism in the processing of the 
food metabolome of animal protein. Abbreviations BA-taurine, tauro-conjugated bile acids.   
 
 
A metabolic phenotyping strategy for discovery of nutritional biomarkers in 
individuals and populations: proline betaine as a marker of citrus consumption 
A strategy for food biomarker discovery is presented, based on untargeted metabolic 
profiling of urine specimens from a nutritional intervention study and subsequent 
validation of the candidate biomarker using epidemiological data [182].  
Urinary excretion of proline betaine was identified as a specific and sensitive biomarker 
of citrus fruit intake. While several nutritional biomarkers, such as total urinary nitrogen 
or urea for protein intake [183], 24-hr urinary sodium and potassium for sodium and 
potassium intake [147, 183] exist, there are to date few validated biomarkers for 
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specific foods, the most cited example being increased excretion of resveratrol after 
red wine consumption [184].  
The study sizes used in nutritional intervention studies tend to be relatively small and 
the dietary intervention given within a controlled background. Therefore, proposed 
food or nutrient biomarkers derived from such studies cannot always be extrapolated 
to population studies in free-living individuals. Here the rich data resource of a well-
validated large-scale epidemiologic study was harnessed to establish whether the 
biomarker for citrus fruit is applicable to populations and to ascertain whether it can 
act as a surrogate indicator of healthier eating patterns. 
First, proline betaine was identified as a candidate citrus fruit biomarker by analysing 
urine specimens from a food intervention trial by 1H NMR untargeted metabolite 
profiling, i.e. without preselection or prior knowledge of the metabolites to be 
measured. The follow–up kinetics study showed that proline betaine is excreted rapidly  
after ingestion in the urine, and that urinary excretion is nearly complete after 24 
hours, indicating that proline betaine is metabolically inert or minimally metabolised in 
humans, which is in agreement with other reports in the literature [185]. Given that 
proline betaine appears to be unmodified by metabolic processes, it overcomes the 
biases and errors introduced by processes such as metabolism that can occur with 
traditional biomarkers such as vitamin C and carotenoids [186].  
Since proline betaine is not metabolised and the CH3-signal used in the measurement is 
in a relatively uncrowded spectral region, and therefore not significantly compromised 
by other metabolite signals, it is a robust indicator not only of citrus fruit intake but also 
of the quantity of citrus fruit consumed. There are, however, small underlying signals in 
this spectral area (e.g. amino acids) and this is the main reason why the integral of 
proline betaine and ratio PB : CREA are not zero in participants not consuming citrus 
fruits. The obtained correlation coefficient between citrus fruit intake and urinary 
proline betaine of 0.80, whereas carotenoids for citrus intake ranged from 0.26-0.41 
[137], plasma vitamin C for vitamin C intake ~0.4 [187] and total carotenoids for fruit 
and vegetable consumption up to 0.38 [137]. Thus the use of proline betaine as a 
biomarker gives both a quantitative as well as qualitative measure of citrus fruit intake, 
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an important advantage over many questionnaire approaches which are qualitative or 
semi-quantitative in nature [188, 189].   
Proline betaine and the PB : CREA ratio predicted citrus fruit consumption equally well. 
The ratio of proline betaine and creatinine allows these results to be extrapolated to 
NMR-independent datasets e.g. by developing a dipstick test to quantify proline 
betaine and creatinine. Since creatinine can be influenced by muscle mass and BMI it 
was therefore chosen to proceed with additional analyses using the proline betaine 
measure only.  
Proline betaine is known to act as an osmoprotectant in citrus fruits, alfalfa sprouts 
[190], molluscs [191] and bacteria [192]. Previous reports have identified proline betaine 
in orange juice [165], and in humans it is reported to be increased in plasma and urine 
after orange juice consumption [193]. From analysis of fruits and commercial juices it 
was ascertained that proline betaine concentrations varied according to type of citrus 
fruit as well as fruit processing (manufactured juice vs. freshly squeezed), suggesting 
the importance of pulp extraction, pasteurisation, etc. [194]. This is consistent with 
reports that phenolic compounds and vitamin C concentration increase with more 
vigorous juice extraction and squeezing techniques [195]. The proline betaine content 
in authentic (100%) orange juice is higher (>6 times) compared with orange soft drinks 
and orange squash, allowing differentiating between citrus fruit juices and synthetic 
citrus drinks, which may not always be correctly differentiated by participants in dietary 
recall studies. 
Urinary excretion of proline betaine was also found to have high specificity and 
sensitivity as a marker of citrus fruit intake in high quality epidemiological data using 
the multi-pass 24-hr dietary recall method as an independent measure of citrus fruit 
intake [147]. Presence of proline betaine in brie or blue cheese [153] and alfalfa sprouts 
has also been reported [196], but at substantially lower levels (~ 1/5 concentration of 
citrus fruits). Interrogation of the INTERMAP data did not find association between 
blue/brie cheese consumption and proline betaine levels and none of the participants in 
the INTERMAP UK samples reported consuming alfalfa sprouts. Thus in the INTERMAP 
sample, the measured proline betaine excretion related overwhelmingly to citrus fruit 
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intake, since other dietary sources do not contribute, and proline betaine is not 
synthesised or metabolised in the lumen or elsewhere. 
We have found proline betaine to be a robust biomarker of citrus fruit consumption in 
the western population. However this biomarker has not yet been validated in eastern 
populations. Furthermore, since proline betaine is predominantly excreted within 24 
hours after consumption, it can only be used as evidence for acute intake of citrus fruit.  
Although it is important to ascertain the effects of single nutrients or foods with 
respect to risk for diseases such as cardiovascular disease or cancers, more recently 
there has been a shift in emphasis to address the relatively greater impact of dietary 
patterns with respect to disease risk. Thus a food pattern dominated by fruit, 
vegetables, fish, whole-grains and legumes correlates negatively with attributes of the 
metabolic syndrome [128], cardiovascular disease risk factors [197], risk of colorectal 
cancer [129], and blood pressure and serum lipids [131]. Analyses of the UK and US 
INTERMAP samples showed that there were significant differences in dietary pattern 
for citrus fruit consumers vs. non-consumers, as confirmed by NMR-detected urinary 
proline betaine excretion. Citrus fruit consumers had a diet lower in total fats, lower 
Na/K ratio, higher in vegetable protein, micronutrients and fibre than non-citrus 
consumers. These associations are likely to derive from the composition of citrus fruits, 
with high proportions of carbohydrates, vitamin C and A, folic acid, magnesium and 
potassium [198], but also from different eating patterns of citrus consumers, such as 
less fats and animal protein and higher vegetable protein.  
Citrus fruits and juice is known to be the main dietary source of vitamin C [199] and that 
was also shown here were citrus consumers had a 2.3x  higher vitamin C intake than 
non-consumers. Furthermore, citrus consumers also had lower BMI and systolic blood 
pressure, conferring to reduced incidence of cardiovascular disease [200].  
 
Conclusions 
The urinary metabolome could clearly be linked to the ingested food metabolome 
following specific dietary challenges. The utility of a strategy combining metabolome-
wide association via untargeted metabolic profiling in nutritional intervention studies 
with validation in free-living populations was demonstrated. The identification and 
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validation of biomarkers of food intake was exemplified here by proline betaine for 
citrus fruit intake. This biomarker could in future serve as a correction factor and 
accuracy control of dietary recalls with regard to intake of citrus fruits. The strategy 
exemplified here is applicable to other techniques, such as mass spectrometry-based 
metabolite profiling and may help for elucidation of more food biomarkers. This 
nutrimetabonomics approach to biomarker identification and verification should 
facilitate the evaluation of individual diets towards healthier eating to promote healthy 
lifestyles and longevity, and promises potential for the discovery and validation of 
additional novel food biomarkers.  
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CHAPTER 4: Inter-individual differences in human metabolic phenotypes  
 
4.1  Summary 
The urinary metabolic profiles of volunteers participating in a nutritional study were 
investigated. The effect of different pattern recognition methods was evaluated with 
reference to the influence on data visualisation and their utility in elucidating inter-
individual differences. Each individual’s inherent imprint on the human urinary 
metabolic phenotypes was demonstrated, as well as individual differences in response 
to food intake.  
 
 
4.2  Aims and Objectives 
 To compare the use of different pattern recognition techniques (both 
supervised and unsupervised) with regard to characterising inter-individual and 
food-related influences 
 To elucidate baseline differences in the metabolite profile of individuals 
 To investigate individual differences in metabolic responses related to food 
intake 
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4.3  Introduction  
One of the main aims of nutritional research is to generate personalised lifestyle 
recommendations to improve health and life quality. It is therefore of interest to 
characterise the metabolic phenotype of individuals and to establish the extent to 
which we can influence this phenotype by nutritional and lifestyle interventions.  
Measuring changes in multiple metabolite concentrations is a powerful approach for 
assessing the nutritional status of humans and can be integrated with anthropometric 
and psychological measurements, to help estimate an individuals’ nutritional 
phenotype [27]. The nutritional status embodies much more as the balance between 
nutrient intake and energy expenditure. Metabolites and nutrients supplied by 
nutritional intake can prevent disease development and promote overall well-being 
and healthy ageing. 
Nuclear magnetic resonance (NMR) spectroscopy and liquid chromatography mass 
spectrometry (LC-MS) are powerful analytical tools for characterising biofluids and 
tissues for defining a metabolite profile. The measurement of many metabolites 
simultaneously in a semi-quantitative way can be achieved efficiently using multivariate 
statistical data analysis techniques (chemometrics) [14] as described in the previous 
chapters. 
In recent years, a number of metabonomics studies have been undertaken to assess 
the metabolic phenotype of humans. These studies mainly focussed on the effect of 
dietary interventions on the metabolic phenotype [101, 106, 107, 201, 202]. Efforts have 
also been directed towards describing metabolic differences between subjects on the 
basis of age, gender and BMI [25], culture and diet preferences [202], menstrual cycle 
[203],  and diurnal variation [204] and as such have focussed on the individual 
metabolic phenotype as a starting point for lifestyle intervention. Distinguishing urinary 
metabolite profiles from individuals has been successfully described by Assfalg et al. 
[205], where multiple urinary samples from 22 individuals were correctly predicted to 
the donors in a supervised pattern recognition approach. Extending the analysis to 
sample collections across 3 years [206] revealed a set of metabolites that consistently 
allowed the identification of these individuals.  
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Factors such as variation in enzyme activity, different muscle mass, estrogen 
production, the status of physical activity, obesity and gut microbial ecology all 
influence the metabolic profile or metabotype: Variation in enzyme activity can for 
example lead to differences in glucuronidation/sulphation rates and muscle mass 
influences the extent of creatinine excretion. Gender differences introduce hormonal 
differences e.g. in estrogens, and these are known to play a role in lipid metabolism 
influencing plasma lipoproteins. Obesity, i.e. higher BMI is linked to creatinine and 
lipoprotein differences and protein and carbohydrate putrefaction products such as 
hippurate and p-cresol-sulphate are influenced by the gut microbiota. 
These individual metabolic differences can also be described by the metabolic space 
each person occupies, and the key question is whether this metabolic starting point 
can predict the outcome of a drug or lifestyle intervention. Clayton et al. described the 
proof-of-principle of such a prediction effort, the pharmaco-metabonomics concept, 
for analgesic intervention in rat [207] and man [63]. They showed the feasibility of 
predicting the outcome of paracetamol intervention based on the metabolic profile of 
a pre-dose urine sample. 
Here, urinary samples from a diet-controlled clinical trial were used to investigate the 
contribution of metabolic baseline differences in healthy individuals using various 
pattern recognition techniques. Several metabolic pathways are described that are 
heavily influenced by metabolic individualism along with metabolites resistant to 
individual variation. This type of analysis will help to better define a healthy phenotype 
and elucidate how modification of lifestyle may assist in reaching and maintaining 
metabolic health.  
 
4.4  Material and Methods  
 
4.4.1  Nutrition study dataset 
Details of the nutrition study dataset, i.e. study design and NMR spectroscopy, are 
outlined in chapter sections 3.4.1 and 2.1.5.1.   
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4.4.2  Pattern recognition techniques:  Principal component analysis (PCA) and 
orthogonal projections to latent structures discriminant analysis (O-PLS-DA)  
PCA was performed as described in chapter section 2.3.2.  Loadings plots of the PCA 
analysis were created calculating the covariance and correlation between the original 
data matrix and the PCA scores. The covariance plot gives a pseudo-1-D NMR spectrum 
and the correlation coefficients (r2) are super-imposed as colour-code. Pair-wise O-PLS-
DA, see chapter section 2.3.4, was carried out comparing urine samples obtained from 
each volunteer to all other volunteers. The Y matrix was used as a sample donor 
identifier.   
 
4.4.3  Hierarchical cluster analysis 
Hierarchical cluster analysis was carried out using the Matlab Statistical Toolbox; the 
same dataset was used as for PCA analysis (i.e. full resolution spectral data, including all 
volunteers). Sample distance was calculated using Euclidian distance and linkage 
analysis was done calculating the average distance. Finally, a dendrogram showing the 
similarity and distance of each sample in the dataset was plotted, and data tree 
branches colour-coded for sample donor (volunteer) and diet challenges.   
 
4.4.4  Self-organising maps 
The self-organising maps algorithm was implemented using the SOM Toolbox 2.0 
(http://www/cis.hut.fi/projects/somtoolbox). The resolution of the dataset was reduced 
to 0.01 ppm for better data handling (e.g. faster model calculation). The algorithm 
randomly assigns node weight vectors in the map and calculates the Euclidian distance 
(batch training) between the node vector and the input (sample) vector and drops the 
sample into the node with the smallest distance. This is an iterative process and the 
node gets constantly updated via a Gaussian neighbourhood function. Each sample is 
then plotted onto the node map and colour-coded for (i) sample donor and (ii) food 
challenge.   
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4.4.5  Investigation of individual excretion kinetics and box plots 
Calculation of the NMR peak integrals is outlined in chapter 2.5. Boxplots were created 
in Matlab using the peak integrals of metabolites to illustrate individuals’ average 
metabolite levels.  
 
4.5  Results 
 
4.5.1  Overview of study participant’s metadata 
The metadata of all volunteers is presented in Table 7. All volunteers were healthy, non-
smokers, non-vegetarian, had a healthy BMI (21-25 kg/m2) and were in an age range of 
28 – 43 years. Volunteers were asked to refrain from drug intake and extensive physical 
activity. Only 1 person (volunteer 6) was male. Volunteers 1a and 1b are in fact the same 
person who participated in the study twice, with 3 months apart. Volunteer 1a were 
treated as an estimator of metabolic stability, and all further analyses were done 
including volunteers 1b-8 to ensure independence of the dataset of each volunteer to 
the others.  
 
Table 7 Metadata of all participants, showing their gender, ethnicity, age and BMI and colour-code used 
for later illustrations. 
 
volunteer gender ethnicity age BMI   
1a F caucasian 28 22.3  
2 F afr.-amer. 29 22.6  
1b F caucasian 28 22.3  
4 F chinese 41 21.4  
5 F caucasian 27 20.8  
6 M caucasian 38 21.0  
7 F caucasian 43 24.7  
8 F caucasian 30 23.1  
 
4.5.2  Principal component analysis (PCA) for unsupervised investigation of inter-
individual and food-related influences on the metabolic phenotype 
1H NMR spectra obtained from the urine of all 7 volunteers were analysed by PCA.  This 
approach was used to detect outliers using the 95% confidence interval of PCA scores 
plots. Outliers were influenced by inadequate spectral acquisition (i.e. due to poor 
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water suppression, low spectra quality, spectral artefacts) and additional outliers 
resulting from predominant peaks (i.e. ethanol) were identified (see Figure 23). Such 
outlier samples were removed from the dataset where appropriate. PCA was carried 
out using two scaling methods (UV scaling and Pareto scaling). The number of 
components is selected on the basis of the fraction of explained variance and 
predictive ability that is added by including more components (Figure 24). 
 
 
Figure 23 Principal component analysis (UV scaled) including all collected samples (N=197). Visual 
inspection of samples outside the 95% confidence interval revealed the reason behind outlying samples, 
as indicated on the scores plot. The scores are coloured by individuals: volunteer 1 (open circle: 1b), 
volunteer 2, volunteer 4, volunteer 5, volunteer 6, volunteer 7, volunteer 8. Abbreviations: S/N, signal-to-
noise ratio. 
 
This is also the cut-off, where R2X and Q2X are still increasing steeply. As this approach 
is slightly arbitrary, more PC’s were looked at and are shown in the appendix (Figure 
110, Figure 111). 
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Figure 24 Overview of proportion of explained variance (R2X) and their predictive ability (Q2X) for (A) 
Pareto-scaled data and (B) UV scaled data for each principal component. Number of included 
components highlighted in red. Abbreviations: cum, cumulated.  
 
4.5.2.1  PCA analysis using Pareto scaled data 
The urine 1H NMR spectra of all 7 volunteers were analysed by PCA to investigate 
pattern, clusters and trends in the dataset. Clustering trends due to inter-individual 
differences were apparent in all principal components, whereas food influences were 
only visible in PC 1 and 3 (animal protein), see Figure 25. No other food group clusters 
were observable in the scores plots. The metabolites driving the separation (i.e. 
loadings plots) are shown in Figure 26 and Figure 27. Principal component 1 is driven by 
urine samples collected after animal protein. PC 2 clusters samples collected from 
volunteer 8. PC 3 clusters samples collected after fish consumption, however the 
loadings plots also include metabolites such as hippurate and gut microbial-mammalian 
co-metabolites. PC 4 is driven by varying concentrations of hippurate (e.g. volunteer 5 
with relatively low levels). PC 5 accounts for differences in creatinine with volunteer 2 
having relatively low levels. And finally PC 6 summarises urinary metabolites detected 
after wine consumption, this is however not clearly visible in the scores plot.  
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Figure 25 PCA scores plots derived from spectral data comparing the influence of inter-individual and 
food related differences on separation after Pareto scaling (PC1-PC6). PCA was carried out including all 
urine spectra, coloured by individuals (left column): volunteer 1b, volunteer 2, volunteer 4, volunteer 5, 
volunteer 6, volunteer 7, and volunteer 8. Right column, coloured by food groups: standard meal, fish 
meal (animal protein), beef meal (animal protein), fruit meal, wine and grapes. 
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Figure 26 PCA loadings plots of the principal components 1 to 3. Discriminating metabolites are 
highlighted according to their contribution to the model (see chapter 2.3.2 for method description). 
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Figure 27 PCA loadings plots of the principal components 4 to 6. Discriminating metabolites are 
highlighted according to their contribution to the model (see chapter 2.3.2 for method description). 
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4.5.2.2  PCA analysis using UV scaled data 
The PCA analysis was repeated using UV scaling. Clustering trends due to inter-
individual differences were apparent in all principal components, and food influences 
were visible in principal components 4 (animal protein; metabolites: 3-methylhistidine, 
TMAO, creatine, taurine, and others) and 6 (fruit meal; metabolites: tartrate, 4-OH-
hippurate, and others), see Figure 28. 
Principal component 1 is driven by variations in baseline/water suppression, and no 
clear clustering for individuals and/or foods are apparent. The scores and loadings of 
principal components beyond PC 6 were investigated and showed that inter-individual 
clustering was still observable. This might be due to the fact that both inter-individual 
and food-related influences occupy the principal components, leading to more than 7 
classes.  
Overall, the main variation in urinary profiles was due to inter-individual influences. The 
variation is dispersed across many principal components so that variation differences 
of one individual is not summarised in one component. Therefore, there is a need for 
additional chemometrics modelling to elucidate the individual differences.   
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Figure 28 PCA scores plots derived from spectral data comparing the influence of inter-individual and 
food related differences on separation after univariate scaling (PC1-PC6). PCA was carried out including 
all urine spectra, coloured by individuals (left column): volunteer 1b, volunteer 2, volunteer 4, volunteer 
5, volunteer 6, volunteer 7, and volunteer 8. Right column, coloured by food groups: standard meal, fish 
meal (animal protein), beef meal (animal protein), fruit meal, wine and grapes. 
 
The initial PCA analysis highlighted that only few principal components are influenced 
by variation introduced by specific food challenges, and that inter-individual differences 
account for the main sources of variation in the data. As such, UV scaled data showed 
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separation due to food challenge in PC 4 (animal protein)  and PC 6 (fruit challenge). All 
other components accounted for inter-individual differences. Pareto-scaled data also 
showed influences of food-derived metabolites: PC1 and PC3 (animal protein). All other 
food influences (e.g. fruit challenge and wine/grapes challenge) did not clearly 
separate samples in the scores plots of the global data set.  
To investigate the contribution of inter-individual differences without possible variation 
introduced by individual responses to diet challenges, a PCA analysis was carried out 
including only metabolic profiles from urine samples collected while consuming the 
standard diet (1st sample day 1 – 3rd sample day 2, 7 samples per volunteer).  
The analysis was performed with both UV scaled and Pareto-scaled data and the 
number of principal components chosen after the same rules as specified in chapter 
4.5.2. The main discriminating metabolite resonances for the different individuals, as 
seen in the loadings plots, were consistent across the two scaling methods, however, 
the separation of clusters in the scores plot of Pareto-scaled data was slightly better. 
Therefore, only results from Pareto-scaled PCA analysis are shown here.  
 
 
Figure 29 PCA scores plots of Pareto-scaled data, including samples only under the standard diet (time 
points 1 to 7). Data points were coloured by donor (individual): volunteer 1b, volunteer 2, volunteer 4, 
volunteer 5, volunteer 6, volunteer 7, volunteer 8. 
 
Separation trends of samples collected from volunteer 8 (PC 1), volunteer 7 (PC 2), 
volunteers 2 and 5 (PC 3) and volunteer 2 (PC4) was observed (Figure 29), and 
metabolites driving these clustering trends are listed in (Table 8).  
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Table 8 Summary of all metabolites accounting for clustering of samples in the PCA loadings plots from 
Pareto-scaled data in PC 1 -6 (* aromatic resonances: δ 6.37 (d), 6.49 (m), 6.53 (m), 6.67 (d), 6.70 (bs), 
6.91 (s), ** putatively assigned as pyridoxine metabolite).   
 
PC Metabolite direction  PC metabolite direction 
PC1 Trigonelline ↑  PC3 hippurate ↓ 
  δ 8.50 (bs) ↓   creatinine ↑ 
  δ 7.67 (s)** ↓    pyruvate ↑ 
  Hippurate ↑    2-OH-isobutyrate ↑ 
  Citrate ↓    3-OH-isovalerate ↑ 
  Dimethylamine ↓  PC4 aromatic resonances* ↑ 
  Dimethylglycine ↓   guanidoacetate  ↓ 
  δ 4.30 (t) ↓    mannitol ↓ 
  various acids  ↓    δ 2.00 (m) ↓ 
  Creatinine ↓    N-acetylated metabolite ↓ 
PC2 Hippurate ↓  PC 5
5 formate ↑ 
  p-cresol-sulphate ↓    betaine ↑ 
  phenylacetylglutamine ↓    creatinine ↓ 
  Creatine ↓    glycine ↑ 
  trimethylamine-N-oxide ↓   PC 6 phenylacetylglutamine ↓ 
  δ 8.50 (bs) ↓   p-cresol-sulphate ↓ 
      indoxyl-sulphate ↓ 
 
In summary, both Pareto- and UV-scaled data return similar results. UV scaling includes 
low small-abundant metabolites; however it is also more prone to over-emphasising 
contributions from noise in the dataset, as it gives each variable of the NMR spectrum 
equal weight. The main variation in the dataset is attributed to inter-individual 
differences and only the animal protein food challenges introduces systematic 
metabolic alterations strong enough to move all individuals out of their own ‘typical’ 
metabolic space. PCA analysis of samples from the standard diet revealed a similar 
                                                        
5
 Differences in water suppression influenced PC 5 
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variation pattern, suggesting that baseline metabolic differences are the main source 
of variation, rather than individual response to diet.  
 
4.5.3  Hierarchical cluster analysis  
A hierarchical cluster analysis (HCA) was carried out, using the full dataset of all n=7 
volunteers, including up to 25 time points per person. Each urine sample is mapped in a 
dendrogram and samples are colour-coded for their donor origin and food challenge 
(Figure 30). To create the cluster tree, the euclidian distance was used for calculation of 
the mathematical distance of the metabolic profile from each urine sample and 
average distance for linkage analysis. The nature of HCA allows variation to be 
summarised into a 1-dimensional space. This can be of advantage, to allow a global 
overview of the data structure but can also be a drawback as it does not open the 
possibility to disperse variation into an n-dimensional space of principal components 
(cf. PCA analysis). This analysis confirms findings of PCA, that (i) each volunteer 
occupies their own metabolic space and (ii) a dietary intervention such as animal 
protein consumption introduces metabolic changes strong enough to move each 
person’s metabolic profile to a new, shared metabolic space (Figure 30).  
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Figure 30 Hierarchical clustering analysis dendrogram (euclidian distance, average distance linkage) derived from the 1H spectral data. Each sample is colour-
coded by “volunteer”, i.e. urine sample donor and “food challenge”, i.e. sample collected in the 24-hr time frame after this food consumption. Volunteers: 
volunteer 1b, volunteer 2, volunteer 4, volunteer 5, volunteer 6, volunteer 7, volunteer 8.Foods: 1- standard, 2-fruit meal, 3-fish meal, 4-wine/grapes, 5-beef meal, 
6-fish meal. 
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4.5.4  Self-organising Maps 
Self-organising maps, or Kohonen maps, are a type of artificial neural network that 
map observations based on their relative similarity to each other in an unsupervised, 
non-linear fashion. This enables a remapping of observations so that similar 
observations (here: metabolic profiles of urine) share a node or are mapped into 
adjacent nodes. This transformation can be called a non-linear projection of the 
probability density function of the n-dimensions from the original data onto a 2D map 
[208]. This approach has previously been applied for classification of lipoprotein 
classes [209], Alzheimer’s disease [210] and cancer [211] using 1H NMR spectral data 
from plasma.  
Figure 31 illustrates such a self-organising map, as carried out with samples collected 
from the nutrition study. (A) shows the map with nodes colour-coded for the sample 
donor (individual) and (B) illustrates colour-coding after specific food consumption.  
Volunteers 1, 2, 6, and 8 occupy most of their nodes alone and most nodes cluster 
closely, while volunteer 5 is dispersed across the map and most nodes with volunteer 
7 contain only 1 sample possibly indicating that there is a high variability between 
urinary metabolite profiles of volunteer 7 (Figure 31A). This is consistent with the HCA 
model, where volunteers 5 and 7 do not occupy their own dendrogram branch. 
Samples from volunteer 4 map closely but 3 out of 5 nodes are shared with other 
volunteers. Figure 31B illustrates the mapping of samples collected according to their 
previous food challenge. Only samples collected after consumption of animal protein 
(green nodes) cluster in terms of systematic food-driven similarities. Other food 
challenges, fruit meal and wine and grapes, do not cluster or share nodes. Urine 
samples collected from volunteers on the standard diet cluster partially; however, 
most nodes contain only 1 sample. Volunteer 6, for example, clusters 16 out of 24 
samples in adjacent nodes (middle bottom of map). Another 7 samples are located in 
the “animal protein space” on the upper left of the map.  
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Figure 31 Self-organising map of the 1H spectral data. The map was created as described in the 
methods and colour-coding superimposed for (A) volunteer, i.e. urine sample donor (colour-code: 
volunteer 1, 2, 4, 5, 6, 7, 8) and (B) food challenge, i.e. sample collected in the 24-hr time frame after 
this food consumption. Food colour-code: 1- standard, 2-fruit meal, 3-animal protein (fish), 4-
wine/grapes, 5-animal protein (beef), 6-animal protein (fish). Whole nodes were highlighted according 
to volunteer or food colour, if majority of nodes belonged to the same class. 
 
This analysis, which is based on a non-linear projection method, confirms findings 
from PCA analysis and HCA analysis that each volunteer occupies their own metabolic 
space and only leaves this space if challenged with a food introducing wide or 
extreme metabolic changes (here: animal protein). Other foods, such as fruit meal 
and wine and grapes meal did not cluster.  
 
4.5.5  Supervised pattern recognition techniques (O-PLS-DA) for investigation of 
inter-individual influences on the metabolic phenotype 
Finally, a supervised pattern recognition approach was carried out to elucidate a set 
of metabolites for each person, which is descriptive for this volunteer. For this 
approach, O-PLS-DA analysis was performed, where each volunteer was compared to 
all others. This resulted in 7 different O-PLS-DA models, from which the scores plots 
are shown in Figure 32. The model parameters from every model revealed good 
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models (R2Y= 74.7% - 92.6%) and good predictive ability (Q2Y=59.6% - 85.8%) describing 
the inter-individual variations (Table 9). The high Q2-value suggests a statistical 
significance.  
 
 
Figure 32 O-PLS-DA analysis scores plots with all urine samples, using 1 predictive and 1 orthogonal 
component for each of the 7 models, and plotting the cross-validated (Tcv) and orthogonal (TYosc) 
scores. Colour-code: (A) volunteer 1, (B) volunteer 2, (C) volunteer 4, (D) volunteer 5, (E) volunteer 6, 
(F) volunteer 7, (G) volunteer 8. Open circles: all other volunteers, for each model.  
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Table 9 Model parameters, R2Y and Q2Y for O-PLS-DA models discriminating the urinary spectral 
profiles of each volunteer to all other volunteers. For each model, 1 predictive and 1 orthogonal 
component was used.  
 
O-PLS-DA model R2Y Q2Y 
volunteer 1 vs. all others  81.7% 70.8% 
volunteer 2 vs. all others  89.5% 82.5% 
volunteer 4 vs. all others  74.7% 59.6% 
volunteer 5 vs. all others  89.1% 82.4% 
volunteer 6 vs. all others  88.7% 80.2% 
volunteer 7 vs. all others  84.1% 71.0% 
volunteer 8 vs. all others  92.6% 85.8% 
 
All resonances with a correlation coefficient greater than 0.2 were regarded as 
important6, selected as a heuristic cut-off. Consistent differences in a volunteer will 
result in a relatively higher correlation coefficient. Some of the metabolite 
resonances known to discriminate samples in the models are related to slight 
differences in food choice, e.g. use of chewing gum (attributed to the detection of 
mannitol in volunteer 1b) and consumption of tea instead of coffee (unknown 
metabolite with resonances at δ 4.51 (s), 6.98 (d), 7.38 (t) in volunteer 2). Also, inter-
individual differences in responses to food were observed, such as a lack of taurine 
excretion after animal protein by volunteer 1b and higher excretion of the unknown 
compound with a chemical shift at δ 2.90 (t) after fish and beef consumption from 
volunteer 6. While some urinary metabolites were present in relatively similar 
concentration across individuals, other metabolites showed a high degree of inter-
individual variation. Among these are high creatinine levels in volunteer 8, high 
glycine levels of volunteer 4, and low hippurate levels in volunteer 5. A summary of all 
metabolite changes is shown in Table 10.  
 
 
 
 
                                                        
6 Based on small group size as a heuristic cut-off after visual inspection. Orientation at n=25 samples 
and p<0.01, correlation coefficient is 0.15. For future analysis including larger datasets standards 
published by Chadeau-Hyam et al. will be used: Chadeau-Hyam, M., et al., Metabolic Profiling and the 
Metabolome-Wide Association Study: Significance Level For Biomarker Identification. Journal of Proteome 
Research,2010. 9(9): p. 4620-4627. 
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Table 10 Summary of inter-individual differences between 7 volunteers, as revealed by 7 independent 
O-PLS-DA analyses. Each independent analysis compared 1 volunteer vs. all other volunteers. (# 
indicates the direction of change, (+) indicates a relatively higher metabolite concentration in this 
person, (-) a relatively lower concentration). Only resonances assigned to a metabolite are shown 
here, a full table is listed in the appendix.  
 
 metabolite chemical shift multiplicity assignment r2 r# 
V
o
lu
n
te
e
r 
1 
(V
1)
 
p-cresol-sulphate 2.35 s CH3 0.35 + 
phenylacetylglutamine 7.35 t H3,H5 0.37 + 
indoxylsulphate 7.50 d H7 0.23 + 
N-methylnicotinamide 8.97 m H6 0.21 + 
trigonelline 8.84 t H2 0.18 + 
taurine 3.42 t CH2NH2 0.2 - 
mannitol 3.84 dd CH2OH 0.29 + 
N-acetylated metabolite 2.02 s CH3 0.27 - 
glutamine 2.45 m gammaCH2 0.39 - 
citrate 2.54 d CH2(ii) 0.34 - 
DMA 2.77 s CH3 0.23 - 
TMA 2.86 s CH3 0.66 + 
V
 2
 creatinine 4.05 s CH2 0.52 + 
2-hydroxy-isobutyrate 1.36 s CH3 0.36 - 
glutamine 2.45 m gammaCH2 0.22 + 
V
o
lu
n
te
e
r 
4
 hippurate 7.55 t H4 0.3 + 
trigonelline 9.12 s CH2 0.28 + 
creatine 3.93 s CH2 0.21 + 
glycine 3.57 s CH 0.55 + 
N-acetylated metabolite 2.03 s CH3 0.28 + 
V
 5
 hippurate 7.55 t H4 0.22 + 
formate 8.45 s CH 0.2 + 
3-hydroxy-isovalerate7 1.27 s CH3 0.35 + 
V
o
lu
n
te
e
r 
6
 2-hydroxy-isobutyrate 1.36 s CH3 0.3 - 
alanine 1.48 d CH3 0.27 + 
glutamine 2.14 m betaCH2 0.33 + 
citrate 2.54 d CH2(ii) 0.25 + 
DMG8 2.93 s CH3 0.28 + 
V
 7
 2-hydroxy-isobutyrate 1.36 s CH3 0.3 + 
N-acetylated metabolite 2.05 s CH3 0.21 + 
V
 8
 
alanine 1.48 d CH3 0.35 + 
citrate 2.54 d CH2(ii) 0.64 + 
DMA 2.72 s CH3 0.43 + 
creatinine 4.05 s CH2 0.62 + 
 
 
 
                                                        
7 and various unassigned aromatic resonances  
8 and various unassigned aromatic resonances 
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4.5.5.1  Investigation of the reproducibility within individual’s metabolic space 
To test the reproducibility and investigate temporal changes in the individual 
metabolic phenotype after a few months, one volunteer (volunteer 1) repeated the 
study after 3 months.  
O-PLS-DA analyses were carried out comparing (i) volunteer 1a with all other 
volunteers, (ii) volunteer 1b with all others and (iii) volunteer 1a with 1b.  All three 
m0dels had a good predictive ability: (i) R2Y=85.3%, Q2Y=75.8%, (ii) R2Y=81.7%, 
Q2Y=70.8%, (iii) R2Y=93.0%, Q2Y=74.7%.  The analyses revealed that volunteer 1 had 
consistent differences in taurine, TMA, DMG, trigonelline, δ 1.12 (d) and metabolite 
with chemical shifts at 1.69 (m), 1.79 (m), 1.99 (m) and N-acetylated compounds (δ 
2.04 m) compared to the other volunteers, regardless of time of sampling. In 
addition, temporal differences in the urine profiles of volunteer 1 (i.e. differences 
between 1a and 1b) included excretion of relatively higher levels of p-cresol-sulphate, 
phenylacetylglutamine, N-methylnicotinamide of volunteer 1b, and lower amounts of 
several energy metabolism-related metabolites (citrate, glycine, glutamine, 
glutamate, alanine) and excretion of mannitol (correlation coefficient r2 >0.2). 
Mannitol is likely to result from occasional consumption of chewing gum or food 
products where mannitol was used as sweetener and is also naturally found in some 
foods [212, 213]. Occasional consumption of chewing gum was reported by volunteer 
1b as a change compared to the first trial. Phenylacetylglutamine, p-cresol-sulphate, 
and N-methylnicotinamide are all known to be influenced by the gut microbiota [214, 
215]. Unfortunately, the clinical trial did not include collection of faecal samples and it 
was therefore not possible to investigate hypothesised changes in the gut microbiota 
in this study.  
 
4.5.5.2  Investigation of effects of diurnal variation 
An O-PLS-DA analysis was carried out to differentiate urinary metabolite profiles from 
morning, lunch-time, evening and bed-time collections to assess the inter-day 
contribution to the overall variance in the data set. The model goodness and 
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predictive ability were fairly weak with a R2Y=0.37 and Q2Y=0.17. No clustering was 
observed for morning samples and no consistent changes were observed with 
respect to the evening samples. However, urine samples collected before lunchtime 
tended to have increased coffee metabolites (δ 4.40 (s), 6.65 (m), 8.78 (d)), and 
increased resonances with chemical shifts at δ 2.21 (s), 2.48 (d), and hippurate (δ 3.97 
(d), 7.55 (t), 7.64 (t), 7.84 (d)) excretion was decreased. Samples collected at bedtime 
had relatively higher concentrations of metabolites related to animal protein 
consumption and wine and grapes consumption.  
In summary, all known metabolites were related to the dietary pattern. Slupsky et al. 
found several metabolites to be different between urine samples collected during 
the morning and the afternoon [216]. These were creatinine, mannitol, 
dimethylamine, N-methylnicotinamide, xylose and acetone. Their analysis was based 
on 60 subjects and each person provided two spot urine samples and no dietary 
standardisation was made. Gavaghan et al. reported diurnal differences in rat urine, 
comparing day and night samples [217]. Especially TCA cycle intermediates were 
different, suggesting that urinary excretion profiles reflect differences in metabolic 
activity between day and night. In this study, only a few day and night differences 
were observable. It is possible that the strong inter-individual diurnal differences and 
the dietary regimen masked possible diurnal variations.  
 
4.5.6  Excretion kinetics of selected metabolites 
Unsupervised (PCA, HCA, SOM) and supervised (O-PLS-DA) analysis revealed 
individual metabolic differences in both baseline metabolic profiles as well as in 
response to food intake. To investigate both of these influences further, integration 
of selected spectral regions (metabolite resonances) was carried out. The mean 
excretion of selected metabolites for every volunteer as well as their volunteer-
specific excretion kinetics are discussed below.  
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4.5.6.1 Excretion kinetics of metabolites in response to carbohydrate challenge 
(fruit meal) 
The first food challenge involved consumption of a carbohydrate- and fibre-rich meal. 
The normalised (probabilistic quotient) peak integrals of discriminatory metabolites, 
4-OH-hippurate, hippurate, proline betaine and tartrate (see chapter section 3.5.3.1) 
are plotted as mean per volunteer and as volunteer-specific excretion kinetics (Figure 
33 and Figure 34).   
Proline betaine and tartrate, metabolites deriving from citrus fruits and grapes/wine 
respectively, are both only present in the urinary profile when these foods are 
consumed. As they are both metabolically inert, no significant excretion kinetics 
differences are observed between the volunteers. Slight differences in the start of 
excretion might derive from variation in meal consumption and time of next urine 
collection, as volunteers were free to choose the time of dinner consumption and the 
time they went to bed.  
Excretion of 4-OH-hippurate was increased after fruit consumption in volunteer 1a, 2 
and 4 but not in volunteer 1b and all other volunteers (see Figure 34). Small amounts 
of 4-OH-hippurate were excreted throughout the study in every volunteer. 4-OH- 
hippurate derives from gut microbial degradation of polyphenols [218]. Volunteer 5 
had exceptionally low hippurate levels compared to the other volunteers. As the 
polyphenols and fibre intake was similar for all volunteers, this result suggests 
differences in the gut microbiota regarding polyphenol breakdown in this volunteer.   
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Figure 33 Boxplots and excretion kinetics of proline betaine and tartrate of each volunteer, across all 
25 time points. The outlying samples were from urine samples collected post fruit meals (fruit mix and 
wine/grapes meal). Colour-code indicates excretion kinetics of every volunteer: volunteer 1, volunteer 
2, volunteer 4, volunteer 5, volunteer 6, volunteer 7, volunteer 8. Time of food consumption is 
indicated with arrows.  
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Figure 34 Boxplots and excretion kinetics of 4-OH-hippurate and hippurate, of each volunteer, across 
all 25 time points. Outlying samples represent higher excretion of 4-OH-hippurate after the fruit meal 
and sporadic high hippurate excretion in 4 volunteers. It is clearly visible, that volunteer 1a and 1b had 
very similar hippurate excretion kinetics, until time point 18, when the diet varied. Colour-code 
indicates excretion kinetics of every volunteer: volunteer 1, volunteer 2, volunteer 4, volunteer 5, 
volunteer 6, volunteer 7, volunteer 8. Time of food consumption is indicated with arrows. 
 
Volunteer 1a (solid black line) and 1b (dashed black line) conducted the study 3 
months apart. Volunteer 1a consumed a different diet on day 5 with a high-fat diet 
instead of ham sandwich for lunch and beef and pasta in the evening (time points 18- 
21), which is mirrored in the divergence of hippurate excretion after that time point. 
All other time points show a remarkable similarity in hippurate excretion for this 
volunteer.  
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4.5.6.2 Excretion kinetics of metabolites in response to animal protein challenge 
(fish and beef meals) 
The second food challenge, animal protein, included consumption of fish (days 3 and 
6) and beef (day 5) and led to increases of TMAO, creatine (Figure 35), taurine, an 
unknown metabolite with chemical shift at δ 2.90 (t) (see Figure 36) and various 
signals in the spectral area 0f δ 3.19 – 3.30 (e.g. choline, carnitine). Overall excretion 
of these metabolites in the absence of food challenge is low but meal consumption 
results in a quick and strong increase of such metabolite excretion. This explains the 
“outliers” for each individual in the metabolite box plots as well as the excretion 
kinetics with increased urinary excretion after animal protein consumption (time 
points 12, 20, 23).  
 
 
 
Figure 35 Boxplots and excretion kinetics of TMAO and creatine of each volunteer across all 25 time 
points. The outlying samples were from urine samples collected post animal protein meal. Colour-code 
indicates excretion kinetics of every volunteer: volunteer 1, volunteer 2, volunteer 4, volunteer 5, 
volunteer 6, volunteer 7, volunteer 8. Time of food consumption is indicated with arrows. 
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Figure 36 Boxplots and excretion kinetics of an unknown compound (δ 2.90 (t)) and taurine for each 
volunteer across all 25 time points. The outlying samples were from urine samples collected post 
animal protein meal. Colour-code indicates excretion kinetics of every volunteer: volunteer 1, 
volunteer 2, volunteer 4, volunteer 5, volunteer 6, volunteer 7, volunteer 8. Time of food consumption 
is indicated with arrows. 
 
An exception to the consistent metabolite responses to animal protein across 
volunteers was the taurine excretion of volunteer 1. Here, basal taurine levels are 
very low, and no increased taurine excretion occurred after animal protein 
consumption, as visualised in the kinetics plot (Figure 36). The low taurine excretion 
was repeated in volunteer 1b, highlighting the reproducibility of this result. Volunteer 
5 also showed low overall excretion of taurine.  
Ingested taurine can follow different metabolic routes: Conjugation to bile acids and 
storage in the gall bladder for later lipid emulsification, incorporation into the 
exchangeable muscle taurine pool, conversion to sulphate by the gut microbiota and 
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unchanged excretion via urine are possibilities. Taurine has many diverse biological 
functions, serving as a neurotransmitter in the brain, a stabilizer of cell membranes 
and a facilitator in the transport of ions such as sodium, potassium, calcium and 
magnesium. It is therefore plausible, that the two volunteers not excreting NMR-
measurable amounts of taurine absorb and retain in some form the majority of 
ingested taurine. Such an observation has been made to the extreme in mongoloid 
subjects (Down syndrome), who retain up to 99% of ingested taurine [219]. This 
observation highlights one individual-specific response to food consumption.  
TMAO and creatine are endogenous metabolites that are present in the urinary 
profile even without animal protein consumption. For these metabolites, baseline 
differences were observable. Basal TMAO excretion was higher in volunteers 6 and 7 
and creatine baseline was high in volunteer 4, 5 and 7. TMAO is produced when TMA 
is oxidised. Creatine is influenced by many factors, such as muscle mass and protein 
turnover. Most creatine gets excreted as creatinine. Both TMAO and creatine are 
mainly introduced by the intake of fish or animal protein as fish is a good source of 
TMAO and fish and beef are good sources of creatine (see chapter 3) and no host 
metabolism is involved for the generation of these compounds.  Therefore, baseline 
TMAO and creatine did not predict or relate to the protein meal response.  
The unknown metabolite with a resonance at δ 2.90 (t), which was putatively 
assigned to glutamylcysteine or glutathione, was not present in urinary metabolite 
profiles prior to animal protein consumption. 
Consumption of an animal protein meal presents a choline load to each volunteer. 
Therefore, metabolites of the choline degradation pathway were investigated. Two 
branches will be further investigated here: (i) microbial degradation of choline, 
generating TMA and further degradation of TMA to TMAO or DMA and (ii) host 
metabolism of choline to glycine via betaine, DMG and sarcosine, followed by further 
metabolism to creatine via guanidoacetate and ultimately excretion as creatinine 
(Figure 37).  
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Figure 37 The choline degradation pathway, with symbiotic microbial activity highlighted in blue and 
human enzymes highlighted in red. Excretion kinetics are shown for every volunteer separately with 
colour-coded as follows: volunteer 1, volunteer 2, volunteer 4, volunteer 5, volunteer 6, volunteer 7, 
volunteer 8. Boxplots of these metabolites are listed in the appendix.  
 
Out of the illustrated metabolites, TMAO and creatine are heavily influenced by 
ingestion of external TMAO and creatine with the diet. This has already been 
described earlier in this chapter. TMA shows small alterations in the overall excretion, 
introduced by animal protein ingestion. Baseline excretion of this metabolite varies 
between individuals. Volunteer 1a/1b had higher levels of TMA compared to all other 
volunteers. The oxidation of TMA to TMAO requires the activity of an enzyme from 
the flavin-containing monooxygenase (FMO) family, FMO3, which is responsible for 
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oxidation of e.g. nitrogen, phosphor and sulphur containing compounds [220]. This 
enzyme family has been implicated in metabolism of xenobiotics (e.g. drugs and 
toxins) [221]. A condition of FMO3 deficiency exists, where patients cannot oxidise 
TMA and therefore excrete high amounts of TMA, giving urine, sweat and breath a 
fishy odour, therefore called fish-odour syndrome [222, 223]. These patients reach a 
urinary TMA : TMAO ratio of 1.4 while the ratio of healthy subjects is 0.07 [224]. In 
comparison, the ratio of TMA : TMAO for each volunteer varied between 0.07 and 
0.35 (Figure 38). Even though volunteer 1a/1b had higher ratios than other 
participants, it was still considerably lower compared to fish-odour syndrome 
patients. Other sources for TMA production are carnitine and TMAO, which are all 
highly abundant in fish and meat. No significant TMA production was observed, for 
example after ingestion of fruit and vegetables [225].  
 
 
Figure 38 Plot of the ratios of urinary TMA : TMAO for each volunteer pre fish or beef consumption. 
Mean ratios for each individual were: 1a – 0.26, 1b, 0.22, 2 – 0.11, 4 – 0.13, 5 – 0.11, 6 – 0.08, 7 – 0.10, 8 – 
0.15.   
 
TMAO and DMA excretion were not different in volunteer 1a/1b compared to the 
other volunteers, indicating that oxidation of TMA to TMAO or DMA was not 
impaired. About 20% of urinary DMA comes from TMA [226]. It can also originate 
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from N-methylation of methylamines, deriving from glycine and sarcosine and from 
the breakdown of creatinine. This latter relationship is illustrated by the strong 
correlation of DMA and creatinine (Figure 39).   
 
 
Figure 39 Boxplots of DMA and creatinine for each volunteer and scatter plot with correlation 
coefficient of creatinine and DMA. The reason for the DMA and creatinine could not be linked to food 
consumption here. Five samples were excluded for the scatter plot, as the integral of DMA was near 
zero due to peak shifts. 
 
As DMA is involved in other pathways, it is not a candidate biomarker for 
investigation of choline breakdown via microbes.  
Choline can also be reduced to glycine via betaine and dimethylglycine and ultimately 
excreted as glycine or further reduced to creatine and creatinine, which is the earlier 
mentioned branch (ii). No strong inter-individual or food-related differences could be 
seen for betaine. Excretion of DMG was reduced in volunteer 1a/1b, as also apparent 
from looking at the ratio of TMA : DMG (Figure 40).  
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Figure 40 Scatter plot of DMG and TMA integral, colour-coded for every volunteer (volunteer 1a/b, 2, 4, 
5, 6, 7, 8) and boxplots of TMA : DMG ratio for each volunteer.  
 
DMG in urine mainly derives from degradation of choline into glycine. Glycine is a 
central amino acid in amino acid synthesis and degradation and enters the 
arginine/proline pathway via metabolism to guanidoacetate and creatine. Glycine is 
also involved in the body's production of DNA, phospholipids and collagen, and in 
release of energy. Furthermore, it is needed for assistance in lipid emulsification as a 
conjugate of bile acids. To investigate the metabolic interactions of glycine, a STOCSY 
analysis was carried out (Figure 41B) and shows correlations of glycine to amino 
acids, dimethylglycine, guanidoacetate, choline, carnitine, creatine and taurine. 
 
 
Figure 41 (A) Boxplots of glycine integral for each volunteer. The glycine excretion in volunteer 4 was 
overall higher and also highly variable. (B) STOCSY plot of glycine (driver peak glycine, δ 3.572, 
indicated as box) illustrated by a mean spectrum colour-coded for the correlation coefficients to 
glycine. Glycine shows weak correlations to amino acids, DMG, taurine, guanidoacetate and creatine. 
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The pathway of choline degradation via betaine, dimethylglycine and sarcosine might 
be highlighted by the correlation of glycine with dimethylglycine and guanidoacetate. 
Correlation of glycine to taurine is likely to be biased by the correlation of glycine to a 
protein-rich diet, as taurine gets excreted after fish and beef consumption. Glycine 
was shown to be elevated in metabolic profiles of volunteer 4, as seen in the 
boxplots in Figure 41A.  
As glycine is involved in many other pathways, it does not represent a good 
metabolite for endogenous choline degradation investigation. The main metabolic 
involvement of DMG, however, is endogenous choline breakdown. It might therefore 
serve as a better biomarker when compared to glycine.  
In summary, the two metabolites mainly altered by choline degradation are TMA and 
DMG. It can therefore be postulated, that the different ratio of TMA : DMG in 
volunteer 1a/1b indicates the preferred pathway of choline degradation. While all 
other volunteers follow host-metabolic reduction via betaine, this volunteer might 
have decreased choline absorption leading to increased gut microbial choline 
fermentation (TMA production) and increased TMA excretion. To further clarify this 
hypothesis, a investigation of dosage of e.g. isotope-labelled choline and 
quantification of labelled TMA, TMAO, DMG and others would be necessary, along 
with screening of TMA-producing bacteria in the different volunteers. This was, 
however, not within the scope of this thesis.  
 
4.5.6.3  Alteration of metabolites of protein putrefaction 
To investigate differences in metabolites related to protein putrefaction by gut 
microbiota, the relative concentration of p-cresol-sulphate (PCS) and phenylacetyl-
glutamine (PAG) were assessed by plotting the integral of NMR resonances. To check 
the robustness of the peak integration and select the most suitable of the three, 
resonances were checked for (i) their proton ratio and (ii) their correlation 
coefficients, r. The resonances assignment of p-cresol-sulphate and phenylacetyl-
glutamine are shown in Table 11.  
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Table 11 Chemical shifts assignment of p-cresol-sulphate and phenylacetylglutamine, including 
multiplicity, and stoichiometry. (*minor overlaps, all other resonances are overlapped) 
 
metabolite chemical shift multiplicity assignment stoichiometry 
p-cresol-sulphate 2.34* s CH3 3H 
  7.21 d H2, H6 2H 
  7.28* d H3, H5 2H 
phenylacetylglutamine 2.26* m alpha-CH2 2H 
  7.36* t H2, H4, H6 3H 
  7.42* t H3, H5 2H 
 4.11 m CH-COOH 1H 
 3.66 m CH2 2H 
 1.89 m gamma-CH2 ½ 2H 
 2.02 m gamma-CH2 ½ 2H 
 
Integration of a representative urine spectrum, revealed a proton ratio of 1.7 : 3.0 : 
2.0 for δ 2.26 : δ 7.36 : δ 7.42 (structural stoichiometry: 2H :3H :2H). The same 
approach was followed for p-cresol-sulphate and the proton ratio for the resonances 
at δ 2.34 (s) : δ 7.21 (d) : δ 7.28 (d) was 4.3 : 2.0 : 1.9  (3H : 2H : 2H stoichiometry), 
indicating a possible baseline influence for the resonance at δ 2.34 (s) (cf. Table 11).  
Secondly, the correlation coefficients were investigated. The correlation coefficients 
for the resonances δ 7.36 : δ 7.42 (PAG, Figure 42A) with r=0.99 and δ 2.34 : δ 7.28 
(PCS, Figure 42B) with r=0.84 are acceptable. This approach could not be carried out 
for indoxyl-sulphate (IS), as only the resonance at δ 7.50 (d) is not heavily 
overlapped. On the basis of best correlation and least baseline overlap, the 
resonances δ 7.42 (t) for PAG and at δ 7.28 (d) for PCS were selected for further 
investigation.  
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Figure 42 Scatter plot showing the correlations of (A) phenylacetylglutamine (δ 2.26 (d), δ 7.36 (t); δ 
7.42 (t), δ 7.36 (t); 7.42 (t), δ 2.26 (d)) and (B) p-cresol-sulphate (δ 7.28 (d), 7.21 (d); δ 2.35 (s), 7.21 (d); δ 
7.28 (d), δ 2.35 (s)) and their corresponding correlation coefficient. 
 
The ratios of PAG and PCS, PAG and IS and PCS and IS were calculated (Figure 43). 
PAG : PCS showed the strongest correlation with a correlation coefficient of 0.87. The 
correlation coefficients of PAG : IS and PCS : IS were lower but still relatively strong 
with 0.67 and 0.63, respectively.  
 
 
Figure 43 Correlation analysis of phenylacetylglutamine, p-cresol-sulphate and indoxyl-sulphate 
including data from all volunteers. Correlation coefficients (r) of PAG:PCS = 0.87, IS:PCS = 0.63, IS:PAG 
= 0.67. (Stoichiometry: IS: 7.50 (d) =1H; PAG: 7.42 (t) =2H; PCS:  7.28 (d) =2H) 
 
 The close correlation of the three metabolites suggests a common dietary source 
and/or metabolism. Indeed, PAG is known to be a product of protein putrefaction in 
the colon from phenylalanine to phenylacetate, and glucuronidation of 
phenylacetate in liver and the gut mucosa [227] (Figure 44). PCS is a product of 
microbial tyrosine break-down via hydroxyphenylacetate to p-cresol, followed by 
conjugation with sulphate [228]. Indoxylsulphate is a product of putrefaction of 
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tryptophan. Phenylalanine and tyrosine are known to be similarly distributed in the 
diet with a ratio of 1 : 1, while dietary tryptophan sources vary [229]. The microbial 
degradation of undigested protein is illustrated in Figure 44.  
 
 
 
Figure 44 Microbial degradation of tyrosine, phenylalanine and tryptophan from undigested protein. 
p-cresol-sulphate, phenylacetyl-glutamine and indoxyl-sulphate were observed in urine. 
Glucuronidation (dotted line) can occur in intestinal mucosa and liver. (Adapted from [214]) 
 
The average excretion of PAG, PCS and IS was investigated and shown in Figure 45. 
Volunteer 1 showed an increase in all three metabolites in the second study (1b), 
compared to the first study (1a). Volunteer 5 had relatively high PAG and PCS levels 
and volunteer 8 showed relatively low levels of PAG, PCS and IS. PCS excretion was 
relatively low in volunteer 6.  
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Figure 45 Boxplots with the average urinary excretion of phenylacetylglutamine, p-cresol-sulphate and 
indoxylsulphate for each individual volunteer. 
 
The change of PAG, PCS and IS in volunteer 1 between the studies a and b (three 
months apart) suggest that factors other than diet and core metabolic processes 
influence protein putrefaction. The integrals of PAG, PCS, hippurate and TMA were 
plotted over time to compare changes in these metabolites for the individual 
repeating the study (Figure 46).  Interestingly, the two other metabolites, TMA and 
hippurate, where microbial metabolism is involved (choline breakdown and 
carbohydrate breakdown, respectively) remained constant between the two studies.  
 
 
Figure 46 Peak integrals of urinary hippurate, PAG, PCS and TMA from volunteer 1a (solid line) and 
volunteer 1b (---) plotted over a time course of 18 time points (4,5 days). There was a small diet switch 
from volunteer 1a after time point 18. 
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4.5.6.4  Inter-individual differences due to food intake alterations  
 
4.5.6.4.1  Mannitol 
O-PLS-DA analysis revealed mannitol as a discriminant metabolite for individual 1b 
compared to all other volunteers. This is highlighted by plotting the peak integrals of 
mannitol for each individual, see Figure 47. All volunteers, including volunteer 1a 
show no significant excretion of mannitol, while volunteer 1b excreted mannitol 
occasionally. This volunteer reported use of chewing gum several times over the 
course of the study and mannitol is known to be an ingredient of chewing gum for 
sweetening purposes.  
 
 
Figure 47 Mannitol excretion in each volunteer as an integral of the resonance at δ 3.86 (d) indicating 
mannitol excretion in volunteer 1b. Sporadic increased peak integrals in the other individuals derive 
from peak shifts of neighbouring resonances. 
 
4.5.6.4.2  Trigonelline 
Trigonelline excretion was very high in each lunch sample of volunteer 4 and each 
evening sample of volunteer 1a and 1b (Figure 48). For the other volunteers, no daily 
pattern could be observed. Volunteers 2 and 5 excreted extremely small amounts of 
trigonelline. Trigonelline is known to be a constituent of coffee and some teas. 
Furthermore, niacin can get metabolised to trigonelline via methyltransferase and 
excreted as trigonelline, whereby trigonelline is an endpoint metabolite of vitamin B3 
metabolism.  
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Figure 48 Boxplots and excretion kinetics of trigonelline of each volunteer, across all 25 time points. 
Colour-code of individual excretion kinetics as follows: volunteer 1, volunteer 2, volunteer 4, volunteer 
5, volunteer 6, volunteer 7, volunteer 8. 
 
4.5.6.4.3  Unknown metabolite detected in volunteer 2  
Inspection of excretion kinetics of the integrals of an unknown metabolite with 
chemical shifts at δ 4.51 (s), 6.98(d), 7.38 (t) revealed that volunteer 2 excreted this 
metabolite only in the urine sample collected before lunch time (Figure 49). The 
person also reported drinking Earl Grey tea instead of coffee every morning for 
breakfast. All other volunteers, all consuming coffee, excreted another metabolite 
with chemical shifts at δ 4.40 (s), 6.65 (dd), 8.78 (d) in the lunch sample. As no other 
person drank Earl Grey tea in this study, it is not possible to confirm its origin to the 
consumption of tea or alterations in the metabolism of this person with tea/coffee 
compounds such as polyphenols.  
 
Figure 49 Boxplots of unknown resonance with chemical shift at δ 4.51 (s), and boxplots and excretion 
kinetics of unknown resonance with chemical shift at δ 8.78 (d) of each volunteer, across all 25 time 
points. Colour-code of individual excretion kinetics as follows: volunteer 1, volunteer 2, volunteer 4, 
volunteer 5, volunteer 6, volunteer 7, volunteer 8. Outliers in the excretion of these two metabolites 
were from urine samples collected after coffee/tea consumption.  
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4.5.6.5 Overview of metabolite correlations 
An overview of the correlation structure of all semi-quantified metabolites is given in 
Figure 50. A hierarchical clustering, using linear correlation to calculate the distance 
and average distance to create the cluster tree was carried out, followed by plotting 
the correlation coefficients (with p< 0.0019, for Bonferroni-corrected p-value 0.05) in 
a heat map in Figure 50. There is a strong clustering observable between gut related 
metabolites from protein putrefaction (PCS, PAG and indoxylsulphate), metabolites 
after fruit consumption (hippurate, proline betaine, tartrate, 4-OH-hippurate) cluster 
(but do not correlate), and all metabolites related to protein consumption and 
choline breakdown, except TMA, cluster as well. For better visualisation, protein 
putrefaction metabolites are highlighted in cyan, animal protein-related metabolites 
highlighted in magenta, in purple are metabolites from choline degradation, and in 
green are metabolites involved in energy metabolism.  
 
Figure 50 Correlation map highlighting all correlated metabolites with a p-value < 0.0019 (p-value = 
0.05, Bonferroni-corrected for multiple testing). Metabolites were sorted using hierarchical clustering. 
Colour-code: gut microbiota-related metabolites, animal protein-related metabolites, metabolites 
from choline degradation, energy metabolism-related metabolites. 
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4.6 Discussion 
The urinary metabolite profile dataset from a nutrition study was explored to 
establish the origin of its major variation. Differences in the metabolic profiles 
between volunteers exerted the strongest contribution to these variations. These 
differences were observed using various unsupervised and supervised pattern 
recognition techniques, and classified into metabolic baseline differences and 
variations to response to food intake and small alterations in food intake to the study 
protocol.   
 
Inter-individual variation in the metabolic phenotype  
A grouping of all samples for each volunteer could be observed with both 
unsupervised and supervised pattern recognition analyses. 
PLS and O-PLS perform particularly well when various variables express common 
information, i.e. when there is a large amount of correlation or collinearity among 
them. However, PCA assumes that n-dimensional data can be reduced in a linear 
fashion. Furthermore, PCA is susceptible to outliers, i.e. the leverage effect of outliers 
can disturb the projection. If many principal components are needed to capture the 
majority of relevant variation, the visualisation power is reduced as information is 
distributed across many components. HCA provides a measure of closeness of 
groups, as the input data are summarised into a dendrogram where the branch 
lengths reflect the differences among the groups and thus provide an easy 
visualisation of the similarities of samples. Different distance measures, such as 
euclidian distance or distance based on correlation can be applied. Self-organising 
maps are, as with PCA and HCA, unsupervised, but use an artificial neural network to 
visualise complex data onto a 2D plane of nodes. It has apparent advantages when 
attempting to visualise and relate non-linear, complicated datasets [230, 231] and is 
not susceptible to outliers. However, the visualisation of variable contribution to 
each component, cluster or node is best developed and easily interpretable in PCA 
analysis (i.e. the loadings plots). All three unsupervised pattern recognition 
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techniques showed similar results, in that metabolic profiles collected from the same 
person cluster closely.  This shows remarkably, that for each person, although dietary 
changes were present, a personal metabolic fingerprint exists. This fingerprint may 
consist of various differences in presence/absence and concentration of metabolites 
with respect to those of other individuals. As such, one can imagine that a 
combination of many host metabolism, gut microbiota composition, dietary habits, 
physical activity, and body composition all shape and influence specific metabolites, 
resulting in a fingerprint that is to a large extent distinct to each person (Figure 51).   
 
 
Figure 51 Schematic illustration of a simplified composition of the individual metabolic phenotype. 
Different parts of host metabolism, microbiota metabolism and dietary behaviour influence a variety 
of metabolites leading to an overall position in an n-dimensional metabolic space. Example here: 3 
volunteers (A,B,C) donate 10 urine samples and 5 metabolites representative of host metabolism, 
microbiota metabolism and dietary behaviour are quantified. Representation of this data in a 2-
dimensional PCA space results in clustering of samples in each person’s metabolic space. 
 
The findings presented here confirmed reports in the literature, where inter- and 
intra-individual variations were found. Among them are Lenz et al. and Walsh et al., 
who reported inter-individual differences being bigger than intra-individual 
differences with largest variation in first morning sample [23, 201]. Assfalg et al. [205] 
and Bernini et al. [206] outlined the elucidation of a personal metabolic phenotype 
using a series of supervised pattern recognition techniques.  
 
Other sources of variation  
Additional variation was introduced by food intake. This could clearly be 
demonstrated by unsupervised and supervised pattern recognition techniques (see 
chapter 3). These findings are also reported by others, where specific food intake 
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introduced variations to the metabolic profile, either due to exogenous components 
or endogenous response to the food challenge. Other sources of variation are 
believed to be of diurnal origin [23], differences physical activity [232], and 
menstruation cycle [203], however this could not be confirmed in this study. In 
addition, BMI, age and gender affect the metabolic profile. Due to the small sample 
size and limited age and BMI distribution, it was not possible to investigate these 
influences here. Furthermore, spot urine sampling rather than 24-hr urine sampling is 
known to hold more variation, as reported by Lever et al. on the investigation of 
betaine and DMG [233].  
Carrying out this study in a metabolic unit would most likely have given a clearer 
overview of influences due to diurnal and other variations, as it opens the possibility 
to accurately control time and amount of food intake, activity levels and prevents 
small deviations from the dietary protocol, such as consumption of chewing gum.  
Relative metabolite quantification was carried out by integrating the area under the 
curve of NMR resonances representative for metabolites of interest. This procedure 
faces two main challenges. Peak overlap can impact the integration and absolute 
quantification is not possible as the NMR experiment was not fully relaxed and 
normalisation had to be done using probabilistic algorithm rather than TSP or 
creatinine normalisation. The normalisation was done for reasons of varying 
creatinine over the day and dilution influences in urine. For future studies, better 
quantification could be undertaken using Chenomix software [234].  
 
Role of the gut microbiota 
Several gut microbiota-related co-metabolites were found in urine. Among them 
were trimethylamine, hippurate, 4-OH-hippurate, phenylacetylglutamine, 
indoxylsulphate and p-cresol-sulphate. Phenylacetylglutamine, p-cresol-sulphate and 
indoxylsulphate were shown to be closely correlated. It is well established, that the 
gut microbiota is involved in the anaerobic formation of these compounds from 
tyrosine, phenylalanine and tryptophan [235, 236]. Undigested protein reaches the 
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colon and depending on the microbial composition, transit time, efficiency of host 
digestion and protein intake, gut bacteria form phenylacetate, p-cresol and indole. 
After conjugation with sulphate or glutamine respectively, p-cresol-sulphate, 
phenylacetylglutamine and indoxylsulphate get excreted via urine. Besides the 
strong correlation of protein putrefaction metabolites PAG, PCS and IS, there was no 
relationship observed between the choline putrefaction metabolite TMA and the 
fibre putrefaction metabolite hippurate. This suggests different microbiota and/or 
different sites of production. Indeed, hippurate is known to be mainly produced in 
the proximal colon, PAG is produced in the distal colon. Dietary habits are reported to 
shape the microbiota [57] and this could be an explanation for the different levels of 
metabolites between individuals, where e.g. volunteer 5 might not be equipped with 
a large amount of fibre-digesting bacteria or produces metabolites other than 
hippurate due to a different microbiota setup. This theory could also explain the large 
number of unassigned resonances in the aromatic area for this volunteer, suggesting 
that volunteer 5 inhabits bacteria predominantly digesting fibre to aromatic 
compounds other than (phenyl-)benzoic acid (e.g. phenylacetic acid and 
phenylcinnamic acid metabolites [166]) . 
 
Limitations of the current study 
The fact that differences in several urinary metabolite concentrations held across 
different unsupervised methods, supervised models were valid, and volunteer 1, 
sampled twice 3 months apart was largely reproducible across most parts of the 
NMR urine spectrum, gives some reassurance. In addition, all volunteers followed a 
standardised diet, which eliminated major variations introduced by dietary habits. 
However, the extent to which volunteers show a “reaction to changing their dietary 
habits” cannot be assessed. Inclusion criteria of volunteers were chosen so that 
variation introduced by BMI (21 – 24 kg/m2) and age (26 – 44 years) was relatively 
small. This limits the translatability of findings from this study to a larger, diverse 
population. 
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Conclusion 
This work shows the existence of a personal metabolic phenotype and highlights 
several metabolic pathways that are affected by inter-individual differences and 
differing response to food intake. These findings emphasise the importance of 
conducting clinical trials in a cross-over rather than parallel design to have each 
person as a control of themselves and demonstrate a different metabolic basis and 
starting point for dietary and drug intervention, indicating the importance of defining 
individual metabolite phenotypes for future personalised health care.  
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CHAPTER 5: The influence of gut microbiota on host metabolism: Host 
metabolite alterations and gut microbial co-metabolites in wildtype and 
ob/ob C57Bl/6 mice colonised with a defined microbiota 
 
5.1  Summary 
The metabolic profiles of several tissues and biofluids of an obese mouse model, the 
ob/ob mouse was analysed and compared to its lean counterpart. The effect of 
colonisation with a synthetic microbiota on the metabolic profiles was investigated 
and the covariance of bacterial abundance and faecal metabolites was characterised 
with a view to understanding host-microbial interactions in the obese mouse model.  
 
 
5.2  Aims and Objectives 
 To investigate the effect of an obese genotype on the metabolic phenotype of 
a murine model using NMR-based metabolic profiling techniques 
 To investigate the effect of colonisation of a defined microbiota on metabolic 
phenotype of  wildtype and ob/ob C57Bl/6 mice 
 To relate alterations in host metabolic phenotypes to gut microbial 
composition 
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5.3  Introduction 
 
Obesity and gut microbiota 
Obesity exacerbates many health problems such as type 2 diabetes, coronary heart 
disease and osteoarthritis and hence it is of great importance to understand the 
mechanisms and aetiology of this prepathological condition. Recent studies have 
highlighted microbial contributions to obesity and these are briefly introduced here.  
Backhed et al. observed that conventionally raised animals had higher body fat than 
their germ-free counterparts, and transplantation of this microbiota into germ-free 
animals increased body fat by 60%, showing that the gut microbiota are involved in 
energy extraction from the diet [237]. It was shown that fermentation of fibre, 
absorption of monosaccharides and short-chain fatty acids and induction of hepatic 
lipogenesis mediated these effects. Another study, conducted by Turnbaugh et al., 
showed how the distal gut microbiome differs between lean and ob/ob animals. The 
ob/ob mouse is a mouse with a defect of the ob gene, introducing leptin-deficiency 
[238]. This gene defect results in a lack of leptin production, leading to hyperphagia, 
obesity, hyperinsulinemia, hyperglycaemia, hypercholesterinemia and 
hypertriglyceridemia [239]. The obese microbiome was rich in bacteria containing 
enzymes encoding polysaccharide breakdown [54]. Furthermore, products of 
fermentation, acetate and butyrate, were increased and faeces contained fewer 
calories, directing to an increased calorie extraction of ob/ob gut microbiota. These 
results were reproducible when transplanting obese microbiota to lean gnotobiotic 
mice [54]. The described results were linked to human gut microbiota, where obese 
volunteers participated in a diet loss program, inducing a gut microbial change 
directed towards a more “lean microbiota” (i.e. ratio bacteroidetes : firmicutes 
increased) [240]. This is however, in contrast to findings that food rich in 
nondigestible fibre decrease body weight and fat mass [241]. It is also not clear 
whether small modifications in calorie extraction induced by the microbiota can 
contribute to meaningful body weight changes or if these are introduced by tiny 
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differences in food intake [242]. Obesity, often induced and accompanied by a diet 
high in fat and low in (indigestible) carbohydrates modulates the ratio of gram-
negative to gram-positives bacteria inducing endotoxemia through circulating 
bacterial lipopolysaccharides, which can result in mild chronic systemic inflammation 
[243]. The influence of high-fat diet to increase bacteroidetes : firmicutes ratio was 
also shown, independent of associated obesity in a knock-out mouse model [244]. 
Such high-fat diet induced microbial alterations might be driven by a bloom of 
mollicutes, from the firmicutes phyla, and allow better import and processing of 
sugars [37].  
Investigation of interactions between gut microbiota and metabolite profiles 
promises to extend our understanding in this field.  
 
Investigation of microbial influences on the host 
Historically, investigation of microbial effects and changes had to be carried out by 
culturing collected biological matter. The invention of oxygen-free chambers allowed 
extending this research to obligate anaerobes such as the Bacteroidetes [245]. 
However, there was still a bias, because data for uncultivable species were 
underrepresented [246, 247]. New methods based on DNA and 16S RNA allow 
identification of uncultivable species [248, 249] and allow unrestricted research 
across cultivation borders in a high-throughput and cost-efficient way [250].  
The normal mouse microbiota exhibits a variety of bacteria, as revealed by 16S RNA 
sequencing described by Salzman et al. and Kine et al. [251, 252]. Detailed 
investigations of the contribution of microbiota on the host were carried out by 
comparing germ-free animals to their conventional counterpart, and morphological, 
immunological and physiological differences [253] were observed. Such severe 
morphological changes make it difficult to pinpoint specific metabolic alteration 
introduced by the microbiota [20]. Another option is therefore the colonisation of 
germ-free animals with a defined microbiota or a specific microbiota of interest. The 
humanised mouse model, a germ-free animal with human microbiota [38, 254], is an 
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excellent model to investigate the effects of human flora on the host as well as 
effects of host behaviour (i.e. diet switches) on the microbiota. This technique is 
advantageous because it takes into account the uniqueness of the human flora when 
assessing products developed for human application (i.e. probiotics, probiotics, and 
specific diets). However, even if the microbiota is the same, its effect on the host and 
its development and adaption in the host gut as well as specific influences might still 
be different because of the host genotype and intrinsic host metabolism. This factor 
has to be taken into account when translating results from such studies to humans. 
When attempting to draw direct conclusions between specific bacterial species on 
the host, it is still difficult to do so, given the vast number of different bacterial 
species and their extensive interaction both with the host and with each other. One 
option to investigate effects of specific bacteria on the host is colonisation with one 
known bacterium i.e. mono-associations [29, 255, 256]. These models clearly limit 
possible microbiome-host interactions to one species. However, they do not allow 
the investigation of possible microbiome-microbiome interactions. On this note, an 
extended association e.g. a 3-member “mesocosm” [257] or the colonisation with a 
defined but still limited microbiota, e.g. Schaedler flora [258, 259] can be carried out. 
The metabolome of Schaedler altered microbiota rats indicated alterations in 
hippurate and chlorogenic acid metabolites in comparison to conventional animals 
[215]. Systemic influences of alterations of the gut microbiota were revealed by a 
systems biology approach using metabonomics of various biofluids and tissues [20, 
254, 260].  
In this project, germ-free mice were colonised with a defined microbiota that aimed 
to mimic a simplified human microbiota with regard to phylogenetic composition. To 
investigate how the genetic background of the host influences the colonisation of 
such a microbiota, two different genotypes: lean wildtype C57Bl/6 and their obese 
equivalent leptin-deficient ob/ob mice, were examined. The collection of several 
tissues and biofluids allowed a holistic model of effects on the complete biological 
system to be generated.  
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5.4  Methods 
 
5.4.1  Animal handling and experimental design    
The animal study was carried out at the Centre of Genome Sciences, Washington 
University, where 3 germ-free wildtype C57Bl/6 mice and 3 ob/ob mice were 
colonised with a 13-member synthetic gut microbiota. All animals were housed in 
individual cages in a shared germ-free isolator. Mice were 16 weeks of age at 
colonisation with a 13-member community (inoculum) and the colonisation 
experiment was carried out for 30 days. The experiment was repeated under the 
same experimental conditions. In the first batch (“experiment 1”), plasma, urine, 
caecal content, faeces, liver and kidney were collected at sacrifice. In the repeat 
experiment (“experiment 2”), plasma, urine, caecal content, faeces, liver and kidney 
were collected at sacrifice. In addition, colon content (middle 1/3) and ileal content 
were collected at sacrifice and urine samples were collected at 5 additional time 
points (days 0, 2, 9, 16, 23 after colonisation).  In both experiments, faecal pellets 
were collected on days on days 1, 2, 4, 7, 14, 21, 28 and 30 for conducting CoPro-
Sequencing to monitor the bacterial colonisation process. An overview of the study 
design is illustrated in Figure 52.  
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Figure 52 Illustration of the study design. 3 germ-free wild-type C57Bl/6 and 3 germ-free ob/ob C57Bl/6 
mice were inoculated with 13-member bacteria community at 16 weeks of age. Faecal samples were  
collected for Copro-Sequencing 8 times throughout the experiment. Urine, plasma, gut contents 
(caecum, faeces) and tissues (liver, kidney) were collected at sacrifice. The repeat experiment 
(experiment 2) included time point urine collections and additional collections of gut contents from 
ileum and colon. 
 
Animals with a conventional gut microbiota were not included in the described 
experiments. To be able to compare the spectral data of collected biofluids and 
tissues, in-house available spectral data from various mouse experiments was 
therefore consulted. Animals were selected to have the same genotype and the same 
age.  
 
5.4.2 1H NMR spectroscopy  
Sample preparation procedure and NMR spectroscopy analysis are described in 
chapter sections 2.2 and 2.1.5.  
 
5.4.3 Pattern recognition techniques: Principal components analysis (PCA) and 
orthogonal projections to latent structures discriminant analysis (O-PLS-DA)  
Spectral processing and pattern recognition techniques are described in chapter 
section 2.3. Loadings plots of the PCA analysis were created calculating the 
covariance and correlation between the original data matrix and the PCA scores. The 
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covariance plot gives a pseudo-1-D NMR spectrum and the correlation coefficients (r2) 
are super-imposed as colour-code. Considering the small sample size, mainly PCA 
analysis was performed, and only in certain cases was supervised O-PLS-DA carried 
out. The latter analysis was carried out assuming that the metabolic variation in the 
given small sample set represents the metabolic variation of a larger sample set of 
wildtype and ob/ob mice and the result must be interpreted conservatively.  
 
5.4.4 Workflow  
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Figure 53 Illustration of the workflow to analyse all collected biofluids and tissues for their metabolic 
influences. Experiment 1, experiment 2. 
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5.5 Results 
 
5.5.1 Phenotypic data  
The mean body weights of wildtype (lean) and ob/ob animals were significantly 
different with an average body weight of 29.3 g (experiment 2) and 28.2 g 
(experiment 1) of lean mice and 58.1 g (experiment 2) and 56.88 g (experiment 1) of 
ob/ob mice (Table 12). Weight differences between the two experiments were not 
observed for lean mice and ob/ob mice, respectively.  
 
Table 12 Overview of total mouse body weight at sacrifice and fat pad weight for each mouse from 
both experiments. * and # indicates statistical significant differences between the indicated groups.  
 
Mouse Genotype 
total mouse weight 
at sacrifice (g) 
Fat Pad 
#1 (g) 
Fat Pad 
#2 (g) 
Avg. Fat Pad 
(g) 
1 B6 (WT) 28.81 0.2 0.19 0.19 
2 B6 (WT) 28.55 0.2 0.2 0.2 
3 B6 (WT) 27.25 0.19 0.19 0.19 
  average B6 (WT)  28.20 ± 0.84#     0.19 ± 0.005 
13 ob/ob 56.86 1.07 1.09 1.08 
14 ob/ob 56.54 1.08 1.04 1.06 
15 ob/ob 57.25 1 0.92 0.96 
  average ob/ob 56.88 ± 0.36#     1.03 ± 0.06 
2 B6 (WT) 26.4 0.222 0.218 0.22 
12 B6 (WT) 29.7 0.222 0.2 0.211 
14 B6 (WT) 31.85 0.237 0.25 0.2435 
  average B6 (WT)  29.32 ± 2.7*      0.22 ± 0.02 
1 ob/ob 62.61 1.366 1.475 1.4205 
3 ob/ob 57.32 1.892 1.896 1.894 
4 ob/ob 54.39 1.383 1.44 1.4115 
  average ob/ob 58.11 ± 4.2*     1.58 ± 0.28 
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5.5.2 Bacterial abundance 
 
5.5.2.1 Composition of inoculum  
To investigate the effect of bacterial colonisation of the mouse gut and the possible 
differences in colonisation and metabolism between lean and ob/ob mice, germ-free 
mice were given a 13-member bacterial community per gavage. The gavage consisted 
of an inoculum including 13 bacterial species in equal counts (all 7.73% of total 
abundance). Due to viability problems with one bacterium, the inoculum of the 
second experiments consisted of only 0.02% R. obeum and 14.9% E. rectale. All other 
species were similar in composition to experiment 1. This work was carried out by 
Nathan McNulty from the Gordon Lab, Genome Center at Washington University, St. 
Louis, MO, USA. The bacteria species were chosen by criteria: (i) The composition on 
phylum level is similar to that of the human gut microbiota, (ii) the whole genome is 
known and (iii) good knowledge of the species’ physiology is on hand. The 
colonisation process was monitored by 16S RNA CoPro-Sequencing at days 1, 2, 4, 7, 
14, 21, 28, and at sacrifice. CoPro-Sequencing was carried out by Nathan McNulty.  A 
summary of all 13 bacteria species is shown in Table 13.  
 
Table 13 List of all 13 bacteria species present in the inoculum. (* in the second experiment only 0.02% 
of R. obeum established and 14.9% of E. rectale) 
 
Abbreviation Full scientific name Phylum Genus %  
B. WH2 Bacteroides sp. WH2 Bacteroidetes Bacteroides 7.73% 
B. caccae Bacteroides caccae ATCC 43185 Bacteroidetes Bacteroides 7.73% 
B. ovatus Bacteroides ovatus ATCC 8483 Bacteroidetes Bacteroides 7.73% 
B. thetaiotaomicron Bacteroides thetaiotaomicron VPI-5482 Bacteroidetes Bacteroides 7.73% 
B. uniformis Bacteroides uniformis ATCC 8492 Bacteroidetes Bacteroides 7.73% 
B. vulgatus Bacteroides vulgatus ATCC 8482 Bacteroidetes Bacteroides 7.73% 
P. distasonis Parabacteroides distasonis ATCC 8503 Bacteroidetes Parabacteroides 7.73% 
C. scindens Clostridium scindens ATCC 35704 Firmicutes Clostridium 7.73% 
C. spiroforme Clostridium spiroforme DSM 1552 Firmicutes Clostridium 7.73% 
D. longicatena Dorea longicatena DSM 13814 Firmicutes Dorea 7.73% 
E. rectale Eubacterium rectale ATCC 33656 Firmicutes Eubacterium 7.73%* 
R. obeum Ruminococcus obeum ATCC 29174 Firmicutes Ruminococcus 7.73%* 
C. aerofaciens Collinsella aerofaciens ATCC 25986 Actinobacteria Collinsella 7.73% 
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5.5.2.2 Overview of the colonisation process  
To give a good overview of the colonisation process as compared between day 1 and 
day 30 (sacrifice), bar plot charts of all 13 bacterial species for all animals, both lean 
and ob/ob, and experiments 1 and 2 are presented in Figure 54 and Figure 55. 
Throughout the experiment, the faecal microbiota were dominated by Bacteroidetes. 
On day 1, 99% of the faecal microbiota were Bacteroidetes. These numbers dropped 
to 86.9% in experiment 1 and 96.9% in experiment 2. The reason for this divergence 
between the two experiments was the non-colonisation of R. obeum and P. 
distasonis. Experimental differences and obesity differences of Bacteroidetes 
colonisation are further illustrated in Figure 56. B.WH2 increased in its abundance 
over the time course from 10-20% across all samples to 20-45%, B. caccae decreased in 
the abundance over time. The initial difference between the two experiments of 
abundance in B. caccae, B. vulgatus and B. ovatus disappeared towards the last time 
point: C. spiroforme, D. longicatena and R. obeum did not colonise and colonisation 
was minimal for P. distasonis in experiment 2. E. rectale did not colonise in either 
experiment. A detailed illustration of the colonisation of each bacterial species is 
given in the appendix.  
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Figure 54 Bar charts of abundance data comparing abundance at time point 1 and at sacrifice. Animals 
are sorted as follows: Lean animals in experiment 1 (xL1), ob/ob in experiment 1 (xO1), lean in 
experiment 2 (xL2), ob/ob in experiment 2 (xO2). 
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Figure 55 Bar chart of abundance data comparing abundance on time point 1 and at sacrifice, focussing 
on the less abundant bacterial species. Note, that the y-axis of time point 1 represents 2% of 
abundance, time point at sacrifice 20% of abundance data. Animals are sorted as follows: Lean animals 
in experiment 1 (xL1), ob/ob in experiment 1 (xO1), lean in experiment 2 (xL2), ob/ob in experiment 2 
(xO2). 
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Figure 56 Time trajectory of Bacteroidetes abundance in lean and ob/ob animals. Clear differences can 
be observed between experiment 1 (solid line) and experiment 2 (dashed line), whereas no apparent 
lean vs. ob/ob differences were observable. 
 
Principal component analysis showed an influence of colonisation effects of time 
point 1 to time point 30 of 35.5% (experiment 1) or 46.6% (experiment 2) of the total 
variation and obesity differences accounted for only ~10% of the variation (see 
appendix).  
In summary, systematic differences in the colonisation of lean and ob/ob animals 
were seen for B. caccae and B. vulgatus across both experiments. Additional obesity 
differences were observed in the second experiment for B. WH2, B. ovatus and B. 
thetaiomicron. R. obeum was not present at day 1 of the first experiment and in one 
animal of the second experiment. Colonisation of P. distasonis was extremely low in 
R. obeum-absent mice. E. rectale did not colonise in either experiment.   
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5.5.2.3 Correlation analyses to visualise inter-species correlations 
To visualise species-species correlations suggestive of metabolic interactions, a 
correlation analysis was carried out. The analysis was performed using data from 
both experiments and all time points (n=96 observations, see Figure 57). Strong 
correlations are seen for R. obeum and P. distasonis.  
 
 
Figure 57 Correlation analysis of abundance data, using the data of all mice at all time points. 
Correlation is colour-coded for positive and negative correlation (see r key). Only correlations with 
r>0.4 and r<-0.4 are shown and all correlation coefficients are filtered for statistical significance, i.e. 
only correlations with a p-value < 0.05 are shown.  
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5.5.3 Liver analysis 
 
5.5.3.1 Typical profiles of liver tissue  
Liver profiles were dominated by glucose resonances, glycogen, choline species 
(choline, phospatidylcholine, phosphorylcholine), TMAO, taurine, lactate, amino 
acids, glutathione, acetate and nucleosides/nucleotides, see Figure 58.  
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Figure 58 Representative 1H CPMG MAS spectra of (A) lean and (B) ob/ob liver samples. The spectral area 5.5 – 9.5 ppm is vertically expanded by 20 times.   
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5.5.3.2  PCA analysis of experiment 1 and 2 
Principal component analysis was carried out for each experiment separately. 
Maximal variation was attributed to obesity differences (40.6% and 47.6%) in both 
experiments, see Figure 59. While lean samples clustered closely, ob/ob animals were 
more metabolically diverse, as seen in PC 2. This divergence was due to small 
variations in lipid concentrations (experiment 1 and 2) and ethanol contamination 
(experiment 2), where 1 ob/ob liver sample had very high concentrations of ethanol 
(see section “ethanol contamination”). Liver metabolic profiles of ob/ob animals in 
the first experiment were characterised by higher amounts of lipids, ethanol and 
acetate (contamination) and lower levels of glucose, choline metabolites, 
phenylalanine, tyrosine and nucleosides (Figure 60). The metabolic characteristics of 
ob/ob livers in the second experiment were higher relative concentrations of lipids, 
taurine and lower levels of glucose, choline metabolites, phenylalanine, tyrosine and 
nucleosides (Figure 61). 
 
 
Figure 59 Principal component scores plots of metabolic profiles from liver of (A) experiment 1 and (B) 
experiment B, colour-coded for lean and ob/ob animals, (each experiment n=6). Maximal variation 
(PC1) in metabolic profiles was attributed to obesity in both experiments (40.6% and 47.6%). 
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Figure 60 Loadings plot of the first principal component from liver metabolic profiles from experiment 
1. ob/ob animals had higher levels of all lipids, ethanol and acetate (contamination) and lower levels of 
glucose, choline metabolites, phenylalanine, tyrosine and nucleosides. 
 
 
Figure 61 Loadings plot of the first principal component from liver metabolic profiles from experiment 
2. ob/ob animals had higher levels of all lipids, taurine and lower levels of glucose, choline metabolites, 
phenylalanine, tyrosine and nucleosides. 
 
5.5.3.3  Common features of obesity and differences between replicate 
experiments 
As ethanol seemed to have an influence on the model characteristics, ethanol (δ 
1.18(t), 3.66 (q)) and its oxidation product acetate (δ 1.91 (s)) were excluded from the 
dataset (see section “ethanol contamination”) and spectra re-normalised. As 
visualised in the PCA scores plot in Figure 62, the greatest source of variation (33.0%) 
in the dataset was attributed to obesity, across both experiments. Metabolic features 
associated with obesity were: increased concentrations of all lipids, and decreased 
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levels of glucose, choline metabolites, phenylalanine, tyrosine and nucleosides 
(Figure 63).  
 
 
Figure 62 PCA analysis of liver metabolite profiles including n=12 samples, (A) colour-coded for lean, 
ob/ob animals, (B) colour-coded for experiment 1 and experiment 2. 
 
 
Figure 63 Loadings plot of the first principal component from liver metabolite profiles including all 
samples from both experiments. ob/ob animals showed higher levels of all lipids and lower levels of 
glucose, choline metabolites, phenylalanine, tyrosine and nucleosides. 
 
Principal component 3 and all following components captured variation caused by 
only one particular sample. A PCA model with a limited number of samples can easily 
be influenced by outliers. These outliers will then influence following components. 
PCA analysis did not reveal a consistent pattern for experimental differences.  
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 Ethanol contamination 
The animal husbandry team used an ethanol aerosol to wet the mouse fur, before 
collecting the biofluids and tissues at sacrifice in the first experiment. This procedure 
was changed to water aerosol in the second experiment to exclude the possibility of 
ethanol contamination. As a result, none of the samples (liver, kidney, urine, plasma) 
from the second experiment contained ethanol (as shown here for liver samples, 
Figure 64). It was therefore concluded, that the ethanol signals observed in the first 
experiment were the results of the ethanol aerosol. The concentration of ethanol 
was slightly different between the animals, and animal # 14 (ob/ob mouse) had the 
highest concentrations of ethanol in all mentioned biofluids and tissues. As a result of 
ethanol contamination, the break-down product of ethanol, acetate, could also be 
found in some biofluids/tissues. Ethanol contamination mainly affected liver, kidney, 
and plasma collections. Subsequent data analysis was therefore carried out excluding 
ethanol and acetate resonances for these tissues/biofluid prior to normalisation of 
the spectra. Samples from gut contents and urine were not influenced by ethanol 
contamination.  
 
 
Figure 64 Mean liver 1H CPMG spectra of all animals from experiment 1 and experiment 2 overlaid. 
Ethanol and acetate resonances are only present in spectra from the first experiment. 
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The differences between the two experiments and the two mouse groups, lean and 
ob/ob, are summarised in Table 14. Besides ethanol contamination, no other 
differences between the experiments were observed in liver metabolite profiles.  
 
Table 14 Summary of metabolic differences in liver between lean and ob/ob animals of experiments 1 
and 2. Table key: the highlighted group had higher metabolite levels. 
 
metabolite lean 1 vs. ob/ob 1 lean 2 vs. ob/ob 2 
lipids ob/ob ↑ ob/ob ↑ 
sugar lean ↑ lean ↑ 
phenylalanine lean ↑ lean ↑ 
tyrosine lean ↑ lean ↑ 
choline lean ↑ lean ↑ 
taurine  ob/ob ↑ 
nucleosides lean ↑ lean ↑ 
 
 
5.5.4 Kidney analysis 
 
5.5.4.1 Typical profiles of kidney tissue 
Kidney profiles are characterised by osmoprotectant compounds such as myo-inositol 
and scyllo-inositol, taurine, glycine, betaine and cholines (choline, phospatidylcholine, 
phosphorylcholine) and by glucose resonances, as well as creatine, citrate, acetate, 
amino acids, lactate and nucleosides/nucleotides (see Figure 65).  
 
 156 
 
Figure 65 Representative 1H CPMG MAS spectra of (A) lean and (B) ob/ob kidney samples. The spectral 
area 9.5 – 5.2 ppm is vertically expanded by 20 times. The spectral area 3.8 – 3.15 ppm is horizontally 
expanded.  
 
5.5.4.2  PCA analysis of experiments 1 and 2 
Principal component analysis was carried out for each experiment separately. 
Maximal variation was attributed to obesity differences (30.0% and 35.6, see PC 1 of 
Figure 66A,B) in both experiments. One sample (lean, experiment 1) showed 
insufficient water suppression and was therefore not included in the PCA analysis. 
Obesity differences in experiment 1 were attributed to higher lipids, choline and 
betaine and lower glycine, cysteine, glutamine and acetate in ob/ob animals 
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compared to lean animals. Experiment 2 showed higher lipids, choline and betaine 
and lower glycine, glutamine and cysteine in ob/ob samples. The spectral regions for 
ethanol and acetate were excluded (see “ethanol contamination”).  
 
 
Figure 66 Principal component scores plots of 1H NMR spectral kidney metabolic profiles of (A) 
experiment 1 (n=6) and (B) experiment 2 (n=5), colour-coded for lean and ob/ob animals. 
 
5.5.4.3  Common features of obesity and differences between experiments 
The main variation in the metabolite profile could be attributed to metabolic 
differences between experiment 1 and 2 (PC 1: 22.6%) and between differences of 
lean vs. ob/ob animals (PC 2: 14.8%), see Figure 67. Compounds describing the 
metabolic differences attributed to obesity were higher lipids content and betaine 
and lower cysteine, glutamine and glycine in ob/ob mice (Figure 68).  
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Figure 67 PCA analysis of kidney metabolic profiles including n=11 samples, (A) colour-coded for lean, 
ob/ob animals, (B) colour-coded for experiment 1 and experiment 2. 
 
 
Figure 68 Loadings plot of the second principal component, accounting for metabolic differences 
between lean and ob/ob mice. 
 
Metabolic differences of kidney profiles between the two experiments were assigned 
to higher concentration of most amino acids, glucose and choline in experiment 1 and 
higher concentration of phosphocholine (δ 3.23 (s)) in experiment 2. All differences 
are summarised in Table 15.  
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Table 15 Metabolic differences in kidney between lean and ob/ob and between the two experiments. 
Table key: the highlighted group had higher metabolite levels. Abbreviations: BCAA, branch-chain 
amino acids. 
 
metabolite exp 1 vs. exp 2  lean 1 vs. ob/ob 1 lean 2 vs. ob/ob 2 
lipids  ob/ob ↑ ob/ob ↑ 
choline exp 1 ↑ ob/ob ↑ ob/ob ↑ 
phosphocholine exp 2 ↑   
betaine  ob/ob ↑ ob/ob ↑ 
glycine  lean ↑ lean ↑ 
glutamine exp 1 ↑ lean ↑ lean ↑ 
cysteine exp 1 ↑ lean ↑ lean ↑ 
BCAA exp 1 ↑   
alanine exp 1 ↑   
phenylalanine exp 1 ↑   
tyrosine exp 1 ↑   
 
5.5.5  Gut compartments 
 
5.5.5.1 Faecal water 
 
5.5.5.1.1 Typical profiles of faecal water 
Metabolic profiles of aqueous extracts from faecal pellets are dominated by amino 
acids, ethanol, SCFA, choline, taurine, methanol, lignin, malate, sugar resonances, 
fumarate, and several unassigned metabolites, see Figure 69.  
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Figure 69 Representative spectra of faecal content from (A) lean and (B) ob/ob animals. (* resonances from one molecule, as confirmed by TOCSY).   
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5.5.5.1.2 PCA comparison of faecal water from lean and ob/ob animals from 
experiments 1 and 2 
Principal component analysis was carried out for each experiment separately. 
Maximal variation was attributed to obesity differences (36.5% and 36.3%) in both 
experiments Figure 70A,B. Outlying samples (in PC 2) were samples with lower 
sample volume which resulted in influence on water suppression.  
 
 
Figure 70 Principal component scores plots of faecal water from (A) experiment 1 and (B) experiment 
2, colour-coded for lean and ob/ob animals (each experiment n=6). 
 
Experiment 1 showed higher levels of succinate, malate, sugars, δ 0.83 (t) and 
fumarate in ob/ob animals and increased ethanol, acetate, δ2.50 (dd), choline, 
(taurine-conjugated) bile acids and taurine in lean animals. Obesity differences in 
experiment 2 were visible as increases of branch-chain amino acids, threonine, 
alanine, methionine, 5-aminovalerate (protein breakdown product), succinate, 
malate, sugars, tyrosine and phenylalanine in ob/ob animals and increased (taurine-
conjugated) bile acids, choline, δ 3.60 (s) and δ 2.50 (dd) in lean animals. To check a 
possible influence of ethanol and acetate contamination on the data modelling, 
ethanol and acetate resonances were excluded and the dataset re-normalised. PCA 
scores plots were largely unchanged and PCA loadings plots were congruent, with 
the exception of missing ethanol and acetate resonances (see appendix). It was 
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therefore concluded, that ethanol and acetate did not unduly influence the model of 
faecal water metabolic profiles.  
 
 
Figure 71 Loadings plot of the first principal component PCA analysis of faecal water from the first 
experiment, accounting for metabolic differences in faecal water of lean and ob/ob mice.  
 
 
  
Figure 72 Loadings plot of the first principal component of PCA analysis of faecal water from the 
second experiment, accounting for metabolic differences in faecal water of lean and ob/ob mice. 
Abbreviations: 5-AV, 5-aminovalerate; BCAA, branch-chain amino acids,  
  
5.5.5.1.3  Common features in faecal water metabolite profiles of obesity and 
differences between experiments 
Maximal variation of metabolite profiles was attributed to differences between 
experiments 1 and 2 (37.9%). These differences were higher amounts of propionate, 
ethanol, lactate, acetate, δ 1.91 (t), δ 1.89 (t) and lower concentration of an N-
acetylated metabolite (δ 2.07 (s)), malate, succinate, lignin, δ 3.35 (t), and δ 5.42 (d) 
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in experiment 1 compared to experiment 2. Principal component 2 (14.5% of total 
variation) was mainly driven by lean animals of the second experiment which were 
characterised by lower amounts of tyrosine, phenylalanine, sugars, branch-chain 
amino acids, methionine and 5-aminovalerate, and higher amounts of choline.   
 
 
Figure 73 PCA analysis of faecal water spectral profiles including n=12 samples, colour-coded for lean, 
ob/ob animals from experiment 1 and experiment 2. 
 
To obtain a clearer pattern of shared obesity differences across both experiments, I 
chose to model the data with supervised pattern recognition, O-PLS-DA (see Figure 
74). These obesity differences were increased bile acids, choline, δ 2.50 (dd), δ 3.60 
(s) in lean animals and increased succinate, malate, sugars and fumarate in ob/ob 
animals (Figure 75).  
 
 
Figure 74 Scores plot of O-PLS-DA analysis of faecal extract 1H NMR spectra showing the predictive 
(T[1]) and orthogonal (TYosc[1]) scores of lean and ob/ob animals (n=12). Model parameters: R2Y = 
97.0%, Q2Y =85.8%. 
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Figure 75 Loadings plot of O-PLS-DA analysis on faecal water metabolic profiles, differentiating the 
metabolic profiles of lean (signals pointing up) and ob/ob (signals pointing down) animals. 
 
The differences in NMR-detected presence/absence of (taurine-conjugated) bile acids 
are further illustrated in Figure 76, where sections from 1H NMR spectra from lean 
and ob/ob animals are shown. The chemical shifts of δ 0.71 (s) and δ 3.08 (t) suggest 
the assignment of these shifts to tauro-β-muricholic acid, which is a common bile acid 
in mice.  
 
 
Figure 76 Spectral expansions of the regions (A) 3.13 – 3.05 ppm (vertically expanded by x2) and (B) 
0.80 – 0.60 ppm to illustrate obesity-dependent presence/absence of (taurine-conjugated) bile acids. 
Chemical shifts (δ 0.71 (s) and δ 3.08 (t)) suggest presence of tauro-β-muricholic acid. Spectra are 
coloured by their donor: lean and ob/ob animals. 
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5.5.5.2  Caecal content 
 
5.5.5.2.1  Typical profiles of caecal content 
The aqueous extract of caecal content of all mice was analysed via 1H NMR 
spectroscopy and revealed metabolic profiles. These were characterised by amino 
acids, ethanol, SCFA, choline, taurine, methanol, malate, sugar resonances, fumarate, 
and several unassigned metabolites (Figure 77).  
 
  
Figure 77 Representative spectra of caecal content from (A) lean and (B) ob/ob animals. The profiles 
were remarkably similar to faecal profiles (chapter section 5.5.5.2.1). For horizontal expansions of 
selected areas refer to Figure 69.  
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5.5.5.2.2 PCA comparison of caecal content of lean and ob/ob animals from 
experiments 1 and 2 
Principal component analysis was carried out for each experiment separately. 
Maximal variation was attributed to obesity differences (40.3% and 34.3%) in both 
experiments Figure 78.  
 
 
Figure 78 Principal component scores plots of (A) experiment 1 and (B) experiment 2, colour-coded for 
lean and ob/ob animals (each experiment n=6). 
 
Obesity differences in experiment 1 were associated with higher amounts of 
succinate, fumarate, malate, sugars, an unknown at δ 0.83 (t), lactate and δ 1.10 (d) 
and lower amounts of choline, δ 3.60 (s) and δ 2.50 (dd), see Figure 79 in the obese 
mice. Experiment 2 was characterised by ob/ob animals having higher amounts of 
acetate, succinate, sugars, fumarate and malate and statistically weaker correlations 
were attributed to increased amino acids and 5-aminovalerate. Lower amounts of 
choline, bile acids and unknown resonances at δ 2.50 (dd) and δ 3.60 (s) were 
observed in the caecal content of ob/ob mice Figure 80.  
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Figure 79 Loadings plots of the first principal component from PCA analysis of caecal content of the 
first experiment, accounting for metabolic differences between lean and ob/ob mice. 
 
 
Figure 80 Loadings plot of the first principal component of caecal content the second experiment, 
accounting for metabolic differences between lean and ob/ob mice. Abbreviations: phe, 
phenylalanine; tyr, tyrosine; BCAA, branch-chain amino acids; 5-AV, 5-aminovalerate.  
 
5.5.5.2.3  Common features of obesity and differences between experiments in 
caecal content 
The maximal variation of the metabolite profiles of all 12 animals was attributed to 
metabolic differences between the experiments (48.9%, Figure 81). These differences 
were higher amounts of propionate, ethanol, acetate, δ 1.92 (t), δ 1.89 (t), δ 3.35 (t), δ 
3.60 (s) and lower concentrations of methanol, lignin, sugars, fumarate and δ 3.84 (s) 
in experiment 2 compared to experiment 1. The two obesity groups are separated in 
PC 2, which accounts for 14.8% of the total variation in the PCA model. Compounds 
describing the metabolic differences were choline, bile acids and δ 2.50 (dd), which 
were found to be increased in lean animals and succinate, fumarate and sugars 
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increased in ob/ob animals (see Figure 82). These obesity differences were, however, 
mainly driven by 3 out of the 6 ob/ob samples. Further studies are necessary to clarify 
the precise biological impact of obesity on these metabolite levels.  
 
 
Figure 81 PCA analysis of metabolic profiles from caecal content including n=12 samples, colour-coded 
for lean, ob/ob animals from experiment 1 and experiment 2. 
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Figure 82 Loadings plot of principal components 1 and 2, accounting for metabolic differences 
between (A) experiments and (B) lean and ob/ob mice. (* from one molecule, as confirmed by a 
TOCSY experiment). Variation in the aromatic area was introduced by small differences in manual pre-
processing of spectra (phasing and baseline correction) between experiment 1 and 2.  
 
5.5.5.3  Colon content 
 
5.5.5.3.1  Typical profiles of colon content aqueous extract 
Colon content samples were only collected in the second experiment. Metabolic 
profiles were remarkably similar to caecal and faecal aqueous extract samples and 
showed presence of amino acids, lignin, ethanol, short-chain fatty acids, choline, 
taurine, methanol, malate, sugar resonances, fumarate, and several unassigned 
metabolites, see Figure 83.  
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Figure 83 Representative spectra of colon content from (A) lean and (B) ob/ob mice with key spectral 
resonances assigned. 
 
5.5.5.3.2  PCA analysis of colon content of experiment 2 
The PCA analysis of samples from experiment 2 of the aqueous extracts of colon 
content is shown in Figure 84. Principal component 1 (40.2%) is attributed to obesity, 
however, the model is strongly driven by 1 sample. Metabolic differences associated 
to principal component 1 are higher concentration of most amino acids, sugars, 5-
aminovalerate, malate  and lower levels of bile acids, choline, and unknown 
compounds with resonances at δ 2.50 (dd), and δ 3.60 (s), see Figure 85.  
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Figure 84 Scores plot from PCA analysis of colon content spectral profiles including (all) 3 lean and 3 
ob/ob animals from experiment 2. 
 
 
 
Figure 85 Loadings plot of PCA analysis of colon content spectra with the loadings of principal 
component 1. Abbreviations: BCAA, branch-chain amino acids; 5-AV, 5-aminovalerate.   
 
5.5.5.4  Ileal content 
 
5.5.5.4.1  Typical profiles of ileal content aqueous extract 
Ileal matter was characterised by high concentration of bile acids, presence of amino 
acids, lignin, taurine, methanol, ethanol, sugar resonances and several unassigned 
signals. In addition, ileal content profiles of ob/ob animals showed presence of 
raffinose (Figure 86).  
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Figure 86 Representative 1H NMR spectra of ileal content from (A) lean and (B) ob/ob mice with the 
key spectral resonances assigned. 
 
5.5.5.4.2  PCA analysis of ileal content from experiment 2 
Ileal content was only collected in experiment 2 and the principal component analysis 
is shown in Figure 87. Maximal variation (55.1%) was attributed to variation of the 
concentration of bile acids, which was very pronounced in 2 samples. These two 
samples also showed variation (here: relatively lower concentration) in several 
aromatic signals, including lignin. Principal component 2 was attributed to obesity 
 173 
differences (18.5%), which were driven by the presence of raffinose in ob/ob animals 
and higher taurine levels in lean mice, see Figure 88A,B.  
 
 
Figure 87 Scores plot from PCA analysis of ileal content spectral profiles including (all) 3 lean and 3 
ob/ob animals from experiment 2. 
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Figure 88 Loadings plot of PCA analysis with the loadings of (A) PC 1 and (B) PC 2, highlighting 
increased concentration of bile acids in samples discriminated by PC 1 and increased raffinose in 
samples separated in PC 2. 
 
5.5.5.5  Overview of all gut compartments from the 2nd experiment 
 
5.5.5.5.1  Unsupervised investigation of metabolic variation 
To compare similarities of the spectral profiles from contents of different sections 
along the gut (ileum, caecum, colon, faeces) and to investigate the contribution of 
obesity on these profiles, a principal component analysis was carried out including all 
samples from gut content and faeces from the second experiment and shows 
maximal variation (50.2%) to be attributed to ileal content samples (Figure 89 A). 
After exclusion of ileal content samples, grouping in the PCA scores plots can be seen 
according to obesity and gut compartment (Figure 89 B and C).  
 
 175 
 
Figure 89 PCA scores plots including all samples from contents of (A) ileum, colon, caecum and faeces 
from both lean and ob/ob mice of the second experiment.  (B, C)  PCA scores plot (PC1 and PC2, PC1 
and PC3) including all samples from contents of colon, caecum and faeces from both lean and ob/ob 
mice (black encircled) from the second experiment. 
 
Similar results were observed with another unsupervised pattern recognition 
technique, hierarchical clustering analysis (Figure 90), where the geometric distance 
of the samples was calculated via euclidian distance measure and single linkage was 
used to link the samples in the cluster tree. Ileal samples with high bile acids content 
clustered closely. Also, samples from the same genotype group and same gut 
compartment clustered. There was a division between lean and ob/ob mice (from 
colon, caecum and faces) observable along the linkage axis. These results emphasise 
the finding that ileal content is metabolically different from the rest of the gut 
compartments and metabolic differences introduced by obesity are more 
pronounced than compartmental differences. Interestingly, animal #1 (ob/ob mouse) 
did not cluster with the ob/ob group for any of the gut compartment groups. 
Investigation of the metabolic profile revealed lower levels of succinate, malate and 
fumarate of this animal compared to the other ob/ob animals in faeces, caecal and 
colon content.  
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Figure 90 Hierarchical clustering analysis dendrogram visualising the clustering of samples from 
contents of ileum (SI), colon (CoC), caecum (CC) and faeces (FW) from both lean and ob/ob mice 
(underlined) of the second experiment. Numbers correspond to numbers for each mouse (2, 12, 14 – 
lean animals; 1, 3, 4 – ob/ob animals). The hierarchical clustering was done using euclidian distance (y-
axis) and single linkage (x-axis).   
 
A summary of obesity differences in the metabolic profiles of each of the 
compartment (as described in pages 161-174) is shown in Table 16. All metabolites 
that showed a strong contribution towards separation in the PCA loadings plots were 
selected. Obesity differences in colon content, caecal content and faeces extract 
were remarkably similar. While lean animals had high amounts of choline, (tauro-
conjugated) bile acids, unknown (δ 2.50 dd) and another unknown with chemical 
shift at δ 3.60 (s), ob/ob animals had higher amounts of different amino acids, 5-
aminovalerate (protein breakdown product), different sugars in all of colon and 
caecal content, and faeces. Succinate, acetate and fumarate showed tendencies to 
be higher in the ob/ob animals in comparison to the lean phenotype in all 
compartments. These associations were strongest in the caecum. Bile acids are a 
chemically homogeneous group, and therefore it is difficult to differentiate the 
isomers from NMR spectra. As these isomers have different biological properties, it is 
 177 
important to assign the different isomers. The chemical shifts of δ 0.71 (s) and δ 3.08 
(t) suggest the assignment of the here present (tauro-conjugated) bile acid to tauro-
β-muricholic acid, which is a common bile acid in mice. Further clarification of the 
precise structure(s) and their quantification could be achieved by targeted UPLC-MS 
analysis, but this was beyond the scope of the current thesis.   
 
Table 16 Metabolic changes in the ileum, colon, caecal content and faeces in experiment 2. Lean vs. 
ob/ob metabolic differences were elucidated from PCA analyses for each gut compartment separately. 
Key: increased in lean, increased in ob/ob animals, * indicates presence/absence differences between 
lean and ob/ob, BCAA, branch-chain amino acids.   
 
  
 
5.5.5.5.2  Metabolic differences along the gut  
As there were big differences observed between ileal aqueous extracts and the rest 
of the gut compartment extracts and also distinct differences between lean and 
ob/ob animals, these differences were further investigated in O-PLS-DA analyses 
comparing ileal content with pooled samples from colon, caecum and faeces 
(referred to as “lower gut”) of lean animals and ob/ob animals respectively (Table 17). 
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Shared across all animals, ileal aqueous extracts had higher concentration of bile 
acids, methanol, tyrosine, phenylalanine, tryptophan and histidine and lower 
concentrations of succinate, fumarate and several unassigned signals (δ 2.50 (dd), δ 
3.35 (t), δ 6.33 (m)). Lean animals had higher concentrations of taurine and δ 5.90 (d) 
in the ileum and lower concentrations of choline and δ 5.42 (d), while ob/ob animals 
had higher concentrations of raffinose. Visual inspection of raw spectra emphasised 
that succinate, fumarate, malate and δ 2.50 (dd) are only present in the lower gut, 
raffinose only present in the ileum of ob/ob animals. Bile acids (δ 0.7 (bs)) are very 
high in ileum in both lean and ob/ob animals and thereafter only present in lean gut 
and choline levels are very low in ileum of all animals but strongly increased in lean 
gut only (spectral regions are shown in appendix). As seen in the raw spectra, many 
metabolic differences elucidated by O-PLS-DA analysis were differences in NMR-
detectable presence/absence of metabolites rather than variation in concentration 
between the groups.  
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Table 17 Comparison of metabolic changes ileum vs. colon/caecum/faeces (i.e. lower gut), for lean and 
ob/ob animals respectively (colour key: increased in ileum/decreased in lower gut, decreased in 
ileum/increased in lower gut).  Same colours in both comparisons indicate metabolic differences 
between ileum and lower gut independent from obesity. Specific differences linked to obesity are 
indicated by changes only seen in one comparison. (* indicates presence/absence differences between 
ileum and the lower gut) 
 
 
 
5.5.6  Plasma analysis 
 
5.5.6.1  Metabolic profile of plasma 
Illustrations of typical plasma metabolic profiles are shown in Figure 91, which are 
characterised by lipids (saturated and unsaturated triglycerides, cholesterol), 
glucose, lactate, amino acids, creatine, citrate, pyruvate, formate, fumarate, and 
acetate.   
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Figure 91 Standard 1H plasma profiles of (A) lean and (B) ob/ob mice. The aromatic area (δ 10.0 – 5.5) is 
vertically expanded 30 times. 
 
5.5.6.2  PCA analysis of experiment 1 and 2 
Principal component analysis was carried out for each experiment separately. Obesity 
differences were not manifested in the first 4 principal components: Experiment 1 did 
not show separation of lean and ob/ob animals and in experiment 2, obesity 
differences were distributed in PC 1 and 2 and PCA of (Figure 92A,B). Although PCA 
plots did not give a clear indication of the separation of the spectral data from the 
two classes lean and obese, visual inspection of raw spectra showed elevated 
resonances of all lipids in ob/ob animals (see Figure 93).  
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Figure 92 Principal component scores plots of (A) experiment 1 (n=6) and (B) experiment 2 (n=6), 
colour-coded for lean and ob/ob animals. 
 
 
 
Figure 93 Spectral comparison of plasma from lean and ob/ob animals (n=12). Clearly visible, the lipid 
areas are higher in ob/ob animals. The aromatic area (10 – 5.5 ppm) is vertically expanded by x 18. 
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5.5.6.3  Common features of obesity and differences between experiments 
Principal component analysis including plasma metabolic profiles from both 
experiments revealed a maximal variation due to experimental differences (PC1 
39.4%, see Figure 94), which could be allocated to higher lactate and β-glucose and PC 
3 revealed higher resonances at δ 1.16 (bs) and δ 3.70 (bs) for experiment 2 (11.3%), 
see Figure 95A,C. The spectral regions for ethanol and acetate were excluded. PC 2 
(24.9%) and PC 4 (9.7%) summarise obesity differences. These were driven by 
increased concentration of lipids and phosphoryl- and glycerophoshorylcholine (PC 2) 
and slightly decreased glucose resonances, pyruvate and creatine (PC 4) in ob/ob 
animals (Figure 95 B,D). Interestingly, ob/ob mice did not show increased levels of 
glucose, indicating no development of type 2 diabetes in the ob/ob mice at this time. 
All differences are summarised in Table 18.   
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Figure 94 Scores plots from PCA analysis of 1H NMR spectra from plasma samples (PC1 – PC4), and 
colour-coded for obesity (lean and ob/ob animals, A and C) and experiments (experiment 1, 
experiment 2, B and D). Principal component 1 summarises experimental differences, PC 2 and PC 4 
account for differences due to obesity. 
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Figure 95 Loadings plots of PC 1 - 4 from PCA analysis of 1H NMR spectra from plasma samples. (A) PC1 
and (C) PC3 summarise experimental differences, (B) PC 2 (lipids) and (D) PC 4 (sugar resonances) 
account for differences due to obesity. 
 
Table 18 Differences in metabolic profiles of plasma from lean and ob/ob animals: metabolites being 
increased and decreased in ob/ob animals compared to lean animals.   
 
 
 185 
5.5.7  Urine analysis 
 
5.5.7.1  Metabolic profile of urine 
Representative urine spectra of conventional (from an in-house database), lean and 
ob/ob mice are shown in Figure 96. Predominant compounds in urine profiles were 
citrate cycle intermediates (citrate, 2-oxoglutarate, succinate, fumarate), allantoin, 
creatine, creatinine, taurine, amino acids, trigonelline, N-methylnicotinamide and 
short-chain fatty acids (e.g. hydroxyisovalerate, 2-ketoisocaproate). The conventional 
animals were raised under different husbandry conditions (e.g. different chow), 
however, the genotype and age was the same. Apparent differences between 
conventional mice and mice colonised with a synthetic microbiota were the absence 
of hippurate, methylamines (TMA and DMA), glycine, and higher metabolites of 
energy metabolism (citrate, 2-oxoglutarate).  
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Figure 96 Representative spectra of urine from (A) conventional, (B) lean and (C) ob/ob mice. (* 
tentative assignment, **unknown compound with chemical shifts at δ 5.12(m), 2.38(m), 1.93(m), 
1.76(m), as confirmed by COSY) 
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5.5.7.2  PCA investigations of experiment 1 and 2 of urine 
Principal components analysis was carried out for each experiment separately. The 
first experiment had one urine sample with very low volume and this sample is the 
cause of the score plot pattern observed in PC 1 (Figure 97A). PC 2 however partly 
accounts for obesity differences (28.4%), see Figure 97A.  Maximal variation in the 
second experiment was attributed to obesity differences (48.1%, Figure 97B). Obesity 
differences in experiment 1 were higher excretion of metabolites 3-OH-isovalerate, 
ketoleucine, and several unassigned aromatic resonances in lean animals and higher 
excretion of N-methylnicotinamide in ob/ob animals. Obesity differences in 
experiment 2 were characterised by higher excretion of taurine, 2-oxoglutarate, 
citrate, 3-OH-isovalerate, ketoleucine, short-chain fatty acids, unknown (δ 5.12 (m), δ 
1.76 (m), 1.93 (m), 2.38 (m)), indole, phenylalanine and tyrosine metabolites in lean 
animals compared to ob/ob. In both experiments, the main variation was seen in 
disappearance of broad resonances in the area 0.5 – 1.3 ppm in ob/ob animals. A 
representative lean animals’ urine sample was analysed with a CPMG experiment, 
where these signals disappeared, suggesting a macromolecular structure and were 
therefore tentatively assigned to major urinary proteins [261].  
 
 
Figure 97 Principal component scores plots of urine metabolite profiles from (A) experiment 1 and (B) 
experiment 2, colour-coded for lean and ob/ob animals. 
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5.5.7.3  Common features of obesity and differences between experiments 
Maximal variation of metabolite profile can be attributed to obesity (PC 1: 33.2% of 
the total variation), as shown in Figure 98. Compounds describing these metabolic 
differences were higher taurine, 3-OH-isovalerate, ketoleucine (i.e. 2-
ketoisocaproate), short-chain fatty acids, unknown (δ 5.12 (m), δ 1.76 (m), 1.93 (m), 
2.38 (m)), indole, phenylalanine and tyrosine metabolites and major urinary proteins 
(tentative assignment) in lean animals (Figure 99A).  Principal component 3 described 
experimental differences (11.6%) and these were differences in 2-oxoglutarate, 
citrate, taurine, N-methylnicotinamide and several aromatic resonances (δ 9.36 (s), 
8.58 (m), 6.90 (d), 6.38 (d)), see Figure 99B.  
 
 
Figure 98 PCA analysis of urine metabolite profiles including n=12 samples, colour-coded for lean, 
ob/ob animals from experiment 1 and experiment 2. PC 1 separates lean and ob/ob animals; PC 3 
separates samples from experiment 1 and 2. 
 
 189 
 
Figure 99 Loadings plots of PC 1 and PC 3 from PCA analysis of 1H NMR spectra from urine samples. 
Principal component 1 summarises obesity differences, PC 3 account for differences between the 
experiments. Abbreviations: U1, unassigned metabolite with resonances at δ 5.12 (m), δ 1.76 (m), 1.93 
(m), 2.38 (m); indole (etc.) m., indole (etc.) metabolite; SCFA?, tentative assignment to short-chain 
fatty acids; * tentative assignment. 
 
5.5.7.4  Metabolic variation associated with obesity and colonisation/ageing 
(second experiment)  
To investigate the influence of both obesity and metabolic changes over time (i.e. 
colonisation, ageing), a PCA analysis was carried out with all urine samples from the 
2nd experiment. Maximal variation (33.0%) separated lean from ob/ob animals (Figure 
100), PC 2 (18.4%) showed trends to cluster lean animals of the timepoints 23 and 30 
and PC 3 (8.4%) clustered all animals of the timepoints 0 and 2 (see Figure 100B). 
Clearly, obesity and introduced major variation to the urine metabolic profiles, and 
the effects of colonisation can also be found in the metabolic profiles (PC 2 and 3).   
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Figure 100 PCA scores plots of urine spectra including all time points, from lean and ob/ob animals 
(encircled). (A) PC1 and PC2, lean and ob/ob animals. (B) PC2 and PC3, colour-coded for time points 
(TP): TP0, TP2, TP9, TP16, TP23, TP30. Abbreviations: phe, phenylalanine metabolite; tyr metabolite, 
tyrosine metabolite; indole, indole metabolite.  
 
PCA loadings of principal component 1 (obesity) were driven by higher taurine, 3-OH-
isovalerate, δ 4.52d (sugar), unknown metabolite (δ 1.76m, 1.93m, 2.38m, 5.12m), δ 
2.07 (s) (acetylated metabolite), indole metabolite (δ 7.50d, 7.70d), major urinary 
proteins (tentative assignment) and lower N-methylnicotinamide for the lean 
animals. Principal component 2 (separating late time points of lean animals) indicated 
higher taurine, citrate, 2-oxoglutarate, urea and δ 5.41 (s) in lean animals of late time 
points (Figure 101A). Animals at time points 0 and 2 (PC 3) excreted less indole, 
phenylalanine and tyrosine metabolites, 2-oxoglutarate, citrate, fumarate, δ 5.41 (s) 
and unknown metabolite (δ 1.76 (m), 1.93 (m), 2.38 (m), 5.12 (m)), see Figure 101B. 
 
Citrate, 2-oxoglutarate ↑ 
Urea, fumarate ↑ 
δ 5.41 (s) ↓ 
Phe, Tyr, Indole metabolites ↓ 
Taurine ↓ 
Unknown (δ 1.76m, 1.93m, 2.38m, 5.12m) ↓  
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Figure 101 Loadings plot of PCA analysis from urine metabolic profiles with the loadings of (A) PC 2 and 
(B) PC 3. Abbreviations: Phe, phenylalanine; Tyr, tyrosine 
 
A quantification of the unknown metabolite with resonances at δ 5.12 (m) over time 
can be seen in Figure 102 and clearly shows time and obesity differences. While lean 
animals reach a steady maximum after day 2, ob/ob animals reach a steady level only 
after day 9 and levels are significantly different to lean animals at all time points after 
colonisation. 
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Figure 102 Integral of unknown compound with resonances at δ 1.77m, 1.93m, 2.38m and 5.12m in urine 
as a mean for lean (N=3) vs. ob/ob (N=3) animals. Resonance at δ 5.12 (m) was integrated here. 
Excretion of this unknown compound is almost zero at time point 0 (before colonisation) but gets 
excreted after colonisation and stays constant over time. Significant differences: **p<0.005, *p<0.05, 
by unpaired students t-test.  
 
5.5.8 PLS-regression of selected faecal metabolites and abundance data 
Faecal metabolites are a good mirror of metabolism in the lower gut. Besides 
absorption processes by the host, the gut microbiota metabolises compounds that 
are “left over” from host metabolism and absorption, such as production of short-
chain fatty acids from indigestible carbohydrates and phenolic compounds from 
undigested protein. Faecal metabolic profiles contain metabolites that are “left over” 
from host digestion (i.e. indigestible for host and microbiota), metabolites produced 
by the upper intestine (predominantly aerobic fermentation) and metabolites 
produced in lower intestine (predominantly anaerobic fermentation). As it is known 
that faecal bacterial abundance data is mainly a good estimate for “lower gut” 
microbiota, further effort has been made to link metabolites produced in the lower 
gut with the faecal microbiota.  
It is well established, that the members of gut microbiota produce short-chain fatty 
acids, and therefore the short-chain fatty acids (propionate and acetate) here 
present were regressed against microbial abundance data. Several other metabolites 
in the gut content metabolite profiles were not present in the ileum, but newly 
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appeared in the lower gut (see Table 17, metabolites indicated with *). Such 
metabolites cannot derive from the diet and are likely to be of gut microbial origin. 
These metabolites (fumarate, succinate, malate and unknown compound δ 2.50 (dd)) 
were also regressed against the microbial abundance data.  
 
5.5.8.1  Propionate and acetate 
First, propionate and acetate, which both showed inter-experimental differences 
(chapter section 5.5.5.2.3), were regressed against bacterial abundance data. 
Propionate and acetate were strongly correlated to R. obeum (Figure 103), across 
both experiments. The raw spectral data illustrate this in Figure 104, where black 
acetate and propionate peaks derive from animals with R. obeum colonisation, while 
colonisation with R. obeum was not successful in animals highlighted in green (2nd 
experiment) and magenta (ob/ob animal, 1st experiment) lines. 
 
 
Figure 103 PLS regression analysis of propionate and acetate with the bacterial abundance data 
illustrating the correlation coefficients (r2) to all bacteria species. Correlation: bars pointing up, anti-
correlations: bars pointing down. Strong correlation can be seen for both metabolites to R. obeum and 
P. distasonis. 
 
 194 
 
Figure 104 Illustration of peak height of propionate and acetate, spectra are coloured according to 
experiment: 1st experiment and 2nd experiment. The peak height of all three metabolites is high in all 
animals of the first experiment, except mouse #13 from the 1st experiment (highlighted in magenta). In 
all animals with low excretion of acetate and propionate, R. obeum did not colonise (i.e. highlighted in 
green and magenta).   
 
As there is a strong correlation of R. obeum and P. distasonis, propionate and acetate 
also correlated strongly and it cannot be determined which of the two bacterial 
strains are responsible for the high amounts of these metabolites in faeces. The 
correlations of propionate and acetate to R. obeum was tested in a permutation 
models (1000 permutations) and was shown to be statistically significant (both 
p<0.001). 
 
5.5.8.2  Succinate, fumarate and malate 
Among the metabolites absent in the ileal content and present in all compartments 
of the lower gut were succinate, fumarate, malate and the unknown compound with 
a chemical shift at δ 2.50 (dd). These compounds also showed a positive correlation 
with ob/ob mice. A regression of each metabolite with the abundance data matrix 
showed strong anti-correlation to B. caccae and a positive correlation with C. scindens 
(Figure 105).  
The correlation of succinate, fumarate and malate with C. scindens was tested in a 
permutation model (1000 permutations) and showed to be statistically significant 
(succinate and malate p<0.001, fumarate p=0.002).  
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Figure 105 PLS regression analysis of the abundance data with (A) fumarate, (B) succinate, (C) malate 
and (D) unknown at δ 2.50 (dd) illustrating the correlation coefficients (r2) of all bacteria species to 
selected metabolites. Correlation: bars pointing up, anti-correlations: bars pointing down. Strong anti-
correlations and correlations can be seen for all four metabolites to B. caccae and C. scindens, 
respectively. 
 
5.5.9  PLS-regression of abundance data and faecal water metabolite profiles 
The bacterial species’ of interest, B. caccae, C. scindens, P. distasonis and R. obeum, 
were then in a second step regressed against the whole faecal metabolic profile to 
ensure that all metabolites that are linked to these bacteria were detected.  
 
5.5.9.1  PLS-regression of P. distasonis and faecal water metabolite profiles 
P. distasonis correlated positively with propionate and acetate, as previously 
observed.  Furthermore, ethanol, taurine and several unassigned resonances in the 
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aromatic area correlated positively and methanol, lignin and δ 5.42 (d) correlated 
negatively with P. distasonis. Ethanol showed the same pattern as previously 
described for propionate and acetate (cf. Figure 104), where ethanol concentration 
was much lower in all R. obeum-absent animals. The same results were obtained 
when correlating R. obeum with the faecal profile.  
 
 
Figure 106 PLS regression analysis of P. distasonis (Q2Y=0.672) with the metabolic profiles of faecal 
water (n=12). 
 
5.5.9.2  PLS-regression of B. caccae and faecal water metabolite profiles 
As already observed, fumarate, succinate and malate correlated negatively with B. 
caccae and the metabolite with chemical shifts at δ 2.50 (dd), 2.56 (dd), 3.73 (m) 
showed a strong positive correlation. In addition, there is a tendency for positive 
correlations of acetate and δ 3.60 (s) and negative correlations of δ 3.61 (s) and 
several sugar resonances. All observations were congruently the opposite for C. 
scindens.  
 
 
Figure 107 PLS regression analysis of B. caccae (Q2Y=0.64) with the metabolic profiles of faecal water 
(n=12). 
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5.6  Discussion  
A murine study was undertaken to investigate the effects of the obese genotype, i.e. 
ob/ob gene defect, on the systemic host metabolism and on influencing the 
colonisation process of synthetic microbiota and of the microbiota on host 
metabolism. To address these objectives, germ-free wildtype (lean) and ob/ob mice 
were colonised with a defined synthetic microbiota, 1H NMR metabolic profiles from 
key tissues and biofluids, i.e. liver and kidney, plasma, urine, gut contents and faeces 
were generated and the microbiota characterised.     
Metabolic investigation of a variety of biofluids and tissues confirmed a systemic 
impact of obesity on the metabolome of mice. This was especially evidenced in the 
plasma and liver, where an increase in lipid particles in 1H NMR spectral profiles could 
be observed. All other biological matrices also exhibited metabolic differences 
introduced by the ob/ob genotype. Collection of gut content material from different 
sites along the intestine enabled detailed analysis of absorption and bacterial 
fermentation processes with regard to obesity differences and bacterial colonisation. 
Timed faeces and urine samples collected over 30 days post colonisation promoted 
detailed characterisation of the colonisation process and its effects on the host. 
Finally, the metabolic profiles of gut material and bacterial abundance were 
statistically linked to explore gut microbial activities in and on the host.  
 
The microbiome is susceptible to genotypic influence 
The experiment was designed to investigate possible lean (wildtype) vs. obese 
(ob/ob) differences in the colonisation with a defined microbiota. For this approach, 
germ-free mice with a different genetic background (i.e. wildtype and ob/ob) were 
used. It is well known, that genotype can influence the microbiome composition [36, 
262]. This is believed to happen through immunological parameters and specific 
glycan synthesis by the host as “mucosal docking station” for bacteria [36]. Other 
factors such as the constant excess supply of nutrients and systemic changes in 
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metabolism such as bile acids are also likely to influence the bacterial colonisation of 
the gut.   
The main variation of the microbiome profile was introduced by the colonisation 
process rather than genotype. The inoculum was comprised of 7 Bacteroidetes, 5 
Firmicutes and 1 Actinobacterium, with all 13 bacteria were present in same quantities. 
However, CoPro-sequencing quantification revealed that 99.0% of bacteria of the 
faecal microbiota were Bacteroidetes at the first time point. These numbers dropped 
over the course of the colonisation process to 86.9% (in animals where R. obeum did 
colonise, i.e. all animals experiment 1 and 1 animal from experiment 2) or 96.6% (in 
animals where R. obeum did not colonise, i.e. 5 animals from experiment 2) at 
sacrifice. This observation is consistent with reports that the faecal microbiota are 
dominated by anaerobic bacteria [37, 263]. However, we also know that the faecal 
microbiota measurements do not provide us with a good estimate of the colonic and 
ileal microbiota. Turnbaugh and co-workers showed the taxonomic distribution of 
different segments of the intestine via 16S RNA sequencing, caecum and colon and 
revealed a 5% abundance of bacteroidetes in the intestine, compared to 50% in the 
caecum and colon [38]. This observation was consistent between gut content and 
mucosal adherent. These abundance differences have several probable causes. The 
colonisation of the gut with microbes is highly influenced by its availability of oxygen, 
and oxygen drops dramatically from small intestine to caecum and colon, resulting in 
an increase of obligate anaerobes. Furthermore, Eckburg et al. suggest that stool 
samples represent a mix of shed mucosal bacteria and non-adherent luminal bacteria 
rather than a representative profile of all bacteria of the whole intestine [35]. 
Therefore, linkage of e.g. ileal metabolite and faecal microbiota analysis has only 
limited interpretability. As quantified by PCA analysis, only 10% of the variation was 
attributed to obesity differences (see appendix). These obesity-related differences 
were a relatively higher abundance of B. caccae in lean animals and higher abundance 
of B. vulgatus in ob/ob animals. B. vulgatus makes up 10-12% of bacteria in human 
faeces and is known to utilise monosaccharides but not fibre [264] and has abilities to 
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deconjugate tauro-conjugated bile acids [265]. B. caccae, as most other 
Bacteroidetes, has the ability to ferment plant polysaccharides [266]. No obesity 
differences were observable for the overall abundance of bacteroidetes and 
firmicutes, whereas a lower ratio of bacteroidetes : firmicutes has been reported for 
ob/ob animals in earlier studies [53, 54].  
The second experiment revealed additional obesity differences. In this experiment, R. 
obeum was not present in the inoculum which could potentially have a microbe-
microbial interaction effect. Since these results are only based on N=6 animals, 
further studies are required to validate these findings.  
 
Systemic metabolic changes in the leptin-deficient obese phenotype 
All animals in the two studies were raised under tightly controlled conditions: same 
age, same husbandry, same diet, sterile environment and colonisation with a defined 
microbiota. This highly controlled environment seemed to exclude inter-individual 
variations to the spectral metabolic profiles. This observation leads to the first 
assumption that once extrinsic factors as well as genotype are tightly controlled, the 
metabolome exhibits only minor inter-individual variations. For this reason it was 
possible to observe statistically significant results, reflecting e.g. group differences 
between lean and ob/ob animals, even though the number of animals included in the 
experiments was very small. Furthermore, many metabolic differences in the 
metabolic profiles were based on NMR-detectable presence-absence of metabolites 
rather than relative concentration differences. This also allowed meaningful 
conclusions on the impact of genotype on metabolic profiles. In the following 
sections, each compartment will be discussed separately.  
 
Liver analysis  
The liver is the central organ for protein metabolism, glycolysis, gluconeogenesis, 
lipid and bile metabolism and metabolism of xenobiotics. Metabolic profiling analysis 
of liver tissue was therefore undertaken to evaluate the possibility of metabolic 
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changes arising from the obese genotype and systemic differences in the host 
introduced by the synthetic microbiota.   
HR-MAS analysis of intact liver tissue suggested a fatty liver condition (steatosis) in 
ob/ob animals. Conversely, sugars (e.g. glucose), amino acids, nucleosides and 
choline species (phosphatidylcholine, phosphocholine, choline) were reduced in 
ob/ob liver tissue. The latter observation can have two causes: (i) the proportion of 
healthy liver is reduced in ob/ob mice resulting in the observation of relatively 
reduced levels of carbohydrates etc. and/or (ii) normalisation of 1H NMR spectra is 
affected by the presence of large additional resonances arising from lipids, resulting 
in an overall decrease of all other metabolites. It is a well-established knowledge that 
pronounced obesity, as it was the case in these studies with a body weight of twice 
of the lean wildtype, introduces hypertriglyceridemia, hypercholesterinemia and 
hepatic steatosis [267, 268], as also confirmed in the here presented study. 
  
Kidney  
The kidney functions as the central excretion organ, responsible for fluid- and 
electrolyte balance, acid-base homeostasis, production site of several hormones and 
excretion of end products from amino acid metabolism and xenobiotics.  
Metabolite profiles of kidney tissue showed the presence of lipids in the ob/ob 
kidneys. Resonances arising from lipidic compounds were not seen in lean animals’ 
kidneys profiles. The amount of lipids in NMR spectra was highly variable between 
the ob/ob animals, indicating that either the distribution of fat in kidney was differing 
between the animals or lipid resonances were mainly introduced by contamination 
with the abdominal adipose tissue surrounding the kidney when preparing the kidney 
tissues for HR-MAS analysis. Furthermore, betaine and choline were increased in 
ob/ob kidney tissue. These osmotically active molecules protect tissue under chronic 
(metabolic) stress, as it the case in obesity [269]. Other compounds, such as cysteine, 
glycine and glutamine were relatively more abundant in lean animals’ kidneys, 
however the correlation coefficient was weak.  
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Gut content  
The gastrointestinal tract is responsible for digestion and absorption of nutrients and 
houses the mucosa-associated immune system. Digestion and absorption by the host 
occurs mainly in the small intestine, while the large intestine is predestined for water 
resorption, storage and compacting of indigestible matter to get excreted in the 
faeces. However, the large intestine is also the location for most of the bacterial 
species, predominantly anaerobes, and is therefore the site of extensive 
fermentation processes.  
Gut content was collected at four different locations, i.e. ileum, colon, caecum, and 
faeces. This strategy enabled differentiation of region-specific metabolic processes 
occurring along the gut. 
The genotype introduced marked differences to the metabolite profile of the gut 
content. As suggested by PCA analysis and HCA analysis, metabolic differences were 
dominated by the two genotypes rather than the differences within the lower gut 
content samples (colon, caecum and faeces). PCA analysis of each gut segment 
separately showed a similar pattern of differences between lean and ob/ob animals. 
Therefore, the colon content, caecal content and faeces will be collectively referred 
to as “lower gut content”, and put in contrast to the “ileal content”. Across both 
experiments, lean mice showed presence of choline and (tauro-conjugated) bile acids 
in lower gut content. These metabolites were not seen in ob/ob mice. Choline was a 
component of the mouse chow; however, only small amounts of choline were still 
observable in the ileum. Therefore it can be assumed that the choline observed in 
colon, caecum and faeces is not a “left-over” from host digestion. If choline reaches 
the large intestine, it usually gets metabolised to methylamine by microbes [270]. 
Conventional animals usually exhibit significant amounts of methylamines (e.g. 
trimethylamine, dimethylamine) in their urine. However, methylamines were not 
found in gut or urine spectral profiles of the here presented animals. It is possible 
that the introduced microbiota did not include methylamine-producing bacteria 
species. Choline can be synthesised de novo in the liver, to form phosphocholine. Loss 
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of choline occurs in two ways; oxidation of choline in liver and kidney to betaine and 
metabolism to phosphocholine, for use in bile and VLDL [271]. The origin of 64% of 
phosphocholine in the lumen is from bile and about 28% from intestinal secretion 
[272]. Choline secretion in ileum is increased in the presence of detergents, such as 
taurocholic acid [272]. Secretion in the caecum or colon is minimal. This secretion in 
the ileum is assumed to help increase the mucus volume to protect the mucosal 
surface from e.g. toxins [272]. The work here presented showed that choline 
secretion may also occur in the colon as choline was observed in the colon and 
thereafter but not in the ileal content.  
Small quantities of bile acids were present in the lower gut content of lean animals, 
but not in ob/ob animals. A targeted LC-MS analysis would be necessary for further 
clarification and quantification of bile acids; however, this was not within the scope 
of this thesis.  
Furthermore, ob/ob animals showed higher concentrations of sugar, fumarate, 
malate, succinate and lower amounts of an unknown compound with chemical shifts 
at δ 2.50 (dd). Other chemical shifts relating to the same compound, as revealed by 
TOCSY, were δ 2.56 (dd) and δ 3.73 (m) suggesting an aspartate-type metabolite 
shifted towards lower field. However, no resonances from possible modifications to 
the aspartate molecule (e.g. acetylation, methylation, esterification) could be 
observed with 2D experiments or STOCSY. It is therefore possible, that pH 
differences introduced shifts of aspartate resonances. Fumarate, malate and 
succinate are involved in the TCA cycle. The elevation of these metabolites was 
consistent in colon, caecum, and faeces, and suggests an increased activity of 
anaerobic bacteria involved in reductive TCA cycle.   
Ileal content was only collected in experiment 2. The spectral profiles of ileal content 
were dominated by bile acids. As resonances appear across the whole spectral width, 
signal from several other metabolites (e.g. acids and amino acids in the spectral area 
of 0.8 – 2.4 ppm), which were overlapping with the dominant bile acids, were 
obscured. Obesity differences were characterised by the presence of raffinose in 
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ob/ob animals and higher levels of taurine in lean animals. The diet consisted of 
raffinose and stachyose. Mice cannot produce α-galactosidase, an enzyme necessary 
for the break-down of both compounds, which makes them dependent on gut 
microbes for energy harvest from oligosaccharides. However, no strong microbial 
obesity differences were observable between lean and ob/ob mice, while raffinose-
metabolic differences were severe with high presence in ob/ob ileal samples and 
absence in the ileum of lean mice. This may suggest that the reason for raffinose 
presence in the ileum is not linked to the microbiota, as there were no strong lean vs. 
ob/ob differences in any of the bacterial species. However, it is well established that 
faecal microbiota do not give a good estimate on ileal or colonic microbiota. Detailed 
information on the ileal microbiota was not collected in the present study. Therefore, 
we can only speculate on the reason of raffinose fate in ob/ob animals. First, the over-
eating of hyperphagic animals might cause a temporary repletion of raffinose-
digesting bacteria. Secondly, it is possible that ob/ob animals have a lower bacterial 
abundance of bacteria able to break down raffinose specifically in the ileum.  
Lean animals were found to have elevated free taurine levels in ileal contents. 
Taurine is essential for the synthesis of conjugated bile acids, and also acts as a 
neurotransmitter, membrane stabiliser and ion transport facilitator. The vast majority 
of taurine is normally supplied by diet but can be de novo synthesised in liver and 
other tissues from cysteine. Free taurine in ileal content samples might point towards 
less or delayed re-absorption of free taurine after deconjugation from bile acids [260, 
273].  
 
Plasma  
Plasma is the systemic transport path, distributing nutrients, signalling molecules, 
oxygen etc. to all locations in the body, especially the central organs. Analysis of 
plasma therefore gives an overview of systemic changes impairing the body 
homeostasis, but it is a tightly regulated biofluid.  
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Plasma analysis confirmed hypertriglyceridemia and hypercholesterinemia in ob/ob 
mice, as already seen in liver tissue and discussed in the literature. The C57Bl/6 ob/ob 
mouse is a model for severe obesity, but only mild insulin resistance. Insulin release 
capacity remains high throughout life and hyperglycaemia is only transient and 
disappears after 6 months of age [239]. This has been evidenced in this study, where 
no increase in plasma glucose was seen in ob/ob mice. The development of insulin-
resistance is dependent on the mouse strain. It has been reported, that ob/ob mice 
on a C57Bl/6 background are resistant to diabetes but other strains, e.g. BTBR ob/ob 
mice, develop diabetes [274]. Genetic loci linked to the differences in diabetes 
development were identified; the mechanisms for the protection of pancreatic islet 
cells despite the massive obese condition are to date not known [274].   
 
Urine  
Urine is the secretory body fluid allowing the system to discharge unwanted, 
redundant soluble metabolites. Urinary metabolites can also hint at changes in 
general metabolic processes. These include end products of metabolism, metabolites 
introduced by diet and drugs, and gut microbial-mammalian co-metabolites.   
Metabolic profiles of lean urine samples revealed an increase of metabolites of 
leucine degradation, 3-hydroxyisovalerate and ketoleucine (2-oxoisocaproate). 
Interestingly, leucine has previously been linked to interacting with the insulin 
signalling pathway in muscle [275] and both 3-hydroxyisovalerate and 2-
oxoisocaproate have previously been shown to have possible stimulatory effects on 
insulin release from pancreatic cells [276]. The fact that these metabolites appear to 
be excreted at a lower level in the ob/ob group might point towards an increased use 
for insulin signalling and therefore prevention of hyperglycaemia in the ob/ob animals 
despite their severe obesity.  
The intensity of the spectral area 0.6 – 1.3 ppm was very low in ob/ob animals 
compared to lean animals. It could not be clearly identified where these broad 
resonances are derived from. A potential candidate are major urinary proteins 
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(MUPs). These are low molecular weight proteins from the liver that have a function 
in binding pheromones in urine. Such MUPs are decreased in obese mice (as also 
observed here) and have recently been found to have effects on increasing energy 
expenditure and decreasing glucose intolerance and insulin resistance [261], when 
administered to type 2 diabetic mice. An unknown compound with resonances at δ 
1.76 (m), 1.93 (m), 2.38 (m), 5.12 (m) was increased in lean animals and further analysis 
of time point data revealed a lack of excretion at time points 0 and 2 in both 
genotypic groups; lean animals reached their excretion maximum at 9 days compared 
to the ob/ob at 16 days, and the lean animals had higher final excretion levels of this 
metabolite. The lack of excretion at early time points clearly suggests this metabolite 
is of gut microbial metabolic origin. Spectral resonances suggest a chemical structure 
similar to X-CH2-CH2CH=CH-X. Chemical shifts in the area 5 ppm generally derive from 
sugar resonances or double bonds; other resonances of sugars were not found, 
therefore the presence of a C=C double bond is assumed. The chemical structure 
could however not be confidently assigned. Some tendencies for a faster 
establishment of microbiota in lean animals were observed (e.g. B. WH2 and B. 
uniformis), however these observations were too vague to assign these bacterial 
species to the cause of this metabolite change in urine.  
Other metabolites of gut microbial origin were indole-, phenylalanine-, and tyrosine-
metabolites. These metabolites are likely to be indoleacetate, phenylacetylglycine 
and p-cresol-glucuronide [20]. An obesity-dependent excretion pattern was observed 
for these metabolites with lean animals excreting more and reaching a maximum of 
level of excretion at time point 16, while the ob/ob excretion rate remained smaller 
and continued to increase until time point 30. For further clarification of the gut 
microbial origin of these metabolites it will be helpful to quantify all metabolites of 
the phenylalanine/tyrosine/tryptophan microbial pathway (see chapter 4) per 
targeted LC-MS profiling and statistically link these to the microbial abundance data.  
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Host-microbiome interactions  
The metabolic profiles of urine and gut compartments (ileum, colon, caecum, faeces) 
exhibited significant differences in comparison to conventional mice. Urinary profiles 
lacked hippurate and methylamines, both metabolites are known to be produced by 
gut microbiota [167, 270]. Furthermore, glycine (δ1H 3.57 (s), δ13C 44.3) was not found 
in any urinary profile, however, an unknown metabolite with chemical shifts at δ1H 
3.60 (s) and δ13C 62.4 was present in all profiles. Faecal profiles from conventional 
animals normally contain significant amounts of butyrate and higher amounts of 
amino acids. The metabolites choline, lignin and unknown compound δ1H 3.60 (s) 
ppm are generally not observed [16, 260, 277] in conventional animals, however, they 
have been found here in gut content aqueous extracts. Lignin could be linked to the 
(unusual) ingredient of the mouse chow (see appendix Figure 121) and breakdown 
requires enzymes normally present in fungi, while bacteria have very limited or no 
lignin-degradation capabilities [278]. Differences in lignin concentration were also 
observed between experiment 1 and 2. As lignin is insoluble in water, differences 
could also derive from small variation in gut content aqueous extractions rather than 
effects of microorganism breakdown. To investigate statistically meaningful links 
between the faecal metabolites and faecal microbiome, PLS regression modelling 
was carried out and several correlations between metabolites and the microbiome 
were revealed, as described herein.  
 
R. obeum and P. distasonis 
R. obeum did not successfully colonise in 7 animals. This included all 6 animals of the 
second experiment and 1 animal in the first experiment. The fact that the non-
colonisation was observed across both experiments made this observation not 
entirely dependent upon batch effects and allow careful investigation of specific 
colonisation effects. However, as the number of animals not colonised with R. obeum 
was not balanced across both experiments, a follow-up experiment is needed for 
confirmation of the here described species – metabolite linkages. In each of these 7 
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animals, the colonisation of P. distasonis was minimal even though this species was 
present in the inoculum. This strong correlation between R. obeum and P. distasonis 
(r=0.8, see Figure 57) hints at a co-species dependency, which is a feature of ecology 
and ecological stability. Indeed, P. distasonis is known to have a very specialised gene 
set-up [279]. It seems therefore possible, that P. distasonis depend on metabolites or 
other environmental factors introduced by R. obeum. Regression analysis of the R. 
obeum abundance data and faecal metabolite profiles revealed strong correlations 
(r=0.81, p<0.001) to acetate. Strong correlations were also observed to propionate 
and ethanol. R. obeum is known to produce acetate and ethanol from glucose, 
pyruvate, fructose and broth [280]. Propionate is produced with acetate and CO2 
from glucose, glycerol and lactate by species from Bacteroides (e.g. P. distasonis), 
some Clostridia, Propionibacterium and Veillonella [281]. All three metabolites, 
acetate, ethanol and propionate, are present in low quantities in all other animals, 
suggesting that R. obeum (and P. distasonis) are the main, but not exclusive 
producers. From this limited dataset, however, it cannot be ascertained, which of the 
two, or both, bacterial species produce the named metabolites, and through which 
metabolites or signalling molecules the species might depend on each other.  
 
B. caccae and C. scindens 
B. caccae was anti-correlated with the faecal metabolites fumarate, succinate and 
malate, and positively correlated with an unknown metabolite with δ 2.50 (dd) 
(potentially an aspartate-type metabolite). The opposite was true for C. scindens, 
which correlated with fumarate, succinate and malate, and anti-correlated with the 
unknown metabolite at δ 2.50. The correlation matrix of the abundance data showed 
that B. caccae and C. scindens are anti-correlated. B. caccae was observed to colonise 
better in lean animals across both experiments, and ob/ob faecal metabolic profiles 
showed higher relative concentrations of fumarate, succinate and malate and lower 
amounts of the unknown compound. In contrast to the here described observations, 
B. caccae is known to produce succinate and acetate [266]. C. scindens is known to 
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produce acetate, ethanol and pyruvate and nothing is reported to date about the 
production or use of the above listed metabolites [282]. A common fermentation 
process is mixed acid fermentation, where glucose is metabolised to oxaloacetate, 
via conversion of pyruvate and phosphoenolpyruvate. This is followed by formation 
of malate, fumarate and finally succinate. Alternatively, oxaloacetate can also be 
metabolised to aspartate, which might explain the anti-correlation of the 3 
metabolites to the unknown (putatively aspartate-type) metabolite. 
 
Limitations of the study and translatability as a model for human obesity 
The ob/ob mouse model with its defect in producing leptin leads to a hyperphagia 
and therefore introduces severe obesity, accompanied by hyperlipidemia, insulin-
resistant, infertility and impaired immune functions. Therefore, the ob/ob phenotype 
is more complex than “just” obesity [283]. The causes of human obesity are very 
diverse, and a positive energy balance is often accompanied by a diet high in fat and 
low in carbohydrates, fibre and micronutrients [37]. Therefore, the ob/ob animal 
model exhibits a very specific phenotype and thus has restricted translatability to 
human obesity.  
The choice of a limited and defined microbiota was made based on the aim to 
investigate the colonisation differences of each species between lean and ob/ob 
animals, and to be potentially able to link species abundance to metabolites. 
However, as observed through global metabolic profiling of different biofluids, the 
metabolic profiles, particularly those of gut content and urine exhibited several 
differences compared to conventional animals and also lacked metabolites normally 
observed in animals with a conventional gut microbiota. For example, degradation of 
choline escaping the small intestine as TMA did not occur, as choline could still be 
found in faeces, and TMA was not observed in urine. The chosen microbiota is 
therefore not fully representative of a conventional (simplified) human microbiota.  
The experiment was set up using a very limited number of animals due to feasibility, 
as germ-free ob/ob animals are very difficult to breed. Therefore, a second 
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experiment was carried out, to increase the total number of animals. The inoculum in 
the second experiment was different in the way that R. obeum concentrations were 
very low and therefore did not colonise. This fact complicated the allocation of 
“batch effects” (e.g. possible husbandry or seasonal effects) and “inoculum effects”. 
However, one animal of experiment 1 had similar colonisation differences (i.e. low or 
absent R. obeum and P. distasonis) similar to those in experiment 2, which then made 
it possible to draw more robust conclusions on the metabolic effects of these 
species. 
A future study should be carried out with larger number of animals and including 
conventional animals of the two genotypes. Furthermore, timed collections should 
be made for both urine and faeces to be able to better pursue the appearance and 
disappearance of metabolites. Faecal 16S RNA-sequencing is believed to give an 
overview of non-adherent and shed bacteria of the intestine [35]. It would therefore 
be ideal to include ileal and/or colonic material, in addition to faecal material in the 
16S RNA-sequencing to collect information of microbiota composition throughout 
the gut.   
 
Conclusions   
It was confirmed that obesity introduced marked metabolic changes in all 
investigated bodily compartments: steatosis in the liver, elevated plasma lipids, 
increased levels of osmoltyes in the kidney, decreased levels of choline and tauro-
conjugated bile acids in gut compartments, and decreased levels of leucine 
metabolites (e.g. 3-hydroxyisovalerate, ketoleucine) and several metabolites 
associated to gut microbial-mammalian co-metabolism (e.g. indole metabolites) were 
observed. Comparison of metabolite profiles with profiles from animals with 
conventional microbiota showed distinct differences in urine (e.g. lack of hippurate 
and trimethylamine), faecal and caecal water (e.g. lack of butyrate and presence of 
choline), while liver, kidney and plasma analysis showed a metabolite profile similar 
to that of conventional animals. Urinary collection at multiple time points allowed 
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elucidation of resonances (e.g. deriving from tryptophan, tyrosine and phenylalanine 
metabolites) directly linked to the transition from germ-free to gut microbiome 
colonisation. Collection of biological matter of different segments of the gut lumen 
revealed metabolic digestion, resorption and fermentation processes along the 
intestinal tube. Propionate and acetate and metabolites of the TCA cycle were 
statistically significantly linked to specific bacterial species of the faecal microbiome 
and revealed a metabolic activity of the microbiota in the gut.  
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CHAPTER 6: General discussion  
 
The overall aim of this thesis was to provide an untargeted and unbiased 
characterisation of metabolic variation introduced by diet and gut microbiota to the 
metabolic phenotype. A strategy was developed to first identify metabolites linked to 
specific food intake via NMR-based metabolic profiling of spot urine samples and to 
then validate a potential biomarker in a large-scale population study. A secondary aim 
was to describe metabolic differences between participants which were indicative of 
their basal metabolism or of individual metabolic alterations in response to food 
intake. Metabolites known to be of gut microbial-mammalian co-metabolic origin 
were found to be predictive for identifying volunteers’ urinary profiles. Many of the 
metabolic signatures attributable to inter-individual variation or response to 
nutritional intervention were associated with the gut microbiota. To be able to link 
metabolic variations in biofluids to specific features of the gut microbiota, a murine 
model with a simplified and well characterised microbiota was investigated. Short-
chain fatty acids and TCA cycle intermediates in gut contents were linked to bacterial 
species’ leverage. Specific differences in urinary and faecal metabolic profiles in 
comparison to conventional animals were identified. The method of choice was a 
combination of metabolic profiling via 1H NMR spectroscopy and multivariate analysis 
for characterisation and interpretation of metabolic variation introduced by diet, the 
gut microbiota and obesity. 
 
6.1  Dietary intake and the gut microbiota influence the metabolic phenotype 
There is an increasing demand to be able to characterise individual and population 
dietary habits in order to draw conclusions on the impact of diet and lifestyle on 
healthy living and prevention of disease. However, dietary intake is to date mainly 
assessed by food questionnaires and food recall methods and these are subject to 
random and systematic bias. The existence of biochemical markers of food intake can 
be helpful to control or circumvent such problems. However, food biomarkers are 
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sparse and most available indicators (e.g. polyphenols for fruit and vegetable) are 
not validated in free-living populations. Therefore, there is a strong need not only to 
validate existing markers but moreover to develop a strategy that enables the 
identification and validation of new biomarkers in high-throughput approaches. Such 
a strategy has been developed in this thesis with several potential markers identified 
and linked to their dietary origin. This strategy was validated for citrus fruit 
consumption and urinary proline betaine in the INTERMAP study. If pursued further, 
this strategy could lead to the identification of a broad range of food biomarkers that 
then as a package would allow us to monitor food intake, not only for specific foods 
or food groups, but across a wide range of dietary components to describe food 
patterns and general dietary habits. Such patterns could place individuals or 
populations in a dietary multivariate space, which can then be linked to data from 
body composition or medical measurements facilitating the linkage of diet and 
lifestyle behaviour to disease prevention and promotion of good health.  
Most health management approaches so far are mainly focussed on populations, and 
dietary recommendations are calculated as a mean requirement for groups rather 
than each person’s individual need or optimum. It is an obvious assumption that each 
person, as defined by a unique gene make-up and a specific combination of 
environmental influences, has slightly different lifestyle requirements to maintain 
health than his/her neighbour. To establish a personalised healthcare approach, more 
knowledge is necessary on the predictive ability of each person’s health status and 
metabolic set-up. So far, a proof-of-principle of a pharmaco-metabonomics approach 
[63] has been established and the existence of a human metabolic phenotype 
predictive for individuals shown [205]. This thesis has demonstrated that such a 
metabolic phenotype comprises variations in basal metabolites (e.g. mean excretions 
of creatinine or citrate), individual responses to food intake (e.g. excretion levels of 
taurine after animal protein consumption) and in particular the contributions of 
metabolites produced by gut microbial-mammalian co-metabolism (e.g. hippurate, 
TMA). Additional influences are introduced by dietary choices, intake of xenobiotics 
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(e.g. drugs), physical activity etc, but these factors were standardised in this study. It 
was shown that several metabolites of food origin are stable in their excretion 
kinetics and excreted amount across volunteers (e.g. tartrate and proline betaine), 
while others that involve metabolism or microbial degradation (e.g. TMA, hippurate) 
vary strongly between individuals.  
Ultimately, the goal is to be able to identify how such personal phenotypes can be 
linked to body composition, medical measurements or disease development, to 
ascertain if they are  predictive of nutritional intervention outcomes (e.g. probiotics, 
low-fat diet) and to assess whether a possibly unfavourable metabolic space can be 
influenced so that individuals are moved towards a more beneficial and healthier 
phenotype. 
Some contributions of the gut microbiota to the metabolic phenotype have been 
demonstrated in this thesis. To be able to link feature of the microbiota to 
metabolites or metabolic patterns, an additional, tightly controlled animal study was 
carried out and influences of the gut microbiota and obesity on the global metabolic 
phenotype were established. Obesity introduced steatosis, an increase in osmolytes 
in the kidneys and elevated plasma lipids. This confirmed reports in the literature, 
describing the same features of the C57Bl/6 ob/ob phenotype [239]. Despite their 
severe obesity, C57Bl/6 mice do not show hyperglycaemia. The urinary metabolites 
ketoleucine and 3-hydroxyisovalerate suggest a potential role of an alternative 
insulin-signalling pathway in preventing this obese mouse model from excreting high 
amounts of glucose. This study also indicated that the chosen microbiota do not 
represent conventional or human microbiota as key metabolites in faeces (e.g. 
butyrate, low levels of SCFA and amino acids) and urine (e.g. hippurate, TMA) were 
not present or significantly reduced compared to conventional animals or compared 
to humans. Surprisingly, metabolic profiles of colon, caecum and faeces were very 
similar to each other, suggesting that collection of faeces is adequate for future 
studies when aiming to investigate metabolism and fermentation processes in the 
large intestine in mice colonised via the procedure used here.  
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6.2  Critical review of the analytical techniques and study design 
The aim to identify new biomarkers and globally characterise biofluids made the use 
of 1H NMR spectroscopy combined with multivariate pattern recognition techniques 
the method of choice. The NMR-based approach required minimal sample 
preparation, which ensures minimal alterations to the selected biomatrix. No prior 
knowledge or pre-selection of chemical classes of interest is required. 1H NMR 
metabolite profiling captures metabolites across many chemical classes and pre-
selection of measurements is mainly introduced by the detection limit rather than 
specific metabolite classes (cf. targeted analysis). The aim to elucidate new 
biomarkers makes an untargeted approach necessary. The fact that novel biomarkers 
e.g. proline betaine were found, gives reassurance in the adequacy of this technique 
choice. A drawback of NMR-based profiling as opposed to MS-based profiling is 
clearly the limit of detection and sample volume required, being much higher in NMR 
spectroscopy. Targeted analysis is advantageous for accurate quantification of 
metabolites or metabolite classes of interest, but only a limited number of chemical 
classes are covered. Untargeted and targeted analysis can probably be compared 
with a snap-shot of a landscape rather than a detailed zoom in of a small area of 
interest, where the overview and unexpected changes outside this area are lost.  
NMR spectral processing of biofluids faces several challenges. The nature of biofluids 
with their different dilutions across collected samples (e.g. urine) requires 
normalisation of the acquired spectral profiles. Normalisation to an internal standard 
(i.e. a metabolite independent of biological variation) is not possible as there are no 
such metabolites known in urine. Normalisation to total spectral area is susceptible 
to bias where large peaks are introduced in the spectrum (e.g. increase in lipids in 
liver or plasma, increase in bile acids in gut contents). Probabilistic quotient 
normalisation, where the most probable dilution factor is calculated by finding the 
median of all variables, was therefore the method of choice in the current thesis and 
has been shown to work reliably [90]. Other challenges of analysing spectral data are 
peak shifts (e.g. introduced by variation in pH and ionic strength) and peak overlap. 
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Peak shifts are already reduced by controlling the pH with buffer; however small 
shifts are still present and can be corrected with peak alignment algorithms [91]. The 
peak overlap issue can partly be solved by acquiring both 1H and JRES experiments, 
where JRES 1H projections reduce peak multiplets to single peaks [284]. This would 
be an experiment proposed for future studies.  
One of the bottlenecks of untargeted analysis is that both the NMR- and MS-based 
techniques require assignment of peaks or masses. NMR spectroscopy is intrinsically 
well suited for identification of unknown compounds as it gives insight into the 
chemical structure through the chemical shift and peak multiplicity. Combined with 
2D spectroscopy and statistical spectroscopy, a more complete picture of the 
chemical structure can be obtained by adding information on 1H and 13C chemical 
shifts and resonance connectivities. As biological fluids and tissues are complex and 
metabolite-rich matrices, separation techniques e.g. solid-phase extraction and on-
line liquid chromatography (e.g. LC-NMR) can be helpful steps for further metabolite 
purification and for structure clarification. However, these techniques require 
relatively high concentrations of the metabolite of interest or high sample volume 
and the original sample cannot be recovered (which is a problem when e.g. working 
with mouse urine samples). Finally, spiking experiments (as applied here to identify 
proline betaine) can be carried out for confident confirmation of peak assignment.  
NMR spectroscopy is semi-quantitative. Peak height (or peak integral) is directly 
proportional to the number of protons giving rise to the resonance and the quantity 
of the compound. However, this assumes that the acquisition has been carried out 
under conditions where the resonance of interest is fully relaxed and all samples to 
compare are acquired under the same conditions. Here, both of these conditions 
were not fully optimised, i.e. the T1 was too short to allow full relaxation of all 
resonances, being adjusted for a practical compromise of sample throughput. 
However, assessment of the analytical error of metabolite quantification across 
samples has been examined previously [15] and found to be small.  
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Data analysis was mainly focused on dimensionality reduction and projections 
methods, i.e. principal component analysis (PCA), projection to latent structures 
analysis (PLS) and PLS combined with orthogonal filtering (OSC filter), O-PLS analysis. 
These methods work well when one large source of variation is introduced and all 
other variations in the matrix are orthogonal and systematically unrelated to the 
introduced variation. In addition, discriminant analysis, as used here (PLS or O-PLS), 
works best when comparing 2 groups (e.g. control and disease) against each other 
but is suboptimal, when more than 2 groups exist in a dataset. In the nutrition study 
presented here (see chapter 4), 7 “groups” (i.e. volunteers) were compared, which 
were further influenced by different food challenges. Therefore, PCA and O-PLS 
analyses were not used as the ultimate method, but complemented with other 
multivariate analysis approaches, e.g. hierarchical clustering and self-organising 
maps. These additional analyses confirmed the clustering and trends already seen in 
PCA analysis. Furthermore, metabolites highlighted in the PCA/O-PLS loadings plots 
were relatively quantified by peak integration and compared between groups 
(boxplots) and against sampling time (kinetics plots). This approach enabled 
comparison of average metabolite excretion and observation of metabolite excretion 
in relation to food consumption times or possible diurnal variations.  
Several of the spectral features elucidated by PCA/O-PLS showed differences in 
presence/absence between the groups, rather than differences in relative 
concentrations of metabolites. For example, consumption of fruits introduced non-
endogenous compounds such as proline betaine and tartrate.  
 
A major challenge in this thesis project was dealing with studies of limited sample 
size. The human nutritional intervention study undertaken included 7 volunteers. 
Human volunteers are diverse, hard to control, n0n-compliant, limited in availability 
and difficult to collect samples from. One way to get an overview of the variation in 
their metabolic phenotypes is to collect multiple samples (here: 25 samples for every 
volunteer) to increase the significance of such a reduced sample to be able to define 
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a good metabolic space for each person. The variation was reduced by a fairly tight 
BMI and age bracket and limiting inclusion criteria to healthy non-smokers, since such 
factors are already well-established to cause variation in metabolic profiles. Detected 
food biomarkers were validated in a large-scale population study and shown to have 
a high sensitivity and specificity of 80.6% and 92.3% respectively.  
The mouse microbiota study also included only a limited number of animals. To 
reduce variation in the dataset, the diversity of the microbiota (i.e. number of 
variables in microbiota matrix) was greatly reduced by working with a simplified and 
defined microbiota. This approach ensured that only a limited number of bacterial 
species influence the host phenotype, and variation between animals was minimal, as 
the inoculum was standardised. Furthermore, collection of multiple biofluids and 
tissues allowed linkage of metabolites across body compartments to explain causes 
of metabolite variations and be better able to identify sporadic variation.  
 
6.3  Possible future work 
It would be interesting to relate personal metabolic profiles to secondary 
measurements e.g. physical activity, resting metabolic rate, lean body mass, dietary 
habits and gut microbiota characterisation. Such a dataset could enable to 
conclusively link metabolites descriptive of individual variation to specific features of 
host and microbiota metabolism. For such an approach it is also necessary to include 
a larger number of volunteers and investigate the possibility of sub-clustering within 
a cohort.  
The human microbiome mouse model needs further optimisation in terms of 
selection of microbiota members, based on the fact that several metabolites of fibre, 
protein and choline fermentation were absent in the investigated model. This could 
be achieved by a step-wise approach, where germ-free mice and several groups of 
mice with increasing number of bacterial members are compared to each other and 
to fully conventional animals. Additional measurements e.g. targeted bile acid 
quantification and quantification of phenols (e.g. p-cresol-glucuronide, 
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phenylacetylglycine) could support 1H NMR spectroscopic characterisation of 
metabolic profiles.  
Finally, a mouse or human study should be carried out to decipher not only the 
separate effects of diet and gut microbiota, but also the dependency and complex 
interaction of these two factors on host metabolism and to the metabolic 
phenotype.  
 
In summary, the work presented in this thesis provides a strategy for future 
biomarker identification and validation, with particular focus on food intake, inter-
individual metabolite profile differences and gut microbial contributions. In the 
future, work in this field could lead to improvements in the understanding of the 
impact of dietary lifestyle, elucidate the influence of the gut microbiota on health and 
disease and the efficacy of treatment, and be valuable for the development of 
personalised healthcare strategies. 
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Appendices 
Appendix I: Supplemental data to chapter 3 
 
The chemical shifts of the unknown compound, referred to as δ 2.90(t), is shown in 
Table 19. Chemical shifts were derived from TOCSY and HSQC experiments using a 
600MHz spectrometer, equipped with a cryoprobe. 
 
Table 19 1H and 13C chemical shifts of unknown metabolite δ 2.90 (t), from TOCSY and HSQC 
experiment. Putatively assigned to glutamylcysteine. 
 
δ 1H δ  13C  
2.13 28.72  
2.57 28.30  
2.90 32.12  
4.43 55.70  
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A spiking experiment was carried out to confirm proline betaine in urine. A 
representative urine sample collected post orange juice consumption was analysed 
with 1H NMR spectroscopy and the another spectrum acquired after spiking pure 
proline betaine hydrochloride (see Figure 108). The 1H NMR spectrum of proline 
betaine is also given (Figure 108A).  
 
 
Figure 108 1H NMR spectra of (A) proline betaine standard compound and (B) spectra of urine sample 
post orange juice consumption without (black) and with (red) addition of proline betaine. Arrows 
indicate resonances from proline betaine.  
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A standard additions experiment was carried out to ensure the correct quantification 
of proline betaine in citrus juices. Experiments were carried out, where proline 
betaine hydrochloride (Extrasynthese, Genay Cedex, France) in buffer solution was 
added to the orange juice sample step-wise and fully relaxed NMR experiments 
acquired (Figure 109).  
 
y = 1.7114x + 0.2047
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2
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Figure 109 Standard addition  experiment to determine the proline betaine concentration in orange 
juice. A proline betaine-hydrochloride buffer solution (6.4mg /100ul) was added in 5ul steps. The 
calculated proline betaine concentration was 1196.5 mg/L. 
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Appendix II: Supplemental data to chapter 4 
 
 
Figure 110 PCA scores plots comparing the influence of inter-individual and food related differences on 
separation after Pareto scaling (PC7-PC12). PCA was carried out including all urine spectra, coloured by 
individuals (left column): volunteer 1b, volunteer 2, volunteer 4, volunteer 5, volunteer 6, volunteer 7, 
and volunteer 8. Right column, coloured by food groups: standard meal, fish meal (animal protein), 
beef meal (animal protein), fruit meal, wine and grapes. 
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Figure 111 PCA scores plots comparing the influence of inter-individual and food related differences on 
separation after Pareto scaling (PC7-PC12). PCA was carried out including all urine spectra, coloured by 
individuals (left column): volunteer 1b, volunteer 2, volunteer 4, volunteer 5, volunteer 6, volunteer 7, 
and volunteer 8. Right column, coloured by food groups: standard meal, fish meal (animal protein), 
beef meal (animal protein), fruit meal, wine and grapes. 
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An O-PLS-DA modelling approach was carried out, where each volunteer (1b, 2, 4, 5, 
6, 7 and 8) was compared to all other volunteers in 7 separate models (1 predictive, 1 
orthogonal component). Metabolites with a correlation coefficient > 0.2 are listed 
here, in Table 20.  
 
Table 20 Summary of all inter-individual differences between 7 volunteers, as revealed by 7 O-PLS-DA 
analyses. (# indicates the direction of change, (+) indivates a relatively higher metabolite concentration 
in this person, (-) a relatively lower concentration).  
 
 metabolite chemical shift multiplicity assignment r2 r# comment 
V
o
lu
n
te
e
r 
1 
PCS 7.28 d H3,H5 0.22 +  
PAG 7.35 t H3,H5 0.37 +  
indoxylsulphate 7.50 d H7 0.23 +  
 7.95 m  0.21 +  
N-methylnicotin-
amide 8.97 m H6 0.21 +  
trigonelline 8.84 t H2 0.18 +  
 3.16   0.27 - artefact 
taurine 3.42 t CH2NH2 0.2 -  
mannitol 3.84 dd CH2OH 0.29 +  
 4.18   0.22 - artefact 
 4.19   0.22 - artefact 
 1.12 m  0.31 +  
 1.70   0.28 + amino acid (CH2)* 
 1.99   0.29 + amino acid (CH2)* 
N-acetylated 
metabolite 2.02 s CH3 0.27 -  
PAG 2.27 m CH2 0.3 +  
PCS 2.35 s CH3 0.35 +  
glutamine 2.45 m gammaCH2 0.39 -  
citrate 2.54 d CH2(ii) 0.34 -  
DMA 2.77 s CH3 0.23 -  
TMA 2.86 s 3xCH3 0.66 +   
V
o
lu
n
te
e
r 
2 
 6.67 m  0.23 +  
 6.97 d  0.31 + tea consumption 
 7.38 t  0.37 + tea consumption 
 3.61 m  0.24 +  
creatinine 4.05 s CH2 0.52 +  
 4.51 s  0.43 + tea consumption 
 0.64 s  0.72 +  
 1.00 m  0.32 +  
 1.10 d  0.35 - 
4-deoxyery-thronic 
acid* 
2-hydroxy-
isobutyrate 1.36 s CH3 0.36 -  
 1.99 bs  0.48 -  
 2.04 t  0.4 -  
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glutamine 2.45 m gammaCH2 0.22 +   
V
o
lu
n
te
e
r 
4
 hippurate 7.55 t H4 0.3 +  
trigonelline 9.12 s CH2 0.28 +  
creatine 3.93 s CH2 0.21 +  
glycine 3.57 s CH 0.55 +  
N-acetyl 2.03 s CH3 0.28 +   
V
o
lu
n
te
e
r 
5 
 6.71 m  0.2 -  
 6.86 dd  0.37 +  
 6.92 bs  0.55 +  
 6.99 m  0.24 +  
 7.02 s  0.31 +  
 7.30 s  0.64 +  
 7.31 s  0.5 +  
 7.38 s  0.26 +  
 7.40 s  0.47 +  
 7.42 s  0.34 +  
hippurate 7.55 t H4 0.22 +  
formate 8.45 s CH 0.2 +  
 1.10 d  0.27 + 
Putatively 4-
deoxyerythronic 
acid [285] 
3-hydroxy-
isovalerate 1.27 s CH3 0.35 +  
 1.81 bs  0.6 +  
 1.93 s  0.29 +  
 2.00 m  0.24 +  
 2.22 m  0.42 +  
 2.36 s  0.31 + 
oxalacetate/ 
pyruvate? 
 2.61 ddd  0.35 +  
  2.97 s   0.59 +   
V
o
lu
n
te
e
r 
6
 
 6.37 d  0.47 +  
 6.49 m  0.22 +  
 6.53 m  0.31 +  
 6.67 d  0.39 +  
 6.70 bs  0.41 +  
 6.91 s  0.21 +  
 7.49 m  0.22 +  
 7.59 bs  0.21 +  
 0.78 bs  0.28 +  
 0.83 bs  0.3 +  
 1.26 d  0.33 +  
2-hydroxy-
isobutyrate 1.36 s CH3 0.3 -  
alanine 1.48 d CH3 0.27 +  
glutamine 2.14 m betaCH2 0.33 +  
glutamine 2.48 m gammaCH2 0.25 +  
citrate 2.54 d CH2(ii) 0.25 +  
DMG 2.93 s 2xCH3 0.28 +  
 3.50 m  0.23 + sugar alcohol* 
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 3.55 d  0.35 + sugar alcohol
* 
 3.60 m  0.28 + sugar alcohol
* 
 3.62 s  0.35 + sugar alcohol
*  
  3.90 bs   0.35 +   
V
o
lu
n
te
e
r 
7 
 1.25 s  0.2 +  
2-hydroxy-
isobutyrate 1.36 s CH3 0.3 +  
 1.46 d  0.27 +  
N-acetyl 2.05 s  0.21 +  
 2.81 bs  0.32 +  
 3.00 s  0.4 +  
 3.35 s  0.51 + MeOH* 
 3.39 bs  0.35 +  
 3.48 m  0.25 +  
 3.52 m  0.3 +  
  3.90 s   0.23 +   
V
o
lu
n
te
e
r 
8
 
 6.59 s  0.53 +  
 6.85 d  0.26 +  
 6.90 d  0.47 +  
 7.35 s  0.27 +  
 7.41 m  0.32 -  
 7.51   0.33 + artefact 
 7.68 s  0.49 +  
 8.37   0.22 + artefact 
 8.39   0.4 + artefact 
 8.56 bs  0.68 +  
 8.91 d  0.2 +  
 0.72 d  0.21 +  
 0.99 d  0.41 +  
 1.05 t  0.46 +  
 1.10 d  0.28 + 
4-deoxy-erythronic 
acid* 
alanine 1.48 d CH3 0.35 +  
 2.03 bs  0.39 +  
citrate 2.54 d CH2(ii) 0.64 +  
DMA 2.72 s CH3 0.43 +  
 3.59 m  0.55 + background 
creatinine 4.05 s CH2 0.62 +  
 4.10 s  0.56 +  
 4.14   0.37 + artefact 
 4.21 m  0.29 +  
 4.30 t  0.29 +  
  4.53 d   0.28 +   
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The microbial and host degradation of choline were investigated by semi-quantifying 
all associated metabolites for each individual separately. Mean metabolites 
concentrations are illustrated in boxplots in Figure 112.   
 
 
Figure 112 The choline degradation pathway, with symbiotic microbial activity highlighted in blue and 
human enzymes highlighted in red, for each volunteer separately.  
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Appendix III: Supplemental data to chapter 5 
 
Principal component analysis of the abundance data in experiment 1 (Figure 113) and 
experiment 2 (Figure 114) was undertaken, including faecal samples from all time 
points and both lean and ob/ob animals. The PCA biplots show the largest variation 
associated to colonisation over time (PC 1) and small influences are seen for lean vs. 
ob/ob differences in PC 4 (~10%). The biplot also includes variables (i.e. bacterial 
species) driving this separation, as plotted on top of the scores plot with bacterial 
species’ names in black.  
 
Figure 113 PCA biplot of scores and loadings of all abundance data from the first experiment. PC1 
shows the development of bacterial abundance over time, PC 4 shows tendencies of clustering lean 
and ob/ob animals, after day 21. The PC loadings (bacterial species) are plotted onto the scores plot to 
give an overview of the bacterial species responsible for the separation. PC 2 and 3 accounted for 
14.9% and 11.8%, and showed no clustering to time or obesity. Animals 2B, 12B and 14B derive from lean 
animals, animals 1B, 3B, and 4B from ob/ob animals. 
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Figure 114 PCA biplot of scores and loadings of all abundance data from the second experiment. PC1 
shows the development of bacterial abundance over time, PC 4 shows tendencies of clustering lean 
and ob/ob animals, after day 14. The PC loadings (bacterial species) are plotted onto the scores plot to 
give an overview of the bacterial species responsible for the separation. PC 2 and 3 accounted for 14.1% 
and 12.1%, and showed no clustering to time or obesity. Animals 1, 2 and 3 derive from lean animals and 
animals 13, 14, 15 from ob/ob animals. 
 
 
Principal component analysis of the abundance data in lean animals (Figure 115) and 
ob/ob animals (Figure 116) was undertaken, including faecal samples from all time 
points and both experiments. The PCA biplots show the largest variation associated 
to colonisation over time (PC 1) and strong influences are also observable for 
differences between the two experiments in PC 2 (17.6% and 18.8%). The biplot also 
includes variables (i.e. bacterial species) driving this separation, as plotted on top of 
the scores plot with bacterial species’ names in black.  
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Figure 115 PCA biplot of scores and loadings of all abundance data from wildtype (lean) animals. PC1 
shows the development over time, PC 2 differentiates experiment 1 and 2. The PC loadings (bacterial 
species) are plotted onto the scores plot to give an overview of the bacterial species responsible for 
the separation. Animals 1, 2 and 3 derive from experiment 1, animals 2B, 12B, and 14B from experiment 
2. 
 
 
 
Figure 116 PCA biplot of scores and loadings of all abundance data from ob/ob animals. PC1 shows the 
development over time, PC 2 differentiates experiment 1 and 2. The PC loadings (bacterial species) are 
plotted onto the scores plot to give an overview of the bacterial species responsible for the 
separation. Animals 13, 14 and 15 derive from experiment 1, animals 1B, 3B, and 4B from experiment 2. 
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A detailed illustration of the abundance data, CoPro-Sequencing at time points 1, 2, 4, 
7, 21, 28 and at sacrifice, separately for experiment 1 and 2 and colour-coded for lean  
(black) and ob/ob animals (red) is given in Figure 117.  
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Figure 117 Colonisation profiles of the 13-member community from the first (left) and second (right) 
experiment expressed relatively to total abundance. Mouse donors are colour-coded for lean and 
ob/ob animals. 
 
 
PCA analysis of faecal water metabolic profiles after removal of resonances from 
ethanol and acetate and subsequent re-normalisation of the spectral profiles. PCA 
scores plots (Figure 118) and loadings plots (Figure 119) are shown. Comparison with 
scores and loadings plots before re-modelling show that ethanol and acetate do not 
influence normalisation of the spectral profiles and PCA analysis.  
 
 
Figure 118 PCA analysis of faecal water spectral profiles after ethanol and acetate exclusion and re-
normalisation, colour-coded for lean and ob/ob animals. (A) 1st experiment and (B) 2nd experiment.  
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Figure 119 Loadings plots of the first principal components of (A) PCA analysis of faecal samples from 
the first experiment and (B) from the second experiment, accounting for metabolic differences 
between lean and ob/ob animals.  
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A collection of selected spectral areas for lean and ob/ob animals, for all four gut 
compartments is shown in Figure 120. This emphasizes the fact that succinate and 
fumarate is only present in the lower gut, raffinose only present in ob/ob ileum, 
methanol decreases along the gut, bile acids (0.7bs) are very high in ileum and 
thereafter only present in lean gut and choline very low in ileum but strongly 
increased in lean gut. 
 
0
5
10
15
20
25
2.42.412.42
0
5
10
15
20
25
2.42.412.42 2.42.412.42
0.1
0.2
0.3
6.56.526.54
0.1
0.2
0.3
6.56.526.54 6.56.526.54
0.2
0.3
0.4
0.5
2.52.552.6
0.2
0.3
0.4
0.5
2.52.552.6 2.52.552.6
1
2
3
4
3.13.23.33.4
1
2
3
4
3.13.23.33.4 3.13.23.33.4
0
5
10
15
11.52
0
5
10
15
11.52 11.52
0
0.2
0.4
0.6
0.8
1
1.2
4.955.15.25.35.45.5
0
0.2
0.4
0.6
0.8
1
1.2
4.955.15.25.35.45.5 4.955.15.25.35.45.5
E
DC
BA
F
succinate
2.50 ddd
fumarate
bile acids
raffinose
methanol
choline
taurine
 
Figure 120 Spectral areas of (A) succinate δ 2.41 (s), (B) fumarate δ 6.52 (s), (C) unknown δ 2.50 (dd), 
(D) taurine δ 3.27 (t), methanol δ 3.36 (s), and choline δ 3.20 (s), (E) bile region δ 0.5 – 2.50, and (F) 
raffinose δ 5.00 (m), 5.44 (m). Black – ileum, blue – colon, green – caecum, red – faeces. Upper three 
spectral area are of lean animals (#2, 12, 14) and lower three spectra of ob/ob animals (#1, 3, 4).    
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The dietary composition of the (autoclaved) mouse chow (Zeigler Lab animal, 
Gardner, PA, USA) is shown here (Figure 121), to confirm the presence of choline, 
raffinose (in wheat) and lignin in the diet.  
 
 
Figure 121 Overview of ingredients of mouse chow. 
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Oral communication 
 
Joint Conference – 50th CVD Epidemiology and Prevention & Nutrition, Physical 
Activity and Metabolism 2010, San Francisco, USA 
 
Urinary Biomarker Proline Betaine Predicts Citrus Intake and is Associated with 
‘Healthy’ Dietary Pattern: A Metabolic Phenotype Approach to Biomarker Discovery 
 
Silke Heinzmann, Ian J. Brown, Queenie Chan, Elaine Holmes, Paul Elliott, Jeremy K. 
Nicholson, Imperial College London, United Kingdom; Jeremiah Stamler, 
Northwestern University, Chicago, IL; Sunil Kochar, Nestlé Research Center, 
Lausanne, Switzerland 
 
Background: Robust biomarkers provide objective assessment of dietary intakes in 
population studies, but few food-specific biomarkers have been identified. Here, we 
outline discovery by nuclear magnetic resonance (NMR) spectroscopy of a novel 
urinary biomarker for dietary citrus intake, and assess its potential as an indicator of a 
healthy eating pattern. 
Methods: Eight people were fed a high carbohydrate-low fat diet for 4 days, 
supplemented by a fruit mixture containing 2 citrus fruits (day 2), and a fish meal (day 
3). Spot urine samples were collected four times a day; potential biomarkers were 
identified by high resolution 1H NMR spectroscopy and pattern recognition. A 
confirmation study was conducted: 6 volunteers consumed 250ml orange juice; spot 
urine samples were collected 24hr prior (5 time points) and 24hr post consumption (6 
time points). We validated the putative biomarker by comparing concentrations in 
timed 24-hr urine collections with citrus fruit consumption determined by 
standardized multipass 24-hr dietary recall in UK participants of the INTERMAP study. 
Individuals were divided into a training set (N=220) to build the model, and a test set 
(N=279) for final validation. ROC curves were generated in the training set to 
determine the biomarker concentration indicative of citrus consumption. Biomarker 
concentrations were estimated for two 24-hour urine collections from 2646 UK and 
USA INTERMAP participants; mean nutrient intakes were compared for predicted 
citrus consumers and non-consumers.  
 
Results: Proline betaine (PB) was identified as a putative biomarker for citrus fruit 
consumption by 1H NMR spectroscopy. PB excretion occurred within 14 hrs and 
followed a first-order excretion profile. Sensitivity/specificity of citrus consumption 
prediction were 82.1/92.8%. Comparison of mean nutrient intakes of predicted citrus 
consumers (N=1246) and non-consumers (N=775) revealed that predicted citrus 
consumers consumed more carbohydrate (49.0 vs. 45.7% kcal), vegetable protein (5.8 
vs. 5.4% kcal); and less fat (30.9 vs. 34.1% kcal), animal protein (9.7 vs. 10.2% kcal) (all 
P<0.0001) than non-consumers. Fiber, most vitamins (e.g., vitamin C 33.1 vs. 72.2 
mg/1000kcal, P<0.0001), and mineral intakes were higher in predicted citrus 
consumers.  
 265 
Conclusions: Urinary PB concentration successfully predicts citrus intake in our test 
population, and is associated with a healthy eating pattern. This biomarker is 
particularly useful for assessing the vitamin C status, whereas serum vitamin C has 
shown to be a moderate biomarker for predicting fruit intake and vitamin C intake. 
With further development, an inexpensive dipstick test for PB could be used as a 
validation tool for large-scale dietary surveys, or as an indicator of citrus intake where 
dietary survey is unfeasible. Identification of PB as a biomarker for citrus intake 
demonstrates the potential of NMR and pattern recognition for future biomarker 
discovery. 
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Metabonomics in Personalised Nutrition: Inter-individual and food-related 
differences in human metabolic phenotypes 
 
Silke Heinzmann, Elaine Holmes and Jeremy K. Nicholson 
 
Department of Biomolecular Medicine, SAF Building, Imperial College London, SW7 2AZ, 
UK 
 
Introduction: A novel analytical approach has been developed using metabonomics, 
a metabolism-driven top-down systems biology approach (Nicholson, 2006), to 
select metabolite pattern that characterise individuals (i.e. a personal metabolic 
phenotype) and to enable systematic detection of metabolite excretion associated 
with particular foods from nutritional studies. Nutritional research aims to generate 
personalised lifestyle recommendations to improve health (Fay & German, 2008). It 
is therefore necessary to characterise the metabotype of individuals and to establish 
the extent to which we can influence this phenotype by nutritional intervention.  
Methods: A nutrition study was undertaken with six individuals following a strict diet 
plan over six consecutive days. Participants consumed a standard breakfast and lunch 
each day with the evening meal being varied systematically on four of the six days. 
Urine was collected at least four times a day throughout the study period. 1H NMR 
spectroscopy was performed on each sample to generate metabolite profiles. 
Multivariate statistical analysis, including principal component analysis (PCA) and 
orthogonal projection to latent structures discriminant analysis (O-PLS-DA) were 
applied to elucidate distinct patterns for inter-individual and food-related differences 
in the metabolite profiles.  
Results: Intra-individual differences in the metabolite profiles were observed and 
distinct metabolic differences, composed of individual variation in the response to 
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food ingestion and variation independent from immediate food ingestion. Both 
quantitative and qualitative differences in the levels and/or presence of metabolites 
were observed.  Also, for each specific dietary intervention a set of metabolites (i.e. 
increased excretion of trimethylamine-N-oxide, creatine, 3-methylhistidine, carnitine 
and choline after fish consumption), shared across the individuals, were assigned by 
PCA and O-PLS-DA.  
Conclusion: The strategy developed is suitable for defining a human metabolite 
fingerprint. The study design excluded confounding of individual dietary habits and is 
compatible with development of further complementary statistical models to obtain 
a more complete set of metabolites describing individual differences characteristic of 
each person’s metabolism and may be used to probe person-specific responses to 
dietary challenges. These findings support the hypothesis that each person has a 
different metabolic basis and starting point for dietary and drug intervention, 
indicating the importance of defining individual metabolite phenotypes for future 
personalised health care.  
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Obesity-related metabolic and gut microbial differences in humans: Linking 
metabolic phenotyping and metagenomics 
 
Silke Heinzmann, Francesca Fava, Alison Waldram, Kieran M. Tuohy, Glenn R. Gibson 
and Jeremy K. Nicholson 
 
Obesity exacerbates many health problems such as type 2 diabetes, coronary heart 
disease and osteoarthritis and hence it is of great importance to understand the 
mechanisms and aetiology of this predisease condition. Recent studies have 
highlighted the contribution of the gut microbiota to caloric availability and 
investigation of interactions between gut microbiota and metabolite profiles 
promises to extend our understanding in this field.   
To characterize the impact of obesity on gut microbiota and overall health we 
correlated biofluid metabolic profiles generated by 1H NMR spectroscopy and 
metagenomic analysis of the gut microbiota (bacterial enumeration via 16S rRNA 
targeted oligonucleotide probes and fluorescent in situ hybridization (FISH) and 
microbiota profiling using denaturing gradient gel electrophoresis of community 16S 
rRNA gene fragments (DGGE)) combined with advanced multivariate analysis. For 
this approach, fasting blood samples, 24hr urine samples and faeces samples of 13 
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lean (BMI < 25 kg/cm2) and 13 obese people on an open diet and 13 obese people (BMI 
> 30 kg/cm2) on a high-fat diet were collected. High resolution 1H NMR spectroscopy 
was performed and differences in urine, plasma and faecal water metabolite profiles 
elucidated by using pattern recognition techniques. Faecal samples were used to 
assess the diversity of faecal bacterial species through DGGE and to quantify 
dominant faecal microbial populations using FISH.  
We observed distinct differences in the metabolic phenotypes and identified 
differentiative metabolites including urinary hippurate, trigonelline, formate and 
faecal butyrate of host-microbiota co-metabolic origin. Combined transgenomic 
analysis of biofluids and microbiota composition showed clear distinction between 
lean and obese, and between obese individuals on a high fat diet relative to the other 
two groups indicating an underlying relationship between the obese state, diet and 
gut bacteria. This preliminary analysis unveiled promising insight in the contribution 
of gut bacteria on human metabolism and provides the opportunity to perform 
targeted probiotics interventions to improve gut health.  
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Introduction: A novel analytical approach has been developed combining 
metabonomics, a metabolism-driven top-down systems biology approach 
(Nicholson, 2006) and targeted profiling in intervention studies and free-living 
populations to identify and validate a new biomarker, highly specific to citrus fruit 
intake. Robust biomarkers are required to provide objective assessment of dietary 
intakes in population studies (Jenab et al., 2009). Relatively few food specific 
biomarkers have been identified (SA Bingham, 2002) which makes it necessary to 
include food questionnaires in population studies. The here shown approach is 
applicable to other foods and can in future serve as an alternative way to monitor 
food intake.  
Methods: A nutrition study was undertaken with 8 volunteers following a strict diet 
and specific meals (fruit salad, fish meal) were introduced subsequently. Urine 
collection was done over time to monitor metabolite excretion. 1H NMR 
spectroscopy and multivariate analysis was performed on urine samples to extract 
metabolic phenotypes related to food challenges. Putative biomarkers were then 
validated in a large free-living cohort (INTERMAP, Holmes and Loo et al., 2008), 
dividing the cohort in a training set (n=220) to optimise the model and a test set 
(n=279).  
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Results: We identified novel biomarker peaks for citrus fruit consumption using 1H 
NMR spectroscopy. The frequent collection over time of urine samples enabled 
investigation of excretion kinetics of the putative biomarker. Absolute quantification 
of relevant metabolites of several foods revealed the uniqueness of the elucidated 
compounds to the ingested foods. Specificity and sensitivity were then assessed in 
comparison with 24-hour dietary recall data collected in the INTERMAP UK samples. 
Specificity and sensitivity were 92.8% and 82.1% respectively.  
Conclusion: We have identified a novel biomarker for citrus fruits intake coupled to a 
strategy for further biomarker discoveries. This modelling approach can be applied to 
other putative biomarkers and may have application to large-scale epidemiological 
studies to validate dietary information from questionnaires and interviews. Such a 
nutrimetabonomics approach and the biomarker identified will help to analyse 
individual diets towards healthy food consumption and will aid personalized profiling 
in order to promote healthy lifestyle and longevity. 
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Human metabolite profiles contain a wealth of information and are influenced by 
various factors such as gender, age, BMI or genetic background. Diet is another 
important factor, and long-term dietary habits as well as short-term excretion of food 
components alter the metabolic phenotype. We show here that metabonomics, a 
metabolism-driven top-down systems biology approach, is a useful tool to 
systematically detect metabolites that are potential biomarkers for food intake.  
 
Methods: Eight people were fed a standardised diet over 7 days and additional food 
challenges were introduced (fruit mix, fish, beef, wine and grapes). Spot urine 
samples were collected four times a day. 1H NMR spectroscopy and multivariate 
analysis was performed on urine samples to decipher the effect of these food 
challenges. Identified metabolites were plotted over time to investigate kinetics and 
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inter-individual variation. Finally, the origin of potential biomarkers was investigated 
by MAS 1H NMR spectroscopy of all ingested foods.  
 
Results: A set of metabolites was elucidated for each food challenge and metabolites 
were consistent for all individuals. The origin of each metabolite could be linked to a 
specific food component, such as excretion of tartrate after grape consumption. 
While several excreted metabolites were not/minimally metabolised (i.e. tartrate 
from grapes and trimethylamine-N-oxide from fish), human and/or gut microbiota 
metabolism was involved to excrete i.e. hippurate from fruits and trimethylamine-N-
oxide from beef.  
 
Conclusion: We were able to assign metabolite excretion patterns to the tested 
foods. To establish the here shown metabolites as food biomarkers, it is necessary to 
carry out a validation process in a free-living population.  
 
 
 
 
 
 
 
 
 
 
 
